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Abstract
Integral and peripheral membrane proteins account for one-third of the human proteome,
and they are estimated to represent the target for over 50% of modern medicinal drugs. Despite
their central role in medicine, the complex, heterogeneous and dynamic nature of biological
membranes complicates the investigation of their mechanism of action by both experimental
and computational techniques. Among the different membrane bound compartments in
eukaryotic cells, mitochondria are highly complex in form and function, and they harbor a
unique proteome that remains largely unexplored. A growing number of inherited metabolic
diseases are associated with mitochondrial dysfunction, which necessitates the structural and
functional elucidation of mitochondrial proteins. In this thesis, we combine experimental
and computational methods to explore the activity of COQ8 and COQ9, two functionally
elusive proteins of the biosynthetic complex that produces coenzyme Q, a redox-active lipid
component of the mitochondrial electron transport chain.
(i) Conserved Lipid Modulation of Ancient Kinase-Like UbiB Family Member COQ8.
We demonstrate that COQ8 has an ATPase function that is activated when it specifically
associates with cardiolipin-containing membranes. We identify its interaction surface with
the inner mitochondrial membrane, which gives hints about the possible interaction surfaces
with other members of the coenzyme Q synthesis machinery and has implications on how it
mediates functional interactions with lipids. Collectively, this work reveals how the positioning
of COQ8 on the inner mitochondrial membrane is key to its activation, and therefore advances
our understanding of the COQ8 function.
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(ii) Membrane, Lipid, and Protein Interactions of Coenzyme Q Biosynthesis Protein COQ9.
We explore the lipid binding activity of COQ9, and we reveal that COQ9 repurposes an ancient
bacterial fold to selectively bind aromatic isoprenes, including CoQ intermediates that reside
within the bilayer. We elucidate the mechanistic details of its membrane binding process, by
which COQ9 warps the membrane surface and creates a tightly sealed hydrophobic region
to access its lipid cargo. Finally, we establish a potential molecular interface between COQ9
and COQ7, the enzyme that catalyzes the penultimate step in CoQ biosynthesis, suggesting a
model whereby COQ9 presents intermediates to CoQ enzymes to overcome the hydrophobic
barrier of the membrane. Collectively, our results provide a mechanism for how a lipid binding
protein might access, select, and extract specific cargo from a membrane and present it to a
peripheral membrane enzyme.
In conclusion, our work is a good illustration of the interplay between experiment and model-
ing in protein research and specifically in understanding how proteins perform their action
in direct synergy with membrane environments. We anticipate our integrative methodolo-
gies and mechanistic findings will prove relevant to other membrane proteins, whose fine
functional modulation at the membrane-water interface has been historically challenging to
characterize.
Keywords: membrane proteins, biological membranes, molecular modeling, molecular dy-
namics simulations, coenzyme Q biosynthesis, cardiolipins.
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Résumé
Les protéines membranaires intégrales et périphériques représentent un tiers du protéome
humain et on estime qu’ils représentent la cible de plus de 50% des médicaments modernes.
Malgré leur rôle central en médecine, la nature complexe, hétérogène et dynamique des
membranes biologiques complique l’étude de leur mécanisme d’action par des techniques
expérimentales et informatiques. Parmi les différents compartiments liés aux membranes
dans les cellules eucaryotes, les mitochondries ont une forme et une fonction très complexes
et abritent un protéome unique qui reste largement inexploré. Un nombre croissant de mala-
dies métaboliques héréditaires sont associées à un dysfonctionnement mitochondrial, ce qui
nécessite une élucidation structurelle et fonctionnelle des protéines mitochondriales. Dans
cette thèse, nous combinons des méthodes expérimentales et informatiques pour explorer
l’activité de COQ8 et de COQ9, deux protéines fonctionnellement énigmatiques du complexe
biosynthétique qui produit la coenzyme Q, un composant lipidique rédox-actif de la chaîne
de transport d’électrons mitochondriale.
(i) Modulation lipidique conservée de COQ8, le membre d’une ancienne famille UbiB kinase-
like.
Nous démontrons que COQ8 possède une fonction ATPase activée par association spécifique
à des membranes contenant de la cardiolipine. Nous identifions sa surface d’interaction avec
la membrane mitochondriale interne, indiquant sur les surfaces d’interaction possibles avec
d’autres membres du mécanisme de synthèse de la coenzyme Q et a des implications sur la
façon dont elle médie les interactions fonctionnelles avec les lipides. Ensemble, ce travail
révèle que le positionnement de la COQ8 sur la membrane mitochondriale interne est la clé
de son activation et permet ainsi de mieux comprendre la fonction de la COQ8.
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Résumé
(ii) Interactions membranaires, lipidiques et protéiques de COQ9.
Nous explorons l’activité de liaison des lipides de COQ9 et nous révélons que COQ9 réutilise
un ancien pli bactérien pour lier sélectivement les isoprènes aromatiques, y compris les inter-
médiaires de CoQ qui résident dans la bicouche. Nous élucidons les détails mécanistiques de
son processus de liaison membranaire, par lequel COQ9 déforme la surface de la membrane et
crée une région hydrophobe étroitement scellée pour accéder à sa cargaison lipidique. Enfin,
nous établissons une interface moléculaire potentielle entre COQ9 et COQ7, l’enzyme qui
catalyse l’avant-dernière étape de la biosynthèse de CoQ, suggérant un modèle dans lequel
COQ9 présente des intermédiaires aux enzymes CoQ pour surmonter la barrière hydrophobe
de la membrane. Ensemble, nos résultats mettent en évidence un mécanisme expliquant com-
ment une protéine ancrée à un lipide pourrait accéder, sélectionner et extraire une cargaison
spécifique d’une membrane et de la présenter à une enzyme membranaire périphérique.
En conclusion, cette thèse illustre bien l’interaction entre l’expérience et la modélisation
dans la recherche sur les protéines et permet en particulier de comprendre comment les
protéines exercent leur action en synergie directe avec les environnements membranaires.
Nous sommes certains que nos méthodologies intégratives et nos découvertes mécanistiques
pourront s’appliquer à d’autres protéines membranaires, dont la modulation fonctionnelle
fine à l’interface entre le milieu aqueux et la membrane a toujours été difficile à caractériser.
Mots clés : protéines membranaires, membrane biologique, modélisation, simulation de
dynamique moléculaire, biosynthèse du coenzyme Q, cardiolipines.
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1 Introduction
1.1 Biological Membranes and Membrane Proteins
Biological membranes act as a barrier delimiting the cell from its environment, and allow
subcellular compartmentalization to produce discrete organelles. They are composed of a
complex repertoire and a dynamic distribution of proteins, lipids and sugars.
Eukaryotic cells invest a significant amount of resources in synthesizing thousands of
different lipids.1 Lipids are amphipathic molecules that can be grouped into three categories:
(i) glycerolipids, (ii) sphingolipids, and (iii) sterols.
Glycerolipids are the most abundant membrane lipids,1 and they are composed of a hy-
1
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drophilic head group and hydrophobic tails. Due to this amphipathic character, lipids arrange
themselves into a sheet-like structure known as the lipid bilayer, which is composed of two
leaflets where polar head groups interact with the solvent and lipid tails form the hydrophobic
core. The diversity of glycerolipids arises from the head group substituent, the length of lipid
tails, and the number and position of unsaturations in the lipid tails. Phosphatidylcholine
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI) and
phosphatidic acid (PA) are lipids that belong to the glycerolipid class.
The second class of lipids, sphingolipids, have a general structure similar to that of
glycerolipids, except that they contain the fatty acid derivative sphingosine instead of glycerol.
They consist of different surface-exposed head groups, such as phosphorylcholine (sphin-
gomyelin) or carbohydrates (glycosphingolipids). Sphingolipids are particularly abundant in
nerve cells and brain tissues.2
The plasma membrane has the highest abundance of sterols, and the highest sterol
to phospholipid ratio. Cholesterol is the major sterol found in plasma membranes of higher
eukaryotes, while ergosterol is the major sterol component present in lower eukaryotes.3
While the width of biological membranes is about 4 nm considering the lipid bi-
layer only, extra constituents protruding the membrane (membrane-associated proteins,
lipopolysaccharides) can increase the overall membrane width to 10 nm. Membrane-associated
proteins represent about 30% of the whole human genome,4 and more than 50% of the targets
of all drugs.5 Based on their mode of interaction with the membrane, membrane proteins
can be classified into two categories: integral and peripheral membrane proteins (Figure 1.1).
While lipids ensure permeability for the lipid bilayer, integral membrane proteins typically
enable signal transduction and molecular transport. Integral membrane proteins contain hy-
drophilic regions exposed to the solvent on both sides of the bilayer, and one or more segments
embedded into the hydrophobic core of the membrane, typically spanning the entire bilayer
(Figure 1.1). These transmembrane domains can be composed of one or more α-helices, or
multiple β-strands. On the other hand, peripheral membrane proteins are soluble in wa-
ter and they do not fully penetrate the hydrophobic core of the membrane. They associate
reversibly with the membrane through electrostatic/hydrophobic interactions with lipids,
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covalently bound fatty acids (lipidation), or through interacting with other membrane-bound
proteins (Figure 1.1). The interaction of peripheral membrane proteins with the membrane is
highly influenced by the membrane lipid composition.6 They are known to have key roles in
non-vesicular lipid transportation, cell signaling, and detecting lipid packing defects.6, 7
Peripheral Membrane 
Proteins
Integral Membrane 
Proteins
Post-Translationally  
Modified Peripheral  
Membrane Proteins
Figure 1.1 – Protein-Membrane Interaction Modes.
1.2 The Mitochondrial Membrane
As a main source of ATP in eukaryotes, the mitochondria are separated from the cytoplasm
by two specialized membranes called the outer and inner mitochondrial membrane. The
outer membrane has a smooth and unfolded structure, while the inner membrane, encircled
by the outer membrane, has a folded structure, with a large number of inward projections
called cristae. The cristae protrude into the matrix, and increase the surface area of the
inner membrane, which in turn increases the room for respiratory chain complexes and ATP
3
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synthase.8 The two membranes are separated by a 10 nm wide intermembrane space,9 which
resembles the cytosol and contains enzymes that catalyze the interconversion of adenine
nucleotides.
The outer and inner mitochondrial membranes differ in lipid composition. The outer
membrane is characterized by a high lipid to protein ratio and has a higher permeability than
the inner membrane.10 While the outer membrane is rich in sterols, the inner membrane
contains a high percentage of the unusual lipid, cardiolipin. Cardiolipin is a unique anionic
glycerophospholipid that has a dimeric structure. It contains four lipid tails and can carry up
to two negative charges, one per phosphate group. It is the hallmark lipid of the mitochondrial
inner membrane, where it contributes up to 20% of total lipids.11 Due to its chemical structure
with one head group and four acyl chains, cardiolipins adopt a cone-shaped structure and
lead to a negative membrane curvature. Cardiolipins are shown to form microdomains,11 and
they also play an essential role in the stability of protein supercomplexes.12, 13
Figure 1.2 – Chemical structure of glycerolipids. Phosphatidylcholine (PC) and phos-
phatidylethanolamine (PE) are neutral lipids that have two lipid tails, whereas cardiolipin is a negatively
charged lipid with four lipid tails. Cardiolipin is the signature lipid of mitochondria.
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1.3 Coenzyme Q Biosynthesis
Coenzyme Q (ubiquinone, Q, or CoQ), is a lipid that participates in aerobic cellular respira-
tion to produce ATP within the mitochondria in eukaryotes and the plasma membrane in
prokaryotes. CoQ exists in both reduced and oxidized states and the conversion between these
states allows it to transfer electrons to substrates and act as a cofactor of enzymatic reactions,
including those of the mitochondrial electron transport chain. The quinone head group of
CoQ allows it to function as an electron-carrier, while the highly hydrophobic isoprene tail
helps to confine it to lipid-rich areas of cells (Figure 1.3). The extraordinarily long hydrophobic
tail makes CoQ one of the most hydrophobic molecules in nature.
Figure 1.3 – Coenzyme Q Chemical Structure, and the CoQ-Synthome. The chemical structure of
coenzyme Q10 (CoQ10) includes a redox-active head group (which allows it to function as a cofactor
in the mitochondrial electron transport chain), and a hydrophobic polyisoprenoid lipid tail (which
is made of up a varying number of isoprene subunits in different organisms). Proteins crucial for
the biosynthesis of CoQ are known to form a biosynthetic complex on the matrix side of the inner
mitochondrial membrane. This "metabolon" is termed complex Q, or the CoQ-synthome.
Genetic and physical evidence indicates that COQ gene products are interdependent,
and that CoQ biosynthesis requires a multi-subunit complex of the COQ-encoded enzymes,14
termed the "complex Q", or the "CoQ-synthome" (Figure 1.3). In eukaryotes, the biosynthesis
of CoQ requires the collective action of COQ proteins COQ1-9, and mutations of these pro-
teins can lead to CoQ deficiency, which is further linked to cerebellar ataxia, kidney disease,
5
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isolated myopathy, and childhood-onset multisystemic disorders.15 These diseases affect
multiple organ systems, but primarily the heart, the brain, kidneys and skeletal muscles, i.e.
locations where mitochondrial oxidative phosphorylation is needed the most.16 The complex
mechanisms leading to these diseases remain largely unknown because of various gaps in our
understanding of CoQ biochemistry.
CoQ is synthesized in all cells and in organisms across all domains of life. Most eukary-
otic CoQ is known to be generated at the inner mitochondrial membrane, even though it can
also be produced outside of mitochondria.16 The biosynthesis of CoQ involves (i) head group
production, (ii) polyisoprenoid tail production, (iii) attachment of the tail to the head group,
and (iv) successive steps of head group modifications (Figure 1.4). CoQ intermediates become
increasingly hydrophobic throughout the course of the pathway. CoQ and its intermediates are
predicted to diffuse laterally in the hydrophobic core of the phospholipid bilayer, where they
can move toward the bilayer surface, but not past the glycerol backbones.17 It is unclear how
peripheral membrane enzymes gain access to hydrophobic CoQ intermediates to perform
head group modifications.16
Currently, X-ray structures of three COQ proteins have been reported:
- Yeast Coq5p (apo (PBD: 4OBX) and S-adenosyl methionine (SAM)-bound (PBD: 4OBW)),18
- Human COQ8 (apo (PBD: 4PED)19 and ATP analog-bound (PBD: 5I35)20),
- Human COQ9 (apo (PDBs: 4RHP15 and 6AWL21) and isoprene-bound (PDB: 6DEW)21).
COQ4, COQ8, and COQ9 are proteins that have no clear catalytic role in the CoQ
biosynthesis pathway, even though they are known to be crucial for the biosynthesis. This
thesis focuses on two of these functionally uncharacterized proteins, COQ8 and COQ9, and
aims to shed light on the role of these proteins in CoQ biosynthesis.
1.4 The Importance of Molecular Modeling and Simulations
Despite their remarkable role in biology and pharmacology, only 3% of the Protein Data
Bank entries refer to membrane proteins. This is mainly due to their hydrophobicity, high
flexibility, and lack of stability, which make it extremely challenging to treat these proteins by
means of techniques such as X-ray crystallography, NMR or cryo-EM. In this sense, the rise of
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Figure 1.4 – Eukaryotic CoQ Biosynthesis. Head group modifications of eukaryotic CoQ biosynthesis
post-attachment of the polyprenyl tail (R) where S. cerevisiae (Coq#p) and H. sapiens (COQ#) protein
names are shown. PPHB, polyprenyl-hydroxybenzoate; PPAB, polyprenyl-aminobenzoate; PPDHB,
polyprenyl-dihydroxybenzoate; PPVA, polyprenyl-vanillic acid; DDMQ, demethoxy-demethyl CoQ;
DMQ, demethoxy CoQ; DMeQ, demethyl CoQ; CoQH2, reduced CoQ.
computational tools allows to complete and further analyze structural aspects of membrane
proteins that are generally not accessible experimentally.
As membrane biology is surging as a fundamental field of research to understand the
processes involved in cellular function, the role played by lipids in the modulation of the
function of peripheral and integral membrane proteins is nowadays recognized as crucial.
A reflection of this fact is found in the recent advances in techniques (e.g., mass spectrom-
etry, lipid-overlay and lipid pull-down assays, liposome microarray-based assays, affinity-
purification lipidomics, cryo-EM of membrane proteins) that aim at providing a more faithful
characterization of membranes and membrane-protein interactions. As a result, we now
have a better classification of the lipidome repertoire that counts today more than 40,000
different lipid species; however, little is still known about their functional role, and even less
about their subtle interplay with membrane proteins. As these experimental advances are
rapidly changing our classical understanding of biological membranes, it still remains a major
challenge to acquire high-resolution molecular data for membranes and specific lipid-protein
interactions. Additionally, a growing number of lipid-related proteins are associated with
newly identified disease-related genes, which calls for a functional elucidation in order to
improve diagnostics and develop new therapeutic interventions. In this context, optimally
positioned at the crossroads of chemistry, biology, physics and life sciences, computational
modeling and molecular simulations are powerful (and possibly the only) tools able to inte-
grate the outcomes of these developing techniques, providing a molecular and mechanistic
picture of the membrane-protein interplay. In summary, at the dawn of the lipidomics era, it
7
Chapter 1. Introduction
is absolutely required to combine experimental studies with molecular models that mimic as
close as possible the physiological state of biological membranes.
Recent developments on the computational front include a number of tools that allow
the precise multiscale modeling of the membrane. In particular, tools like CHARMM-GUI22
and LipidBuilder23 enable the accurate generation of lipid bilayer geometries and the fine-
tuning of the lipid composition by altering both the head type and the hydrophobic tail.
Moreover, a growing number of validated parameters for lipids in different force fields, both
at the coarse-grained (MARTINI24) and the atomistic level (AMBER,25 CHARMM26) allow the
investigation of membranes and associated membrane proteins at an extremely precise level
of detail, spanning time scales that go from nanoseconds to milliseconds, and length scales
up to micrometers. The rise of these tools requires a deep rationalization about their potential
and limitations in complementing both the traditional and the most innovative experimental
techniques that are being used nowadays in the field of membrane proteins.
1.5 Objectives of the Thesis
The integration of molecular modeling and simulations with structural and biochemical data
represents an effective approach for studying the mechanism and function of proteins in their
biological environments. This thesis combines computational and experimental techniques
to characterize two poorly understood members of the CoQ biosynthesis pathway.
(1) Conserved Lipid Modulation of Ancient Kinase-Like UbiB Family Member COQ8.
COQ8 is a member of the protein kinase-like UbiB superfamily, which includes protein
and lipid kinases, and ATPases. Even though COQ8 was initially thought to act as a protein
kinase, its structural characterization has revealed features that inhibit protein kinase activity.
As COQ8 is known to be localized to the inner mitochondrial membrane, in this thesis, we used
coarse-grained molecular dynamics simulations to explore the protein-membrane interaction
of COQ8 and the inner mitochondrial membrane. We then used biochemical experiments to
validate our computational findings and to further understand how this interplay enhances
CoQ biosynthesis. We demonstrate that COQ8 has an ATPase function that is enhanced when it
specifically associates with cardiolipin-containing membranes, and we reveal that a conserved
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domain on COQ8 drives the membrane association electrostatically.
(2) Membrane, Lipid, and Protein Interactions of Coenzyme Q Biosynthesis Protein
COQ9.
The structural characterization of COQ9 has revealed structural similarity to the bacte-
rial TetR family of transcriptional regulators, and the presence of a lipid-binding pocket. In
addition, COQ9 physically and functionally interacts with COQ7, the enzyme that catalyzes
the penultimate step in CoQ biosynthesis. Nevertheless, which lipid(s) COQ9 binds, how it
accesses these lipid ligands, and how this lipid binding functionality might assist other CoQ
pathway enzymes have remained unanswered. In this thesis, we explore the membrane, lipid,
and protein binding activity of COQ9 through combined computational and experimental
studies. We report the stepwise mechanism for its membrane binding process, and we de-
scribe a potential molecular interface between COQ9 and COQ7, suggesting a model whereby
COQ9 acts as a lipid presenter to overcome the hydrophobic barrier of the membrane.
This thesis is organized as follows. First, computational techniques and concepts used
in this work will be detailed (Chapter 2). Next, results of molecular modeling and simulation
techniques revealing the membrane interaction of COQ8 will be described, and the experimen-
tal work performed by our experimental collaborators to confirm our results will be presented
(Chapter 3). As a continuation of this project, computational and experimental results for
the functional elucidation of COQ9 will be presented (Chapter 4). For both of these projects,
computational methods performed in our lab will be detailed in the Methods sections of
these Chapters, while experimental methods used by our experimental collaborators will be
presented in the respective Supplementary Information sections. Finally, conclusions and
perspectives of these studies will be presented (Chapter 5). A study related to the computa-
tional methods described in this thesis will be presented in the Appendix, which focuses on
the development of a new optimization method for ligand docking that uses pharmacophoric
probes as constraints.
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2 Molecular Modeling and Simulation
Methods
2.1 Modeling Biomolecular Interactions with Molecular Mechanics
Molecular mechanics calculations use a force field that describes the potential energy of the
system through the sum of molecular interactions as a function of atomic positions. This
approximation decreases the computational cost of simulating large and complex biological
systems, while providing a good level of accuracy. Force field parameters are obtained from
experimental or theoretical data. An important feature of force field parameters is that they
should be transferable; in other words, a set of parameters developed and tested for a particular
atom or group of atoms should be valid for the same atom/group of atoms in a different
molecule.
Considering a system composed of N particles where atoms are described as spheres
connected by springs, the interactions are defined as a potential energy, U , which can be
defined as the sum of bonded and non-bonded interactions:
Utot al =Ubonded +Unon−bonded (2.1)
The minima of Utot al represent stable conformations, while conformational transitions can
be described through moving along the potential energy landscape.
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Figure 2.1 – Bonded and Non-Bonded Interactions in Molecular Mechanics. Bond stretching, angle
bending, and proper and improper bond torsions add up to form the bonded interactions, while
electrostatic and van der Waals interactions add up to form the non-bonded interactions.
2.1.1 Bonded Interactions
The bonded potential, Ubonded , describes the intramolecular interactions, and includes four
contributions: bond stretching (2-body), bond angle (3-body), and torsional angle (4-body)
interactions. A special type of torsional interaction (called improper torsion) is mainly used to
maintain planarity in molecular structures (Figure 2.1). Ubonded can therefore be expressed
as:
Ubonded =Ubond +Uang l e +Utor si on +Ui mpr oper (2.2)
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Bond stretching
The first term of the bonded potential, Ubond , represents the energy associated with the bond
stretching between two covalently bonded atoms (Figure 2.1). The most common potential
used in molecular dynamics programs is the harmonic bond potential, expressed as:
Ubond =
∑
bond s
kr (r − req )2 (2.3)
where kr is the force constant, r is the distance between two covalently bonded atoms, and
req is the equilibrium (reference) bond length. Since there are several force field components,
the bond will deviate slighly from this reference value to be able to compensate for other
contributers to the total potential energy.
Angle bending
The second term of the bonded potential, Uang l e , represents the energy associated with the
distortion of an angle between three consecutive atoms (Figure 2.1). Since forces between
bonded atoms are very strong, the energy required for stretching or compressing a bond from
equilibrium is high. Distorting an angle away from equilibrium requires less energy; therefore
force constants for angle bending are proportionately smaller. As with Ubond , Uang l e is also
described using a harmonic potential:
Uang l e =
∑
ang l es
kθ(θ−θeq )2 (2.4)
where kθ is the force constant, θ is the angle between three consecutive atoms, and θeq is the
equilibrium angle.
Torsional angles
The third term of the bonded potential, Utor si on , concerns four consecutive atoms, and is
divided into two types: proper and improper torsion potentials (Figure 2.1). The proper torsion
potential is used to constrain rotations around a bond, and are modelled using a form of a
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cosine series:
Utor si on =
∑
tor si ons
kφ[1+ cos(nφ−φeq )] (2.5)
where kφ is the force constant, φ is the torsional angle between four consecutive atoms, and
φeq is the phase factor, or the equilibrium torsional angle (the angle where the potential passes
through its minimum value). n is the periodicity of the torsional potential that determines the
number of minima in the torsional potential.
Improper torsional angles
The last term of the bonded potential, Ui mpr oper , is commonly considered as an additional
term in the force field to maintain stereochemistry at chiral centers and more generally, to
maintain the planarity of molecules, such as the aromatic rings. The improper torsional angle
can be modelled using a harmonic potential since it would have one minimum to maintain
planarity:
Ui mpr oper =
∑
i mpr oper s
kω(ω−ωeq )2 (2.6)
where kω is the force constant, ω is the torsional angle between four consecutive atoms, and
ωeq is the reference torsional angle.
2.1.2 Non-Bonded Interactions
In addition to the bonded interactions between atoms, force fields also consider non-bonded
interactions, which act both between independent molecules, and between atoms in the same
molecule. Non-bonded interactions are generally the sum of two contributions: van der Waals
interactions and electrostatic interactions.
Unon−bonded =UvdW +UCoul omb (2.7)
Van derWaals interactions
The first term of the non-bonded potential, UvdW , describes the attractive and repulsive
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interactions between non-bonded atoms. It is commonly expressed as the Lennard-Jones
potential:
UvdW =
∑
pai r s
4²i j
[(
σi j
ri j
)12
−
(
σi j
ri j
)6]
(2.8)
where ²i j is the potential well depth, σi j is the collision diameter (the distance where the
Lennard-Jones potential is zero), and ri j is the distance between two atoms i and j .
At short distances, the atomic repulsive forces lead to large positive values of UvdW ,
converging to infinity as the distance approaches zero. At longer distances, the attractive
London dispersion forces lead to small negative values that converge to zero as the distance
approaches infinity. Since van der Waals interactions are short-ranged, a cutoff and a switching
distance are defined in order to decrease the computational cost in molecular dynamics
simulations. Beyond the cutoff distance, van der Waals interactions are ignored. To guarantee
the continuity of the potential, a switching function is applied to UvdW at the switching
distance so that it equals to zero at the cutoff distance.
Electrostatic interactions
The second term of the non-bonded potential, UCoul omb , arises from the uneven distribution
of charge in molecules. The electrostatic interaction between two atoms, in the same molecule
or in different molecules, is generally modelled by a Coulomb potential:
UCoul omb =
∑
pai r s
qi q j
4pi²0ri j
(2.9)
where qi and q j are partial atomic charges of atoms i and j , ri j is the distance between the
two atoms, and ²0 is the electrical permittivity of vacuum.
Since electrostatic interactions are long-range interactions, the calculation of electro-
static contribution is the most computationally expensive part of the force field in molecular
dynamics simulations. Considering larger system sizes and the inclusion of explicit water
molecules, the calculation of all possible pairwise interactions would make simulations in-
feasible. One possible solution to this problem would be to truncate the forces at a defined a
cutoff distance. However, this method is known to introduce artifacts at and beyond the cutoff
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distance.27 The most common method used in overcoming the problem of computing these
long-range interactions is the Particle Mesh Ewald (PME) based on an Ewald summation.28 In
this method, the electrostatic potential within the cutoff distance is calculated in the real space,
whereas beyond the cutoff distance it is computed in the reciprocal space by extrapolating
charge positions on a grid through the fast Fourier transformation.
2.2 Molecular Dynamics Simulations
Molecular dynamics (MD) is a computational method where the dynamics of a number of
particles is simulated by the numerical integration of Newton’s equations of motion for discrete
timesteps δt on the femtosecond timescale, in order to obtain a trajectory of positions ri (t)
and velocities r˙i (t) (Equation 2.10). Each point in the phase space represents a unique set
of positions and velocities. Initial velocities are usually randomly assigned from a Maxwell
distribution for the desired temperature. Initial coordinates of proteins are taken from X-
ray/NMR/cryo-EM structures or computational models while setting up biological systems.
Given the initial set of conditions, the net force Fi (t ) acting on a particle is then calcu-
lated by summing up the forces that particles exert on each other. These forces arise from the
interaction of particles, and hence the changes in the potential energy as a function of the
separation distances of particles. Once the net force is calculated for each particle, its position
and velocities are updated for a small increment in time and the procedure is repeated. For
each particle i , this can be defined as:
ai (t )= r¨i (t )= d
2ri (t )
d t 2
= Fi (t )
mi
, where Fi (t )=−∂U (r)
∂ri (t )
(2.10)
where Fi (t ) is the force exerted on particle i , U (r) is the potential energy of the system, ri and
mi are the position and mass of the particle.
In MD, this numerical integration is performed using timesteps that are smaller than
the fastest characteristic vibration of the system under investigation. In atomistic biological
systems, the fastest motion corresponds to the covalent bond between a heavy atom and a
hydrogen, which is why the typical timesteps for classical atomistic MD are in the order of 1 fs.
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Coarse-grained representation of biological systems explained in Section 2.2.3 allows an in-
crease in the timestep, where timesteps of 15-30 fs can be used depending on the biomolecules
used in the system. This reduces the simulation wall-clock time and enables reaching higher
time and length scales. Coarse-graining also leads to the loss of degrees of freedom and there-
fore enables smoothening the free energy landscape and eliminating fine-scale free energy
barriers.
Several numerical integration algorithms have been developed for molecular dynamics
calculations, where the Verlet algorithm is the most widely used.29 Where the acceleration of a
particle i is defined as in Equation 2.10, the new position of the particle is obtained using a
Taylor expansion at time t+δt and t-δt:
ri (t +δt )= ri (t )+vi (t )+ 12 ai (t )δt 2
ri (t −δt )= ri (t )−vi (t )+ 12 ai (t )δt 2
(2.11)
Summing these two equations, we can obtain:
ri (t +δt )= 2ri (t )− ri (t −δt )+ai (t )δt 2 (2.12)
According to this equation, the Verlet algorithm uses the position and acceleration at time t ,
along with the position at time t −δt to compute the new position at time t +δt . The Verlet
algorithm does not use velocities; however, they can be computed if needed using:
vi (t )= ri (t +δt )− ri (t −δt )
2δt
(2.13)
MD simulations provide detailed information about the fluctuations and conforma-
tional changes of biomolecules, therefore allowing the investigation of structure, function
and dynamics of biological systems. MD simulations provide an accurate dynamic view of
molecular behavior, serving as a link between microscopic intermolecular interactions and
experimental macroscopic quantities. Nowadays, molecular dynamics simulation timescales
can reach micro/milliseconds, and system sizes can go up to tens of millions of atoms. It
has therefore become a prominent tool in biology, chemistry and physics, to generate new
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hypotheses that pave the way for new experiments, or to confirm existing hypotheses about
the structural and dynamic mechanisms of model systems.
2.2.1 The Ergodic Hypothesis
Classical statistical mechanics considers Hamiltonian systems (systems where the equations
of motion can be derived from a Hamiltonian principle), where the Hamiltonian, H , is equal
to the sum of kinetic and potential energies of a system, and therefore it is equal to the total
energy:
H =H(r,p)=K (p)+U (r) (2.14)
where r and p are respectively the position and the momentum of a particle, K (p) is the kinetic
energy, and U (r) is the potential energy.
In statistical mechanics, experimental observables are defined as ensemble averages:
< A >ensembl e=
Ï
dpN drN A(pN rN )ρ(pN rN ) (2.15)
where A(pN rN ) is the observable of interest expressed as a function of p and r (the momenta
and positions of the system), and ρ(pN rN ) is the probability density of the ensemble.
On the other side, in molecular dynamics, a physical quantity A is calculated as the
time average of A along the trajectory:
< A >t i me= lim
τ→∞
1
τ
∫ τ
t=0
A(pN (t ),rN (t ))d t ≈ 1
M
M∑
t=1
∫ τ
t=0
A(pN ,rN ) (2.16)
where τ is the total simulation time, M is the number of timesteps in the simulation.
The ergodic hypothesis states that the ensemble average equals to the time average:
< A >ensembl e = < A >t i me (2.17)
The ergodic hypothesis allows the calculation of thermodynamic properties from molec-
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ular dynamics simulations and it is therefore the basis of molecular dynamics. If one allows the
system to evolve in time indefinitely, the system will eventually pass through all states. Even
though molecular dynamics simulations cannot be infinitely long, it is important that one en-
sures to sample a sufficient amount of the phase space, taking into account the characteristic
timescale of the observable under investigation.
2.2.2 Periodic Boundary Conditions
MD simulations are typically performed on a system where the atoms are confined to a
simulation box of a specific size and shape. Since molecules found on the surface of the box
would experience different forces than the other molecules, MD simulations necessitate the
proper treatment of this surface effect. It is most common to use periodic boundary conditions
(PBC), where the simulation box is virtually replicated in all directions, which mimics the
presence of an infinite bulk surrounding the model system. In the course of the simulation,
when an atom leaves the simulation box at one side, an identical atom enters the box at the
same time on the opposite side with the same velocity. Particle Mesh Ewald (PME, previously
discussed in Section 2.1.2) requires the use of PBC and charge neutrality of the system in order
to accurately calculate the total Coulombic interaction.
PBCs do not completely eliminate the effects of using a finite simulation box. These
effects are especially pronounced when the system size is small. It is therefore necessary to
set up systems that are large enough in order to avoid the influence of PBC on diffusion and
dynamics. The simulation box has to be set large enough to avoid the molecule interacting
with its periodic image when using PBC, but sufficiently small not to be very computationally
demanding. For biological systems, a 12-15 Å water padding is commonly used when solvating
a protein.
2.2.3 Coarse-Grained Representation of Biomolecules
Coarse-graining of biomolecules is a popular method in molecular modeling that replaces
atomistic level detail with lower resolution coarse-grained (CG) representation. CG represen-
tation enables the exploration of biological processes on time and length scales inaccessible
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Figure 2.2 – Periodic Boundary Conditions.The particles and trajectories in the central simulation
box (blue) are replicated in all directions. When a particle leaves the box at one side (red), it is replaced
by an image particle that enters the box on the opposite side with the same velocity.
with an atomic level representation, such as protein-membrane interactions, and membrane
protein self-assembly and gating.30 Due to loss of atomistic degrees of freedom, larger integra-
tion timesteps, and faster sampling through a smoothened energy landscape, CG systems are
faster than atomistic ones by two to three orders of magnitude.30
Figure 2.3 – All-Atom and Coarse-Grained (CG) Representations of Proteins. Several atoms are
grouped into a single CG particle to switch from an all-atom to a CG representation. The coarse-
graining process reduces the number of particles used to describe the system, allowing reaching higher
spatial/temporal scales in MD simulations. Through backmapping methods, one can also reconstruct
the all-atom structure from the CG representation, which enables a multi-scale approach.
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The typical potential energy function for a CG system resembles the previously de-
scribed atomistic molecular mechanics based energy function, expressed as the summation
of bonded and non-bonded interactions:
UCG−tot al =Upseudo−bond +Upseudo−ang l e +Upseudo−tor si on +UvdW +UCoul omb (2.18)
The pseudo-bond and pseudo-angle potentials for the CG beads are generally expressed as
a harmonic potential, while a cosine-series is used to describe the pseudo-torsion potential.
For the Martini force field used in this thesis, the pseudo-bond potential can be written as:
Upseudo−bond =
∑
pseudo−bond s
kr (r − req )2 (2.19)
where kr is the force constant, r is the distance between two pseudo-bonded CG beads, and
req is the equilibrium (reference) pseudo-bond length.
Similarly, the pseudo-angle potential can be written as:
Upseudo−ang l e =
∑
pseudo−ang l es
kθ[cos(θ)− cos(θeq )]2 (2.20)
where kθ is the force constant, θ is the angle between three pseudo-bonded CG beads, and
θeq is the equilibrium angle.
The pseudo-torsion potential can be expressed as:
Upseudo−tor si on =
∑
pseudo−tor si ons
kφ[1+ cos(nφ−φeq )] (2.21)
where kφ is the force constant, φ is the torsional angle between four pseudo-bonded CG beads,
and φeq is the equilibrium torsional angle. n is the periodicity of the torsional potential that
determines the number of minima in the torsional potential.
The non-bonded interactions are generally composed of van der Waals and electro-
statics contributions. The van der Waals potential describes the attractive and the repulsive
interactions between non-bonded atoms and is commonly expressed as the Lennard-Jones
21
Chapter 2. Molecular Modeling and Simulation Methods
potential:
UvdW =
∑
pai r s
4²i j
[(
σi j
ri j
)12
−
(
σi j
ri j
)6]
(2.22)
where ²i j is the potential well depth (interaction strength), σi j is the distance at which the
Lennard-Jones potential is equal to zero, ri j is the distance between two beads i and j .
In addition to van der Waals interactions, charged CG beads also interact through a
shifted Coulombic potential expressed as:
UCoul omb =
∑
pai r s
qi q j
4pi²0²r ri j
(2.23)
where qi and q j are partial atomic charges of atoms i and j , ri j is the distance between the
two atoms, and ²0 is the electrical permittivity of vacuum. A relative dielectric constant, ²r , is
used for screening Coulombic interactions.
The CG-MD simulations performed in this thesis use the Martini 2.2P force field, origi-
nally developed for lipids24 and extended to other biomolecules.31, 32 In the Martini CG model,
a four-to-one mapping is used, meaning that four heavy atoms and associated hydrogens are
combined to represent one CG particle (Figure 2.4). CG particles exist in four types: nonpolar
(N), apolar (I), polar (P) and charged (Q). Each particle type is additionally divided into sub-
types based on hydrogen-bonding capabilities (d=donor, a=acceptor, da=donor-acceptor, or
0=none), or degree of polarity (from 1=low polarity, to 5=high polarity). A special class of CG
beads (S) is also used to model rings, which have a two/three-to-one mapping.
Currently, Martini parameters exist for a wide range of lipids, peptides, proteins, sugars,
polymers, solvents, nucleic acids and nanoparticles (Figure 2.4).32 In addition, the simplistic
mapping procedure and available scripts allow the building of topologies for custom peptides
and proteins. These features allow a realistic modeling of complex systems with Martini. It is
important to note that Martini, like any other model, has its limitations. The current version of
Martini necessitates a preset secondary structure and consequently uses structure constraints
to maintain helical and extended secondary structure elements throughout the simulation,
even though these elements are able to move relative to one another. This means that the
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Martini force field does not make it possible to observe conformational changes and protein
folding.32
Figure 2.4 – Martini Mapping Examples of Selected Molecules. Martini CG beads are shown in cyan
beads overlaying the atomistic structure. (A) CG water particle representing four water molecules. (B)
Polarizable CG water particle with embedded charges. (C) DMPC lipid. (D) Polysaccharide fragment.
(E) Peptide. (F) DNA fragment. (G) Polystyrene fragment. (H) Fullerene molecule. (Figure by Marrink
and Tieleman)32
2.3 Ligand Docking Methods
Molecular docking is a foundational tool used in structure-based drug design to predict the
preferred binding mode of a ligand in the binding site of a protein. The prediction of the
binding of a ligand to a protein requires efficient sampling of the conformational space of
the flexible ligand/receptor, and the minimization of an accurate fitness function. Ligand
docking programs therefore consist of two basic components: an optimization algorithm, and
an energy scoring function. The energy scoring function can be distinguished into three types:
(1) Force-field based scoring functions, where molecular mechanics force fields are
used to compute the interaction energy and estimate the binding affinity. Examples include
the scoring functions of ICM,33 DOCK,34 GOLD,35 SwissDock,.36
(2) Empirical scoring functions, which use protein-ligand complexes with known bind-
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ing affinities as a training set. Multiple linear regression analysis is then used to determine the
weight constants of a function composed of molecular interaction terms. Examples include
the scoring functions of AutoDock Vina,37 GlideScore,38 X-Score.39
(3) Knowledge-based scoring functions, which use interatomic contact frequencies
and/or distances in a large database of known protein-ligand complexes. The observed
frequency distributions of favorable and unfavorable molecular interactions are used to
extract pairwise energy potentials.
A quick and intelligent search over the vast search space necessitates the use of op-
timization algorithms which find the optimal solution of the computationally demanding
fitness function, corresponding to the best ligand pose. Many different optimizers have been
implemented in ligand docking programs, the most common ones being evolutionary algo-
rithms (EAs), implemented in AutoDock,40 GOLD35 and SwissDock36 and particle-swarm
optimizations (PSOs), implemented in PSO@AutoDock.41
Our in-house integrative modeling and optimization protocol termed parallel opti-
mization workbench for enhancing resolution (power),42 is a framework that makes use of
the MD-based conformational ensemble docking approach for macromolecular structure
prediction. It allows the resolution of a large set of optimization problems through the addition
of specific modules. It is an object oriented code developed in Python, and supports parallel
computing by exploiting MPI libraries. The protocol was shown to be efficient in sampling the
protein conformational search space by selecting an ensemble of structures closely resem-
bling that found in nature, as it enabled the near-atomistic arrangement determination of the
aerolysin heptamer pore.42, 43 A new constrained optimizer named mViE (memetic viability
evolution),44, 45 has also been recently implemented within this framework.
In mViE, candidate solutions can survive and reproduce if they satisfy a set of viability
criteria, defined on the problem objectives and constraints (Figure 2.5). The viability criteria
are modified during evolution, where solutions are driven towards desired regions of the
search space. Individuals undergo evolution and show adaptive learning capabilities while
exploring independently their constrained space. The information learned by multiple of
these local search units are combined through a global search operator, where an adaptive
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scheduler decides between advancing the local search units or combining them through global
search operators.45
Figure 2.5 – The Viability Evolution Algorithm. The algorithm consists of defining viability bound-
aries, creating an initial population, repetitive reproduction, elimination and boundary up- dates until
the conditions are satisfied. (A) The population under evolution is in a two dimensional space defined
by the objective functions, f1 and f2. Individuals are randomly generated (black circles), where it is very
unlikely that an individual can satisfy the target viability conditions (the viability boundaries shown
in gray stripes). (B) The viability boundaries are initially set to encompass all individuals. (C) The
viability boundaries are tightened gradually towards the target boundaries and individuals that fall
outside viability boundaries are eliminated (gray shaded circles). (D) In order to evade the tightened
region and to drive further approach to the target boundaries, each individual in the population is
allowed to reproduce by making one mutated copy at each iteration. Mutated copies that fall within
the viability boundaries are allowed to stay with the par- ent while the ones that fall outside are marked
for elimination. (E) Individuals marked for elimination are removed. (F) The process described in
(C-E) is repeated until viability boundaries match the target ones. Finally, the algorithm returns the
population of solutions that satisfy the user-defined criteria, and the user may choose one of them.
(Figure adapted from Maesani et al.45).
mViE was previously successfully used for macromolecular assembly structure predic-
tion in our lab46 and is also highly suitable for use in protein-ligand docking, as it enables the
identification of suitable conformations from ensembles without the need for an exhaustive
exploration of the vast universe of ligand and receptor conformations. In addition, contrary to
majority of other evolutionary algorithms where competitively reproducing individuals cause
the premature convergence to a sub-optimal solution, viability-based evolution maintains
population diversity, resulting in the discovery of alternative solutions. In the Appendix section
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of this thesis, a protein-ligand docking protocol recently developed as an extension to the
(power) framework will be presented, where this constrained optimization will be used to carry
out an evolutionary ligand docking process.
Well-curated public benchmarks are used by method developers for proper assessment
of algorithms and for the establishment of the baseline feasibility of the new technique. Two
of the most common benchmarking sets were used in our study: the Astex-85 set,47 having
high-quality crystal structures of therapeutically relevant targets and drug-like ligands, and
the PDBbind dataset,48 a collection of experimentally measured binding affinity data for all
biomolecular complexes deposited in the Protein Data Bank.
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3 Conserved Lipid Modulation of
Ancient Kinase-Like UbiB Family
Member COQ8
This Chapter includes published work from the following manuscripts. While these two inter-
disciplinary works spanned a large number of techniques and involved work from different
labs, the molecular modeling and simulation data were produced by me.
“Conserved Lipid and Small-Molecule Modulation of COQ8 Reveals Regulation of the An-
cient Kinase-Like UbiB Family.”
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“Cerebellar Ataxia and Coenzyme Q Deficiency Through Loss of Unorthodox Kinase Activ-
ity.”
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27
Chapter 3. Conserved Lipid Modulation of Ancient Kinase-Like UbiB Family Member
COQ8
3.1 Introduction
The ancient UbiB atypical protein kinase-like family is conserved across all three domains
of life.49 The main function of protein kinase-like superfamily members is to catalyze ATP-
dependent phosphorylation.50 The founding member of the UbiB family, E. coli UbiB, and
its orthologs, S. cerevisiae Coq8p and human COQ8A (ADCK3) and COQ8B (ADCK4) support
the aerobic biosynthesis of the redox-active lipid coenzyme Q (CoQ).51 S. cerevisiae Coq8p
and human COQ8A are collectively called COQ8. Mutations in COQ8A and COQ8B result in
neurologic and kidney disorders associated with CoQ deficiency, likely via the destabilization
of complex Q — a protein complex on the inner mitochondrial membrane that synthesizes
CoQ (see Chapter 1, Section 1.3). Despite these clinical findings, the specific role and the
biochemical activity of UbiB proteins remain unclear.
Since COQ8 belongs to the protein kinase-like family, it has been proposed that COQ8
might fill a regulatory gap in CoQ biosynthesis by phosphorylating other proteins in the
CoQ pathway.52 However, to date, the only biochemical activities observed for COQ8 is cis
autophosphorylation with no trans protein kinase activity; and a low-level ATPase activity.19, 20
This necessitates the exploration of other models for its activity.
Recently, Stefely et al. have solved the crystal structure of the apo human COQ8AN∆254
(Figure 3.1B).19 The kinase domain of COQ8A adopts an atypical protein kinase-like fold.
When compared to a well-characterized protein kinase structure (e.g. protein kinase A (PKA),
Figure 3.1A), it has a unique domain, termed the “KxGQ domain". This domain is composed of
an N-terminal extension (GQα1-4, shown in blue in Figure 3.1B) and an N lobe insert (GQα5-6,
shown in green in Figure 3.1B) that folds and positions on top of the protein kinase cleft, while
the signature KxGQ motif occludes the substrate binding pocket, inhibiting protein kinase
activity (Figures 3.1A, 3.1B)).19
The protein kinase-like domain of COQ8A is preceded by a transmembrane helix on
the N-terminal, which is a region rich in small amino acids spaced at i, i+4 forming an
evolutionarily conserved, extended Gly-zipper motif (215-AxxxGxxxGxxxG-227).54 It was
further shown experimentally that the transmembrane domain of COQ8A self-associates in
E.coli, via the Gly-zipper motif.54 The GxxxG motif is statistically overrepresented in membrane
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Figure 3.1 – Crystal Structures of Apo and Nucleotide-Bound COQ8A. (A) Crystal structure of protein
kinase A (PKA) (PDB: 1ATP)53 colored by domains, with ATP shown in black sticks and the peptide
substrate analog in the binding cleft shown in white sticks. (B) Crystal structure of apo COQ8AN∆254
WT (PDB: 4PED)19 colored by domains, and the KxGQ motif residues represented with black spheres.
(C) Crystal structure of COQ8AN∆254 R611K bound to AMPPNP (PDB: 5I35)20 colored by domains, with
AMPPNP shown in black sticks.
proteins, and specifically in transmembrane homodimers. The addition of an appropriately
spaced small residue (G, A, S) leads to a strong helix packing, and results in the formation of
homooligomers.55
Characterization of the protein kinase-like and the transmembrane domains of COQ8A
have provided a strong foundation for understanding the COQ8 structure and function. Protein
kinase-like family members are known to be regulated by lipids and small molecules.56–59
Considering that the COQ8A active site is sterically inaccessible to proteinaceous substrates,
and that CoQ biosynthesis proteins are localized to the inner mitochondrial membrane, COQ8
might also mediate functional interactions with lipids, similar to other protein kinase-like
family members. The role of specific lipids in governing COQ8 function, and how COQ8
localizes to and orients itself on the inner mitochondrial membrane remain unexplored. The
examination of how COQ8A interacts with the inner mitochondrial membrane would be
important for further investigation of how lipid and membrane interactions might alter or
enhance COQ8 activity.
In addition, despite the characterization of the protein kinase-like and the transmem-
brane domains of COQ8A, much less is known about the behavior of the full-length endoge-
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nous form of COQ8A. These two domains are connected with a linker domain, short enough
to enable the interaction of the protein kinase-like domain with the inner mitochondrial mem-
brane from the matrix side, subsequent to the insertion of the transmembrane domain into
the membrane. Since other proteins involved in the biosynthesis of coenzyme Q are localized
on the same side of the inner mitochondrial membrane, the identification of the orientation
of COQ8A relative to the bilayer might give hints about possible interaction surfaces of this
protein with other members of the complex Q.
In this Chapter, we combined computational and biochemical analyses to explore
the nature of COQ8A membrane binding and activation. We revealed that COQ8 possesses
evolutionarily conserved ATPase activity that is activated by binding to membrane containing
cardiolipin, the signature mitochondrial lipid enriched at the inner mitochondrial membrane
where COQ8 is known to reside. Our findings advance our understanding of the COQ8 function,
and reveal how the positioning of COQ8 on the inner mitochondrial membrane is key to its
activation. The biochemical experiments included in this Chapter were led by Dr. Andrew G.
Reidenbach, Dr. Jonathan A. Stefely, and Prof. David J. Pagliarini in University of Wisconsin-
Madison.
3.2 Methods
This section presents the detailed description of the computational methods used in this study.
For experimental methods, please refer to Section 3.5.
3.2.1 Identification and Characterization of Binding Pockets on Nucloetide-Bound
and Apo COQ8A
The X-ray structures of apo COQ8A (PDB: 4PED) and nucleotide-bound COQ8A (PDB: 5I35)
were subjected to the standard protein preparation procedure implemented in Maestro (Mae-
stro package version 9.8 from Schrödinger, LLC). SiteMap60 module in Maestro was used with
its default settings to identify the top 5 ranked binding sites on the two structures. SiteMap first
locates binding sites by grouping site points that are in spatial proximity to the protein and
have favourable interaction energies with the protein. Consequently, for each returned site,
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it constructs hydrophilic (further divided into donor and acceptor) and hydrophobic maps,
and evaluates pockets through their physicochemical properties. The top two ranking pockets
found on nucleotide-bound COQ8A are associated with the signature KxGQ domain of COQ8A,
hence were named KxGQ Pocket 1 and KxGQ Pocket 2. The corresponding pockets on apo
COQ8A ranked the first and the fourth, respectively. Table 3.3 summarizes the characteristics
of these pockets.
3.2.2 Coarse-Grained Molecular Dynamics Simulations of Protein-Membrane Sys-
tems
All simulations were performed using the GROMACS61 simulation package version 5.0.4. The
systems were described with the MARTINI 2.2P24, 62 coarse-grained (CG) force field, together
with the ElNeDyn63 approach to maintain the secondary and tertiary structure of the protein.
Coarse-grained molecular dynamics (CG-MD) simulations based on the MARTINI force field
have been previously used with success for different systems to investigate protein-lipid
interactions.64–67
The systems were built with center of mass of COQ8A (PDB: 4PED) 70 Å away from the
surface of the membrane and checked for whether the protein approaches and interacts with
the membrane. Inner mitochondrial membrane (IMM) models were built according to the
experimental molecular ratio of CL observed for bovine heart mitochondria, namely 15 to 20%
of the phosphorus content.68 Therefore, IMM mimics were featuring a lipid concentration of
16% CL/41% POPC/37% POPE/6% DSPC, while generic membrane models featuring 100%
POPC lipids were built as control. The IMM model was approximated to have a symmetrical
concentration of lipids between the two leaflets since precise lipidomic information about
concentration asymmetry is not known. Lipid bilayers of 130 x 130 Å2 were generated using
the insane (INSert membrANE)69 method of MARTINI. Systems were solvated with polarizable
CG water and counter ions were added to neutralize the system. Following solvation, systems
were energy minimized with a timestep of 5 fs. Successive equilibrations with decreasing
restraints were performed in order to obtain a fully equilibrated system (force constants of
1000, 500, 250 and 0 kJ/mol applied on protein particles, 10 ns of run with a timestep of 10 fs
for each). In the production phase, which is 4 µs for all simulations, the protein, membrane
31
Chapter 3. Conserved Lipid Modulation of Ancient Kinase-Like UbiB Family Member
COQ8
and the aqueous phase (water and ions) were coupled independently to an external bath at
310 K by using the v-rescale thermostat. The pressure was coupled to a pressure bath at 1 bar
by semi-isotropic Parrinello-Rahman pressure coupling. Three MD repeats with randomized
initial velocities were performed for each membrane system and they yielded consistent
results. Average occupancy of cardiolipins was calculated using VMD’s VolMap plugin.70
3.2.3 Modeling of Transmembrane Domain-Containing COQ8A
Khadria et al. have created 5 models for the COQ8A transmembrane domain dimer through a
computational prediction algorithm, where Model 2 is reported as the best structural candidate
according to the ranking based on the energy scores, and the agreement of computational
and experimental mutagenesis data.54 The chain A of the best model, Model 2, was used as
an initial model for the transmembrane domain of our structure. The 24 residue long linker
sequence was added to the C terminus of the helix with PyMOL.71 The linker was modeled
as a random coil, based on the secondary structure prediction obtained from PSIPRED.72
The atomistic model of the transmembrane+linker domain was then converted to a CG
representation using the MARTINI mapping.24 An early timestep from the previously discussed
CG simulation of the protein kinase-like domain of COQ8A with the 16% CL membrane was
used as the initial conformation in order to start with an equilibrated membrane, where
the protein does not interact with the membrane yet, allowing space for the protein to be
linked to the transmembrane+linker domain. The transmembrane domain was inserted in
the membrane manually in VMD70 by shifting some lipid molecules to create space in the
membrane, in a location close to the protein kinase-like domain.
3.2.4 Identification of Residues Important for Membrane Interaction and Selec-
tion of Residues for Mutagenesis Experiments
In Section 3.3.2, the interaction surface of COQ8A with the mitochondrial membrane is
identified as the positively charged surface of COQ8A, mainly comprising the GQα1, GQα4 and
GQα5 domains. In order to identify specific residues important for the membrane interaction
of COQ8A, kinase domain residues in the CG-MD simulation were ranked based on their
interaction frequencies with the membrane (Table 3.1). The interaction frequency of a residue
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j with a lipid molecule L, noted ξ jL , is the time average of instantaneous contacts (Eq. 3.1),
starting from the frame where the first contact is recorded (t0) until the end of the simulation
(T ). A contact is counted when a charged/polar residue is within the first interaction shell
cutoff, δL= 6.5 Å of a phosphate head (Eq. 3.2).
ξ
j
L =
1
T − t0
T∑
t=t0
I jL (t ) (3.1)
I jL (t )=
 1, if d j L(t )≤ δL0, if d j L(t )> δL (3.2)
Table 3.1 – Ranking of Charged/Polar Residues According to their Interaction Frequencies with the
Membrane. Positively charged residues are highlighted in gray.
Residue Helix ξ jL
R262 α1 0.924
T266 α1 0.810
N259 α1 0.798
S370 α5 0.756
N374 α5 0.720
N373 α5 0.628
K269 α1 0.620
Q366 α5 0.601
S367 α5 0.594
N369 α5 0.590
K314 α4 0.589
Q311 α4 0.538
R265 α1 0.523
N318 α4 0.517
S382 α5 0.513
N317 α4 0.505
K310 α4 0.478
N380 α5 0.187
The ranking based on interaction frequencies revealed that GQα1 and GQα4 helices
interact with the membrane through the positively charged Arg and Lys residues (highlighted
in gray in Table 3.1), whereas the membrane interaction surface of GQα5 comprises polar
residues Gln, Ser and Asn. In order to narrow down the list of residues important for membrane
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interaction, we have defined 4 mutants as summarized in Table 3.2, where each mutant is
named after the mutated or electrostatically knocked out domain for ease of understanding.
Table 3.2 – Designed COQ8A Mutants. The residues listed for each mutant are either (i) mutated
to alanines (in electrostatic maps (Figure 3.5A) and in mutagenesis experiments (Figure 3.5D-G)), or
(ii) altered by the removal of charges of the polarizable CG beads, to knockout Coulomb interactions
without changing the residue types (in CG-MD simulations (Figure 3.5B)).
Mutant Altered Residues
GQα1 mutant (Triple A) R262, R265, K269
GQα4 mutant K310, K314
GQα1α4 mutant R262, R265, K269, K310, K314
GQα5 mutant Q366, S367, N369, S370, N373, N374
3.2.5 Modeling of COQ8A Mutants
For Electrostatic Surface Potential Analysis: Atomistic models of the different GQα mutated
COQ8A proteins were built in PyMOL71 by mutating the following residues listed in Table 3.2
to alanines. The effect of these mutations on the electrostatic potential surface of the protein
was visualized through the ICM-REBEL module of the ICM program.33
For CG-MD Simulations: Residues listed in Table 3.2 for each mutant were altered by the
removal of charges of the polarizable CG beads, to knockout Coulomb interactions without
changing the residue types. CG-MD simulations were then performed for these four mutants
following the procedure explained in Section 3.2.2.
3.3 Results
3.3.1 Nucleotide Binding to COQ8A Opens Small-Molecule Pockets
The apo COQ8A structure previously showed that its UbiB family specific KxGQ domain
occludes the typical protein kinase substrate binding pocket (Figures 3.1A, 3.1B).19 The apo
structure does not have any obvious hydrophobic binding pockets that could bind a lipid.
Nevertheless, nucleotide binding to COQ8A could open a substrate binding pocket. To test
this idea, our collaborators crystallized COQ8AN∆254R611K with an ATP analogue, adenosine
5’-(β,γ-imido)triphosphate (AMPPNP), and solved its X-ray structure at a resolution of 2.3 Å
(Figure 3.1C).
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Overall, the apo and nucleotide-bound COQ8A structures are largely similar (RMSD=3.3
Å; Figures 3.1, 3.2A). Even with a nucleotide bound, the KxGQ domain occludes the typical
peptide substrate binding site and hinders trans protein phosphorylation. The comparison of
apo and nucleotide-bound COQ8A shows that the most significant difference between the two
structures arises from deviations in two loops in the KxGQ domain: the GQα2-GQα3 loop and
the GQα5-GQα6 loop (Figure 3.2A). The movement of these two regions due to nucleotide
binding opens two hydrophobic pockets in the KxGQ domain (KxGQ pockets 1 and 2, Table
3.3), which are not present in the apo COQ8A structure (Figure 3.2B). KxGQ pocket 1 is near
the putative phosphoryl acceptor substrate binding region, and it could potentially bind the
kinase’s substrate. In contrast, KxGQ pocket 2, which is partially formed by the “x” of the
KxGQ motif, has the potential to bind an allosteric effector molecule that could communicate
with the active site through the KxGQ motif. KxGQ pocket 2 is additionally very close to the
membrane interacting surface of COQ8A (the positively charged surface comprising GQα1,
GQα4 and GQα5, see Section 3.3.2). This pocket might be accessible to a CoQ pathway
intermediate residing in the membrane, which would enable the head group to interact with
the protein while the hydrophobic lipid tail would stay embedded in the membrane.
Table 3.3 – Characterization of Binding Pockets on Nucloetide Bound- and Apo-COQ8A.
Property Remarks Nucleotide Bound-COQ8A Apo-COQ8A
KxGQ
Pocket 1
KxGQ
Pocket 2
KxGQ
Pocket 1
KxGQ
Pocket 2
SiteScore >1 is promising 1.092 1.057 1.051 0.689
Dscore Distinguishes "druggable"
pockets
0.949 1.114 0.989 0.598
Exposure Lower is better. Average for
good binding is 0.49
0.436 0.535 0.460 0.721
Enclosure Higher is better. Average for
good binding is 0.78
0.835 0.703 0.774 0.570
Volume
(Å3)
1079.42 230.50 360.49 120.39
Hydrophobic/
philic
balance
0.402 1.815 0.379 0.015
Ranking 1 2 1 4
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Figure 3.2 – Nucleotide Binding to COQ8A Opens Small-Molecule Pockets. (A) Superposition of apo
COQ8A WT (PDB: 4PED, light colors) and AMPPNP-COQ8A R611K (PDB:5I35, dark colors), where the
region that differs the most is highlighted in the right panel. (B) Two top-ranking binding pockets
identified by SiteMap on the nucleotide-bound COQ8A structure (PDB: 5I35, in blue cartoon repre-
sentation) and the corresponding pockets on the apo COQ8A structure (PDB: 4PED, in gray cartoon
representation). The accessible areas of the pockets are shown in white beads and the hydrophobic
regions are shown in orange mesh.
3.3.2 COQ8 Interacts with the Membrane through its Signature KxGQ Domain
Mitochondria are characterized by a high percentage of cardiolipins (CL), a unique, anionic,
four-tail lipid that significantly influences the correct functioning of mitochondrial membrane
proteins.73–75 Mature COQ8 resides on the inner mitochondrial membrane (IMM) facing the
matrix where the other complex Q proteins reside and where it can potentially interact with
CoQ intermediates.76–78 This suggests that membrane association might be an important
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modulator of its activity, as has been shown for other membrane-bound kinases.79 To de-
termine the preferential interaction surface of COQ8 with the mitochondrial membrane, we
analyzed the electrostatic surface of the protein kinase-like domain of COQ8A. Examination
of the electrostatic surface potential of the soluble domain of COQ8A revealed an extensive
positive patch, generated primarily by the signature “KxGQ domain". This domain is formed
by the GQα1 (residues 260-270), GQα4 (residues 309-320) and GQα5 (residues 366-381) he-
lices; however, the main contributors to the positive patch are GQα1 and GQα4 (Figure 3.3A).
We hypothesized that this positive surface on COQ8A likely interacts with negatively charged
phospholipids found in the IMM, such as cardiolipins.
Figure 3.3 – Cardiolipin Enhances COQ8A Membrane Binding. (A) The two structures of
COQ8AN∆254 on the left are colored according to Stefely et al. (2015) and turned to show the ori-
entation of the electrostatic maps. The KxGQ domain is colored in blue and green in the structures
on the left. On the right, the electrostatic map of COQ8AN∆254 shows the positively charged region
spanning GQα1, GQα4, and GQα5 (negative [-5 kcal/(mol·e) charge] red, via white, to positive [+5
kcal/(mol·e) charge] blue). (B)Time evolution of the distance between the center of mass of the protein
and the center of mass of the phosphate heads of the leaflet it interacts with, for CG-MD simulations
of (i) COQ8AN∆254 with a PC membrane (black) or (ii) with a PC/PE/CL membrane (red), and (iii) the
COQ8AN∆162 model (transmembrane (TM) domain-containing COQ8) with a PC/PE/CL membrane
(gray). (C) Snapshot from a CG-MD simulation (t∼4 µs) showing the interaction of COQ8AN∆254 with a
PC/PE/CL membrane. CL phosphate heads are shown in red, and PC/PE phosphate heads are shown
in white. (D) Snapshot from a CG-MD simulation (t∼4 µs) showing the interaction of the COQ8AN∆162
model (TM domain-containing COQ8)with a PC/PE/CL membrane. CL phosphate heads are shown in
red, and PC/PE phosphate heads are shown in white. (E) Average occupancy of CL phosphate heads
(red) when COQ8AN∆254 (blue) is centered throughout the trajectory.
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To explore the nature of COQ8 membrane binding and activation, we used molecular
dynamics to simulate the binding of COQ8A to membranes. We used coarse-grained molecular
dynamics (CG-MD) simulations to investigate the binding of COQ8A to PC/PE/CL (47/37/16%),
mimicking inner mitochondrial membrane (IMM)-like membranes, or to PC alone, mimicking
a non-IMM membrane model. In the simulations performed with PC/PE/CL membrane
composition, the protein initially diffuses in the aqueous environment and subsequently binds
to the lipid bilayer through the previously identified positive electrostatic patch (Figure 3.3B,
3.3C). Invariably, the presence of CL at physiological concentration (Horvath and Daum, 2013)
is required to induce rapid (within the first microsecond) membrane association (3.3B). While
a stable interaction with the membrane is seen with the 16% CL membrane, in simulations
featuring a pure POPC bilayer, even though the protein approaches the bilayer several times,
no stable binding event is observed (Figure 3.3B). This suggests that membrane interaction
is strongly influenced by CL. Interestingly, anchoring of COQ8A at the IMM is associated
with local reorganization of lipids, featuring a strong segregation of CL species to the COQ8A
interface (Figure 3.3E).
Endogenous COQ8 contains a transmembrane domain that anchors it to the IMM.19 In
order to test whether an intact transmembrane domain would still allow the soluble domain
to interact with the membrane with the same surface that we have found through CG-MD sim-
ulations of the soluble domain, we modelled the transmembrane domain-containing COQ8A,
including both the transmembrane and kinase-like domains. In the CG-MD simulations
of the full model, COQ8A interacts with the PC/PE/CL membrane with the same positively
charged region (Figure 3.3D). Even though the linker region between the transmembrane and
soluble domains was modelled as an extended loop in the initial state, during the simulation
it rearranges to allow the membrane interaction of the soluble domain.
3.3.3 Cardiolipin Specifically Increases COQ8 Membrane Interaction and ATPase
Activity
To validate the computationally observed membrane association of COQ8A, and to test the
effect of membrane association on its activity, our collaborators first used a liposome flotation
assay to determine how effectively COQ8 binds to liposomes. Without the transmembrane
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domain, COQ8AN∆250 exhibited moderate affinity for PC/PE/CL liposomes; however, the
addition of the transmembrane domain enabled near-complete COQ8AN∆162 and Coq8pN∆41
liposome binding (Figure 3.4A). Strikingly, this association markedly enhanced the ATPase
activity of COQ8AN∆162 and Coq8pN∆41 (Figure 3.4C), which is several orders of magnitude
higher than autophosphorylation (Figure 3.4D). These data imply that UbiB proteins, like
other protein kinase-like family members, may be activated endogenously by binding to
particular membrane environments.
To determine whether the COQ8 membrane binding and activity is driven by a particular
membrane component in these liposome flotation assays, we tested the ability of multiple
individual lipids to activate COQ8 when reconstituted in PC carrier liposomes. Remarkably,
from among the eight individual species tested, only CL was able to activate COQ8 (Figure
3.4E). This increase in activity was matched by the superior ability of CL to facilitate binding
of COQ8 to liposomes, indicating that CL activation of COQ8 is directly linked to its ability to
mediate COQ8-membrane interactions (Figure 3.4B). This experimental result confirmed our
computational finding that CL mediates membrane interaction of COQ8. Interestingly, COQ8
lacking its transmembrane domain still preferentially bound to CL-containing liposomes
(Figure 3.4B) but was not activated by them (Figure 3.4C), suggesting that the transmembrane
domain itself is a regulatory feature of COQ8.
To test whether liposome/CL binding specifically enhances the ATPase activity of COQ8,
we performed [γ32P]ATP kinase reactions with liposomes to follow the location of the gamma
phosphate. We also assessed autophosphorylation using SDS-PAGE and potential phospho-
rylation of copurifying lipid substrates or CL using thin-layer chromatography. In these
experiments, no autophosphorylation or lipid phosphorylation was observed, further sup-
porting the hypothesis that COQ8 acts as an ATPase (Figure 3.4F). Collectively, these data
demonstrate that CL enables COQ8 membrane binding and enhances COQ8 ATPase activity.
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Figure 3.4 – Cardiolipin Enhances the ATPase Activity and Liposome Binding of COQ8A. (A)
Coomassie-stained SDS-PAGE of the liposome flotation assay with COQ8 variants and PC/PE/CL
liposomes. T, top fraction; B, bottom fraction. (B) Coomassie-stained SDS-PAGE and the liposome flota-
tion assay with transmembrane (TM) domain-containing COQ8 and a panel of PC-based liposomes.
T, top fraction; B, bottom fraction. (C) ADP-Glo assay with COQ8 variants and PC/PE/CL liposomes.
Error bars represent SD of two independent experiments performed in technical triplicate. (D) Di-
rect comparison of Coq8N∆41 ATPase (Pi) and autophosphorylation activities with or without PC/CL
liposomes using [γ32P]ATP. (E) ADP-Glo assay with a panel of liposomes and TM domain-containing
COQ8. Error bars represent SD of two independent experiments performed in technical duplicate.
(F) ADP-Glo (ADP produced) and [γ32P]ATP ATPase assay (Pi produced) of COQ8 variants with PC or
PC/CL liposomes performed in parallel.
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3.3.4 Cardiolipin Specifically Increases COQ8 Membrane Interaction and ATPase
Activity
Ranking of residues based on their interaction frequencies with the membrane in our CG-
MD simulations revealed that GQα1 and GQα4 helices interact with the membrane through
positively charged Arg and Lys residues, whereas the membrane interaction surface of GQα5
comprises polar residues Gln, Ser and Asn (Table 3.1). In order to confirm the importance
of these specific residues in membrane interaction, we designed 4 mutants (GQα1, GQα4,
GQα1α4, GQα5) as summarized in Table 3.2, where each mutant is named after the mutated
or electrostatically knocked out domain for ease of understanding.
Previous examination of the electrostatic potential surface of COQ8A had revealed an
extensive positive electrostatic patch which was found to interact with negatively charged
cardiolipins (CL) found in the inner mitochondrial membrane. Visualizing the effect of these
mutations on the electrostatic surface of the protein revealed that the positive electrostatic
surface of COQ8A, which is crucial for membrane interaction, disappears in GQα1α4, where
all positively charged residues interacting with the membrane are altered. In GQα1 and GQα4,
the positive surfaces associated with α4 and α1 remain, respectively, which still might enable
membrane interaction for both. It is important to note that the surfaces observed in GQα1
and GQα4 add up to form the positive electrostatic patch of the wild-type (WT) COQ8A. While
the alteration of positively charged α1 and α4 residues weaken the electrostatic potential of
the interaction surface, the alteration of polar α5 residues does not alter the surface. Overall,
from this electrostatics analysis, it is possible to predict that GQα1α4 will not bind to the
membrane, while GQα5 will. The comparison of the behavior of GQα1 and GQα4 mutants
in the CG-MD simulations will reveal whether α1 and α4 have a complementary effect on
membrane interaction or whether knocking out one of them will suffice to eliminate the
interaction of ADCK3 with the membrane.
CG-MD simulations were performed with the soluble kinase-like domain of COQ8A for
the 4 designed mutants (Figure 3.5B), and as predicted in the electrostatic surface potential
analysis, the alteration of α1+α4 was found to prevent binding to CL-containing membranes.
The alteration ofα5 did not affect membrane association. Furthermore, individual assessment
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of α1 and α4 domains revealed that the alteration of α1 alone is enough to remove binding,
whereas the alteration of α4 is not. Overall, this analysis suggests that α1 is the indispensable
domain for membrane binding and that it compensates for the electrostatic knockout of α4.
α1 residues might be important for (i) driving the initial encounter with the membrane
through electrostatic interactions to ensure the correct binding surface or (ii) the subsequent
interaction with the membrane to establish a stable orientation and to retain the protein on
the surface. To substantiate the role of the α1 domain and to assess the importance of specific
α1 residues in membrane binding we checked the time evolution of the distance between the
polarizable CG bead of positively charged α1 and α4 residues and the closest phosphate head
(Figure 3.5C). R262 is the first residue to interact and also to establish a strong interaction
with the membrane, specifically with cardiolipins. The interaction of α4 residues with the
membrane takes place at a later stage in WT (920 ns), supporting the conclusion that α1
residues (in particular R262) are the crucial residues for the membrane interaction of ADCK3.
Collectively, CG-MD simulations enabled the prediction that three positively charged
residues of the GQα1 helix (R262, R265, and K269) are the key anchor points driving the
initial encounter of the soluble domain with the membrane via electrostatic interactions
with cardiolipin phosphate heads (Figure 3.5B and 3.5C). To validate the importance of these
residues, our collaborators purified a triple mutant of COQ8AN∆250 (R262A,R265A,K269A;
Triple A) and measured its ability to bind liposomes. Indeed, this mutant demonstrated a large
decrease in liposome association (Figures 3.5D and 3.5E).
When the corresponding mutations were introduced into COQ8, its ability to rescue
∆coq8 respiratory deficiency was significantly diminished, suggesting that these residues may
have important ramifications for membrane binding and/or orientation in vivo (Figures 3.5F
and 3.5G). Altogether, our simulations and supporting experiments reinforce the importance
of CL for COQ8 membrane association and suggest that the COQ8-CL interaction is driven by
conserved residues in the signature KxGQ domain.
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Figure 3.5 – COQ8 Interacts with the Membrane through Its Signature KxGQ Domain. (A) The two
structures of COQ8AN∆254 on the left are colored according to Stefely et al. (2015) and turned to show the
orientation of the electrostatic maps. The KxGQ domain is colored in blue and green in the structures on
the left. On the right, there are electrostatic maps of COQ8AN∆254 showing the positively charged region
spanning GQα1, GQα4, and GQα5 (negative [-5 kcal/(mol·e) charge] red, via white, to positive [+5
kcal/(mol·e) charge] blue), illustrating the effect of alanine mutations on different regions of the positive
electrostatic patch proposed as the membrane interaction surface of COQ8A. (B) CG-MD simulations
of different GQα mutated COQ8A proteins and PC/PE/CL membranes. Time evolution of the distance
between the center of mass of the protein and the center of mass of the phosphate heads of the leaflet
with which it interacts. GQα1 (Triple A) mutant, R262A, R265A, K269A; GQα4 mutant, K310A,K314A;
GQα1α4 mutant, R262A, R265A, K269A, K310A, K314A; GQα5 mutant, Q366A, S367A, N369A, S370A,
N373A, N374A. (C) Time evolution of the distance between positively charged residues on COQ8A
GQα1 and GQα4 and the closest phosphate head, during the CG-MD simulation of WT COQ8A protein
and PC/PE/CL membrane. (D) Percent protein associating with liposomes from a liposome flotation
assay with COQ8AN∆250 WT and the Triple A mutant (R262A,R265A,K269A). Error bars represent SD of
three independent experiments. (E) Coomassie-stained SDS-PAGE of top and bottom fraction from the
liposome flotation assay in panel D. +, with PC/PE/CL liposomes; -, no liposomes. (F) Serial dilutions of
∆coq8 transformed with Coq8p WT or the Triple A mutant (R120A,K124A,K127A) on synthetic complete
glucose (2% w/v) or glycerol (3% w/v) containing media. (G) Representative growth curve of ∆coq8
yeast transformed with WT COQ8 or the Triple A mutant in Ura–, glucose (0.1% w/v) and glycerol (3%
w/v) respiratory media.
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3.4 Discussion
Coenzyme Q was identified as a key component of the mitochondrial electron transport chain,
yet there are several unanswered questions regarding biosynthesis. One unknown feature of
its biosynthesis pathway is the unexplained need for multiple auxiliary proteins that have no
clear catalytic role in the pathway, including COQ8. Based on primary sequence alignments,
COQ8 was initially identified as an atypical protein kinase, proposed to fill a regulatory gap in
the CoQ biosynthesis by phosphorylating other proteins in the CoQ pathway.52 Contrary to
this initial proposition, and despite extensive experimentation, no COQ8 trans protein kinase
activity has been observed until now, which necessitates the investigation of other models for
determining its role in pathway.
Multiple members of the protein kinase-like superfamily become activated by binding
to endogenous molecules found at their sites of cellular activity, such as the activation of
PKC or Akt by diacylglycerol and phosphatidylinositol 3,4,5-trisphosphate, respectively, at the
plasma membrane.59, 80, 81 Furthermore, protein-lipid interactions in general are becoming
increasingly recognized as regulatory and structural features of proteins.82–84 These indi-
cate that it may be important to investigate the biochemical function of COQ8 in its native
environment.
Similar to PKC and Akt, our data also indicate that COQ8 is activated via interaction
with a specific lipid, CL. CL is a unique anionic, four-tailed lipid found at particularly high con-
centrations in the IMM where it influences the activity and stability of various mitochondrial
membrane proteins.73–75, 85 and promotes the formation of respiratory chain supercom-
plexes.86 In addition to mere binding, our CG-MD simulations indicate that CL also directs
the orientation of the soluble COQ8 domain along the membrane surface, perhaps thereby
enabling COQ8’s known interactions with other COQ proteins76, 87 and/or with membrane-
embedded CoQ precursors. Furthermore, CL is thought to be distributed nonuniformly
throughout the IMM,88 suggesting that the interaction of COQ8 with CL might seed complex
Q formation at strategic sub-mitochondrial locations. These observations suggest models
whereby the proper positioning of COQ8 at CL-rich domains on the mitochondrial inner
membrane activates its ATPase activity as a requisite first step in enabling complex Q assembly
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and/or CoQ biosynthesis, and that exposure to CoQ intermediates at those sites can further
enhance COQ8 function (Figure 3.6). Within this context, CG-MD is shown once more to
be a powerful resource to understand the molecular determinants underlying protein-lipid
interplay.
Figure 3.6 – Model for How COQ8 Membrane and CL Binding, and ATPase Activity Could Facilitate
CoQ Biosynthesis. First, COQ8 is imported into the matrix. Binding to CL then facilitates COQ8’s
association with, and insertion into, the IMM with its soluble domain properly oriented along the
membrane surface. Next, the CL-induced activation of COQ8 (red glow) allows it to advance CoQ
biosynthesis by coupling the hydrolysis of ATP to the extraction of CoQ precursors out of the IMM
and/or to the formation of complex Q.
More broadly, these results suggest an important and underappreciated connection
between CoQ and CL, two quintessential mitochondrial lipids that enable oxidative phospho-
rylation. Indeed, CL has long been known to enable electron transfer between CI and CIII,89
and in plants, CL was found to have a positive effect on the electron transfer rate from CoQ to
the photosynthetic reaction center.90 These observations in conjunction with our data suggest
a model whereby enhanced CL biosynthesis may augment oxidative phosphorylation function
in part by enabling the biosynthesis of CoQ via COQ8.
3.5 Supplementary Information
This Section details the work done by our experimental collaborators to support our compu-
tational findings. The experimental work included in this Chapter was led by Dr. Andrew G.
Reidenbach and Prof. David J. Pagliarini in University of Wisconsin-Madison.
3.5.1 DNA Constructs and Cloning
Cloning of COQ8AN∆250, Coq8pN∆41, PKA, and p426 GPD COQ8 plasmids was previously
described.19, 91 For MBP-UbiBC∆47 and COQ8AN∆162 standard PIPE cloning methods92 were
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used. PIPE reactions were DpnI digested and transformed into DH5α competent E. coli
cells. Plasmids were isolated from transformants and DNA sequencing was used to identify
those containing the correct constructs. pVP68K, a plasmid for expression of recombinant
proteins in bacteria [8His-cytoplasmically-targeted maltose-binding protein (MBP) with a
linker including a tobacco etch virus (TEV) protease recognition site fused to the protein
construct (8His-MBP-[TEV]-Protein)], has been described previously.93 Oligonucleotides were
purchased from IDT (Coralville, IA, USA). For yeast rescue experiments, COQ8 was cloned
into the p426 GPD vector.94 Point mutations were introduced by PCR-based mutagenesis and
confirmed by DNA sequencing.
3.5.2 Recombinant Protein Expression and Purification
Human COQ8AN∆162 and COQ8AN∆250
Method adapted from.19, 91 COQ8A constructs were overexpressed in E. coli by autoinduc-
tion.95 Cells were isolated and frozen at –80 °C until further use. For protein purification, cells
were thawed, resuspended in Lysis Buffer [20 mM HEPES (pH 7.2), 300 mM NaCl, 10% glycerol,
5 mM 2-mercaptoethanol (BME) or 0.5 mM tris(2-carboxyethyl)phosphine (TCEP), 0.25 mM
phenylmethylsulfonyl fluoride (PMSF)] (4 °C). The cells were lysed by sonication (4 °C, 75% am-
plitude, 10 s x 3). The lysate was clarified by centrifugation (15,000 g, 30 min, 4 °C). The cleared
lysate was mixed with cobalt IMAC resin (Talon resin) and incubated (4 °C, 1 h). The resin was
pelleted by centrifugation (700 g, 2 min, 4 °C) and washed four times with Wash Buffer [50 mM
HEPES (pH 7.2), 300 mM NaCl, 10% glycerol, 5 mM BME, 0.25 mM PMSF, 10 mM imidazole].
His-tagged protein was eluted with Elution Buffer [20 mM HEPES (pH 7.2), 300 mM NaCl, 10%
glycerol, 5 mM BME or 0.5 mM TCEP, 0.25 mM PMSF, 100 mM imidazole]. The eluted protein
was concentrated with a MW-cutoff spin filter (50 kDa MWCO) and exchanged into Storage
Buffer [20 mM HEPES (pH 7.2), 300 mM NaCl, 10% glycerol, 5 mM BME or 0.5 mM TCEP]. The
concentration of 8His-MBP-[TEV]- COQ8AN∆250 was determined by its absorbance at 280 nm
(²=96,720 M–1 cm–1) (MW = 89.9 kDa) and 8His-MBP-[TEV]-COQ8AN∆162 (²=96,720 M–1 cm–1)
(MW = 99.26 kDa). The fusion protein was incubated with∆238TEV protease (1:50, TEV/fusion
protein, mass/mass) (1 h, 20 °C). The TEV protease reaction mixture was mixed with cobalt
IMAC resin (Talon resin), incubated (4 °C, 1 h). The resin was pelleted by centrifugation (700
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g, 3 min, 4 °C). The unbound COQ8A was collected and concentrated with a MW-cutoff spin
filter (30 kDa MWCO) and exchanged into storage buffer. The concentration of COQ8AN∆250
was determined by its absorbance at 280 nm (²=28,880 M–1 cm–1) (MW = 45.6 kDa). The
concentration of COQ8AN∆162 was determined by its absorbance at 280 nm (²=28,880 M–1
cm–1) (MW = 54.99 kDa). The protein was aliquoted, frozen in N2(l), and stored at –80 °C.
Fractions from the protein preparation were analyzed by SDS-PAGE.
Yeast Coq8pN∆41
Coq8pN∆41 plasmid constructs were transformed into RIPL competent E. coli cells for protein
expression. 8His-MBP-[TEV]- Coq8pN∆41 was overexpressed in E. coli by autoinduction. Cells
were isolated by centrifugation, frozen in N2(l), and stored at –80 °C until further use. For
protein purification, cells were thawed on ice, resuspended in Lysis Buffer [50 mM HEPES
(pH 7.5), 150 mM NaCl, 5% glycerol, 1 mM BME, 0.25 mM PMSF, 1 mg/mL lysozyme, pH
7.5] and incubated (1 h, 4 °C). The cells were lysed by sonication (4 °C, 6 V, 60 s x 4). The
lysate was clarified by centrifugation (15,000 g, 30 min, 4 °C). The cleared lysate was mixed
with cobalt IMAC resin (Talon resin) and incubated (4 °C, 1 h). The resin was pelleted by
centrifugation (700 g, 5 min, 4 °C) and washed four times with Wash Buffer [50 mM HEPES
(pH 7.5), 150 mM NaCl, 5% glycerol, 1 mM BME, 0.25 mM PMSF, 10 mM imidazole, pH 7.5] (10
resin bed volumes). His-tagged protein was eluted with Elution Buffer [50 mM HEPES (pH 7.5),
150 mM NaCl, 5% glycerol, 1 mM BME, 100 mM imidazole, pH 7.5]. The eluted protein was
concentrated with a MW-cutoff spin filter (50 kDa MWCO) and exchanged into storage buffer
[50 mM HEPES (pH 7.5), 150 mM NaCl, 5% glycerol, 1 mM BME, pH 7.5]. The concentration
of 8His-MBP-[TEV]-Coq8pN∆41 was determined by its absorbance at 280 nm (²=109,210 M–1
cm–1) (MW = 96.2 kDa). The fusion protein was incubated with ∆238TEV protease (1:50,
TEV/fusion protein, mass/mass) (1 h, 20 °C). The TEV protease reaction mixture was mixed
with cobalt IMAC resin (Talon resin) and incubated (4 °C, 1 h). The unbound Coq8pN∆41 was
isolated and concentrated with a MW-cutoff spin filter (30 kDa MWCO) and exchanged into
Storage Buffer. The concentration of Coq8pN∆41 was determined by its absorbance at 280 nm
(²=41,370 M–1 cm–1) (MW = 52 kDa). The protein was aliquoted, frozen in N2(l), and stored at
–80 °C. Fractions from the protein preparation were analyzed by SDS-PAGE.
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3.5.3 ADP-Glo Assay
ADP-Glo (Promega) was performed according to the manufacturer’s instruction with the fol-
lowing modifications. All solutions were diluted in HBS (150 mM NaCl, 20 mM HEPES pH
7.5). Coq8pN∆41 (1 µM), COQ8AN∆250 (2 or 4 µM), COQ8AN∆162 (2 µM), or MBP-UbiBC∆47 (0.5
µM) were mixed with liposomes (∼3.33 mM), ATP (100 µM), MgCl2 (4 mM), CMK (20 µM)
or DMSO (0.2% v/v), Triton X-100 (1 mM) or reduced Triton X-100 (1 mM) (Sigma Aldrich),
and CoQ headgroup analogs (Sigma Aldrich) dissolved as 200 mM stock solutions in DMSO
(2-PP, 2-propylphenol; 2-MeO-6-MP, 2-methoxy-6-methylphenol; 4-methylcatechol; 4-HB,
4-hydroxybenzoic acid; 2-MeO-HQ, 2-methoxyhydroquinone; 4-MeOP, 4-methoxyphenol;
2-AP, 2-allylphenol; HQ, hydroquinone; 3,4-diHB, 3,4-dihydroxybenzoic acid; MeHQ, methyl-
hydroquinone; 2,6-diMeO-HQ, 2,6-dimethoxyhydroquinone) (1 mM) (final concentrations
for reaction components). Reactions were incubated (30 °C, 45 min). Then ADP-Glo Reagent
(5 µL) was added and incubated (40 min, r.t. [∼21 °C], covered). Kinase Detection Reagent
was added (10 µL) and incubated (40 min, r.t., covered). Luminescence was read using default
values on a Biotek Cytation 3 plate reader. An ADP/ATP standard curve was made according to
the manufacturer’s instructions. Error bars represent SD of technical triplicate measurements
unless otherwise specified.
3.5.4 Cytophos ATPase Assay
The Cytophos ATPase assay (Malachite green) was performed according to the manufacturer’s
instruction with the following modifications. All solutions were diluted in HBS (150 mM NaCl,
20 mM HEPES pH 7.5). COQ8AN∆250 (1µM final), Coq8pND41 (1µM final), COQ8AN∆162 (1µM
final) or MBP-UbiBC∆47 (0.25 µM final) with 100 µM ATP, 4 mM MgCl2, 1 mM 2-alkylphenol,
0.5 mM CoQ1, 1 mM Triton X-100 or reduced Triton X-100. CoQ1 was reduced by adding
1.2 fold molar excess of NaBH4 (Sigma) (10 min, r.t.). Reactions were incubated (30 °C, 45
min) and 35 µL of Cytophos reagent was added and incubated (10 min, r.t.). Absorbance was
measured at 650 nm. Reactions in Figure 2E were incubated for 10 min rather than 45 min
and [Coq8pN∆41] was 0.5 µM. The standard curve ranged from 0–50 µM phosphate. Error bars
represent SD of technical triplicate measurements unless otherwise specified.
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3.5.5 In Vitro [γ-32P] Autophosphorylation and ATPase Comparison Assay
Method for Figure 3.4D. Coq8pN∆41 (4 µM) was mixed with [γ-32P]ATP (0.25 µCi/µL, 100 µM
[ATP]total) and MgCl2 (4 mM) in an aqueous buffer (20 mM HEPES, 150 mM NaCl, pH 7.5)
and incubated (30 °C, 45 min, 20 µL total reaction volume) (final concentrations for reaction
components). 10 µL of reaction was quenched with 10 µL 0.75 M potassium phosphate pH 3.3,
1 µL of quenched reaction was spotted on a PEI-cellulose TLC plate and developed using the
method above. The other 10 µL of the reaction was quenched with 4 µL 4 x LDS buffer and 10
µL was loaded onto an SDS-PAGE gel. [γ-32P]ATP was separated from Coq8pN∆41 by SDS-PAGE
(10% Bis-Tris gel, MES buffer, 150 V, 80 min). The gel was stained with Coomassie Brilliant Blue,
dried under vacuum, and imaged by digital photography. The same storage phosphor screen
was exposed to the TLC plate and the SDS-PAGE gel (1 hr) and then imaged with a Typhoon
(GE) to generate the phosphorimages used for quantification of Pi and autophosphorylation.
3.5.6 In Vitro [γ-32P]ATP ATPase Assay
Method for Figure 3.4F. Unless otherwise indicated, COQ8AN∆162 (2 µM) or Coq8pN∆41 (1 µM)
was mixed with liposomes (3.33 mM), [γ-32P]ATP (0.01 µCi/µL, 100 µM [ATP]total), and MgCl2
(4 mM) in an aqueous buffer (20 mM HEPES, 150 mM NaCl, pH 7.5) and incubated (20 mL total
volume, 30 °C, 45 min, 700 rpm) (final concentrations for reaction components). Reactions
were quenched with 0.75 M potassium phosphate pH 3.3 (20 µL, 4 °C). 1 µL of quenched
reaction was spotted on PEI-cellulose TLC (Millipore) and developed with 0.5 M LiCl in 1 M
formic acid(aq). After drying, a storage phosphor screen was exposed to the PEI-cellulose TLC
plate (∼5 hours) and then imaged with a Typhoon (GE) to generate the phosphorimages.
3.5.7 Yeast Drop Assay and Growth Curves
Yeast cultures for drop assays. S. cerevisiae (BY4742) ∆coq8 yeast were transformed as pre-
viously described96 with p426 GPD plasmids encoding Coq8p variants and grown on uracil
drop-out (Ura–) synthetic media plates containing glucose (2%, w/v). Individual colonies
of yeast were used to inoculate Ura– media (2% glucose, w/v) starter cultures, which were
incubated (30 °C, ∼18 h, 230 rpm). Serial dilutions of yeast (104, 103, 102, or 10 yeast cells)
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were dropped onto Ura– agar media plates containing either glucose (2%, w/v) or glycerol (3%,
w/v) and incubated (30 °C, 2 d). To assay yeast growth in liquid media, yeast from a starter
culture were swapped into Ura– media with glucose (0.1%, w/v) and glycerol (3%, w/v) at an
initial density of 5x 106 cells/mL. The cultures were incubated in a sterile 96 well plate with an
optical, breathable cover seal (shaking at 1140 rpm). Optical density readings were obtained
every 10 min.
3.5.8 Liposomes
Liposomes were made by drying down lipids in a 5 mL plastic tube under Ar(g) at room temper-
ature until a film was left. Liposomes were made of the following lipid (Avanti Polar Lipids) com-
positions: PC, PC/NBD-PE 99.9/0.1; PC/PE, PC/PE/NBD-PE 89.9/10/0.1; PC/CL, PC/CL/NBD-
PE 89.9/10/0.1; PC/PE/CL, PC/PE/CL/NBD-PE 79.9/10/10/0.1; PC/CoQ10, PC/CoQ10/NBD-PE
97.9/2/0.1; PC/PG, PC/PG/NBD-PE 89.9/10/0.1; PC/PS, PC/PS/NBD-PE 89.9/10/0.1; PC/PA,
PC/PA/NBD-PE 89.9/10/0.1; PC/CDP-DAG, PC/CDP-DAG/NBD-PE 89.9/10/0.1; all mol %.
The lipids were dried in a vacuum chamber overnight at 25-30 inHg vacuum. The dry lipid
film was reconstituted in HBS buffer (20 mM HEPES pH 7.5, 150 mM NaCl) at 30–35 °C for
one hour with occasional pipetting to resuspend the lipid film. The total concentration of
lipids in solution was 10 mM. 2 µL of the liposomes were taken before and after extrusion
and diluted with 22 µL of HBS to determine how much the liposomes were diluted during
extrusion by measuring the fluorescence of NBD-PE (excitation: 460 nm, emission: 535 nm).
Liposomes were extruded through 100 nm membranes (Avanti Polar Lipids), 15 passes, 30–35
°C. Liposomes were made fresh before each experiment.
3.5.9 Liposome Flotation Assay
Liposome flotation assay is adapted from Connerth et al.97 with the following modifications.
Liposomes (100 µL) were mixed with protein (50 µL 6 x COQ8) at 4 °C then incubated (r.t.,∼ 10
min). Final concentrations of reagents are as follows: 2–4 µM protein and 3.33 mM liposomes
in HBS (150 mM NaCl, 20 mM HEPES pH 7.5). 2.72 M sucrose (110µL) was added to the protein
liposome mixture (1.15 M [sucrose] final). The sucrose-liposome-protein mixture (250 µL)
was added to the ultracentrifuge tube. The sucrose gradient was made by layering 300 µL HBS
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0.86 M sucrose, 250 µL HBS 0.29 M sucrose, and 150 µL HBS on top of the sucrose-liposome-
protein mix. This gradient was centrifuged (240,000 g, 1 h, 4 °C). 450 µL was removed for the
top layer and 450 µL for the bottom layer. Liposome location was determined by mixing 8 µL
of top or bottom fraction with 16 µL HBS and reading NBD-PE fluorescence for (excitation:
460 nm, emission: 535 nm). To concentrate the protein from the top and bottom fractions, a
CHCl3:MeOH precipitation was performed according to Wessel and Flugge.98 Methanol (1800
µL, 4 volumes) was added to a 450 µL fraction. After thorough mixing chloroform (450 µL,
one volume) was added and vortexed. Water (1350 µL, three volumes) was added and the
mixture was vortexed again then centrifuged immediately at full speed (∼4,200 g, 5 min). A
white disc of protein should form between the organic layer (bottom) and the aqueous layer
(upper). Discard most of the upper aqueous layer, and be careful not to disturb the protein
pellet. Methanol was added (1000 µL) to the tube, inverted 3 times, and centrifuged at full
speed (5 min, 16,000 g). All of the liquid was removed and the pellet was air or vacuum dried.
The precipitated protein pellet was resuspend in 30 µL 1 x LDS with 10 mM DTT, incubated
(95 °C, ∼ 10 min), and analyzed with 4–12% Novex NuPAGE Bis-Tris SDS-PAGE (Invitrogen)
gels (1 hr, 150 V). Band quantification was done with imaging and densitometry on a LI-COR
Odyssey CLx (700 nm) using Image Studio v5.2 software. Error bars for Figure 4G represent SD
of three independent floats. Student’s t-test was used to determine statistical significance.
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4 Membrane, Lipid, and Protein
Interactions of Coenzyme Q
Biosynthesis Protein COQ9
This Chapter is adapted from the following published manuscript:
“An Isoprene Lipid-Binding Protein Promotes Eukaryotic Coenzyme Q Biosynthesis."
Lohman DC*, Aydin D*, Vonbank H, Smith R, Linke V, Weisenhorn E, McDevitt MT, Hutchins
P, Wilkerson E, Russell J, Stefely MS, Beebe ET, Jochem A, Bingman CA, Coon JJ, Dal Peraro M,
Pagliarini DJ.
Molecular Cell (2019) 73(4): 763-774.
doi: 10.1016/j.molcel.2018.11.033
Author Contributions: *D.C.L. and D.A. contributed equally. D.C.L., D.A., M.D.P., and D.J.P.
conceived of the project and its design and wrote the manuscript. D.C.L., H.C.V.B., R.W.S.,
M.S.S., E.T.B., and A.J. prepared samples and performed biochemical experiments. D.A.
performed computational experiments. C.A.B. solved the crystal structures. V.L., E.W., M.T.M.,
P.H., and E.M.W. acquired mass spectrometry data. D.C.L., D.A., E.T.B., C.A.B., P.H., J.R., J.J.C.,
M.D.P., and D.J.P. analyzed data.
The biosynthesis of coenzyme Q presents a paradigm for how cells surmount hydropho-
bic barriers in lipid biology. In eukaryotes, CoQ precursors—among nature’s most hydrophobic
molecules—must somehow be presented to a series of enzymes peripherally associated with
the mitochondrial inner membrane. In this Chapter, we reveal that this process relies on
custom lipid-binding properties of COQ9. We show that COQ9 repurposes the bacterial
TetR fold to bind aromatic isoprenes with high specificity, including CoQ intermediates that
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likely reside entirely within the bilayer. We reveal a process by which COQ9 associates with
cardiolipin-rich membranes and warps the membrane surface to access this cargo. Finally, we
identify a molecular interface between COQ9 and the hydroxylase COQ7, motivating a model
whereby COQ9 presents intermediates directly to CoQ enzymes. Overall, our results provide
a mechanism for how a lipid binding protein might access, select, and deliver specific cargo
from a membrane to promote biosynthesis.
4.1 Introduction
The synthesis and transport of biological lipids in a largely aqueous cellular terrain poses a
longstanding problem in biology.1, 99 A requisite first step in these processes is to access and
separate a lipid from its local membrane environment. One of nature’s strategies for dealing
with such hydrophobicity challenges is to employ lipid binding proteins, which possess di-
verse modes of action (Figure 4.1) Transmembrane enzymes, like stearoyl-CoA desaturase,
penetrate biological membranes and bring enzymatic function to the hydrophobic milieu.100
Lipid chaperones, like acyl carrier protein101, 102 or Ups1/Mdm35,97, 103, 104 solubilize lipids in
a hydrophobic pocket and transport them to soluble enzymes or insert them into membranes.
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Lipid liftases, like saposin C105 or PlsC106 act at the membrane-water barrier to partially lift
the lipid from the bilayer. Biosynthesis and spatiotemporal distribution of cellular lipids, from
fatty acids to sterols, may depend on one or more of these strategies.
Figure 4.1 – Lipid-Binding Proteins. Examples illustrated here include transmembrane enzymes
(stearoyl-CoA desaturase (PDB:4ZYO)), lipid chaperones (acyl carrier protein (PDB:2FAE)), and lipid
liftases (bacterial acyltransferase PlsC (PDB: 5KYM)). Proteins are placed with respect to the membrane
(represented by the gray area), where lipids bound to proteins are shown in pink sticks.
Coenzyme Q is a redox-active isoprene lipid that serves as a cofactor for numerous
enzymes across all domains of life.16 Deficiency in CoQ is linked to many rare inborn er-
rors of metabolism, and to common diseases including Parkinson’s and type II diabetes
mellitus.16, 107, 108 The molecular structure of CoQ is remarkable: its extraordinary isoprene
tail—composed of 50 carbons in humans—places it among the most hydrophobic molecules
in nature. This hydrophobicity keeps CoQ sequestered within the inner leaflet of the inner
mitochondrial membrane where it passes electrons between complexes I & II and complex III
in the electron transport chain. The CoQ tail is attached to an immature head group precursor
at an early step in CoQ biosynthesis. In eukaryotes, enzymes within complex Q (a.k.a., the CoQ
synthome) then modify this precursor to generate mature CoQ (see Figure 1.4).16, 109 For these
modifications to occur, complex Q enzymes must gain access to these hydrophobic precursors,
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which, like mature CoQ,110, 111 are thought to reside within the hydrophobic portion of the
membrane16; however, how this access is granted remains unknown.
Recently, it was shown that COQ9—a poorly characterized protein associated with CoQ
biosynthesis that structurally resembles the TetR family (TFR) of proteins15—can bind lipids,
suggesting that it may help complex Q overcome this hydrophobic challenge. Loss of COQ9
function in many organisms results in severe CoQ deficiency and underlies human disease,
demonstrating its central role in this pathway.112–117 However, which lipid(s) COQ9 binds, how
it accesses this cargo, and how this binding may assist other pathway enzymes have remained
open questions.
Here, we investigate the molecular mechanism of COQ9 lipid-binding biochemically
and computationally. We find that COQ9 binds aromatic isoprene lipids, accesses membranes
via a terminal amphipathic helix, and that both of these functions are crucial to its biological
role in CoQ production. We further establish a likely molecular interface between COQ9 and
COQ7—the hydroxylase that catalyzes the penultimate step in CoQ biosynthesis. Collectively,
these data suggest models in which COQ9 enables CoQ biosynthesis by accessing CoQ inter-
mediates from the leaflet of the mitochondrial inner membrane and presenting them to a
biosynthetic enzyme in the pathway.
4.2 Methods
This section presents the detailed description of the computational methods used in this study.
For experimental methods, please refer to Section 4.5.
4.2.1 Coarse-Grained Molecular Dynamics Simulations
Coarse-grained molecular dynamics (CG-MD) simulations were used to investigate: (i) the
interaction of COQ9 and COQ7 with bilayers containing different lipid compositions, (ii) the
flexibility of the α9-α10 hinge allowing different structural placements of α10. All simulations
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were performed using the GROMACS118 simulation package version 5.1.2.61 The systems
were described with the MARTINI 2.2P24, 62 force field, together with the ElNeDyn (Elastic
Network in Dynamics) approach to maintain the secondary structure of the protein.24, 63 All
simulations of COQ9 were performed using the crystal structure of COQ9 where the α10 is in
an extended conformation (PDB: 6AWL, chain A). Simulations of COQ7 were performed using
a homology model of COQ7 (see below). For visualization purposes, selected frames from
the CG-MD simulations were backmapped into atomistic coordinates using backward.py.119
Images were produced with PyMOL (Schrödinger LLC, Version 2.0) and videos were rendered
with VMD.70, 71
Protein-Membrane Systems
CG-MD simulations based on the MARTINI force field have been previously used with success
for different systems to investigate protein-lipid interactions.64–67 In CG-MD simulation sys-
tems, the center of mass of COQ9 was 70 Å away from the surface of the membrane. Since the
last 7 C-terminal residues of COQ9 were not solved in the crystal structure, these residues were
built to be disordered using Modeller version 9.11.120 Inner mitochondrial membrane (IMM)
models were built according to the CL composition of mammalian mitochondria, namely
10 to 20% of total mitochondrial phospholipids.68 Therefore, IMM mimics were featuring a
lipid concentration of 16% CL/41% POPC/37% POPE/6% DSPC, while generic membrane
models featuring 100% POPC lipids were built as control. The IMM model was approximated
to have a symmetrical concentration of lipids between the two leaflets since precise lipidomic
information about concentration asymmetry is not known. Lipid bilayers of 160 × 160 Å2 were
generated using the insane (INSert membrANE) method of MARTINI.69 Systems were solvated
with polarizable CG water, and ions were added to the system to obtain a 150 mM NaCl aque-
ous solution, with extra ions added to neutralize the system. Following solvation, systems were
energy minimized with a timestep of 5 fs. Successive equilibrations with decreasing restraints
were performed in order to obtain a fully equilibrated system (force constants of 1000, 500,
250 and 0 kJ/mol applied on protein particles, 10 ns of runs with a timestep of 5 fs for each).
In the production phase (10 µs of run with a timestep of 15 fs), the protein, membrane and
the aqueous phase (water and ions) were coupled independently to an external bath at 310
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K by using the v-rescale thermostat. The pressure was coupled to a pressure bath at 1 bar by
semi-isotropic Parrinello-Rahman pressure coupling. Three MD repeats with randomized
initial velocities were performed for each membrane system and they yielded consistent re-
sults (Fig. 4.7A, 4.7B, 4.8B, 4.8D). The minimum pairwise distances between the protein and
the membrane were calculated using the gmx pairdist tool of Gromacs,118 which takes into
account the distance to the periodic image of the membrane. The MSD and lateral diffusion
coefficients were calculated using the gmx msd tool of Gromacs.118 Average occupancies
of lipids were calculated using VMD’s VolMap plugin and visualized using VMD.70 CG-MD
simulations of COQ7 were performed to investigate the binding of COQ7 to 130 × 130 Å2 IMM
models (16% CL/41% POPC/37% POPE/6% DSPC). The procedure applied to COQ9 was used.
Protein-Membrane Systems InvolvingCoQMolecules: We used the readily available CG topol-
ogy for CoQ (ubiquinol), which has been shown to be in good agreement with experimental
data.121 Ideally, we would use DMQ in these simulations, but parametrizing DMQ at CG
resolution was beyond the scope of this study. CoQ is very similar to DMQ at the CG level of
resolution. To investigate how CoQ interacts with COQ9, we performed CG-MD simulations of
COQ9 with a PC/PE/CL/CoQ10 membrane. To build this system, four CoQ molecules were first
placed in solution near the membrane surface without COQ9, and the system was energy min-
imized, equilibrated (25 ns with a time step of 5 fs) and simulated for 3 microseconds where
CoQ molecules diffused inside the membrane, positioning their aromatic head groups on an
inner plane compared to the lipid phosphate head groups, confirming the results previously
obtained.121 The last frame of this simulation was used to add COQ9 to the system, where it
was placed near the membrane surface, minimized and equilibrated through the procedure
described above for protein-membrane systems, and this system was finally simulated for 10
microseconds.
Protein in Solution Systems
The MARTINI force field allows protein tertiary arrangements, whereas local secondary struc-
ture is predefined and imposed. COQ9 was solvated with polarizable CG water and ions were
added to the system to obtain a 150 mM NaCl aqueous solution, with extra ions added to
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neutralize the system. Following solvation, systems were energy minimized with a timestep of
5 fs. Successive equilibrations with decreasing restraints were performed in order to obtain a
fully equilibrated system (force constants of 1000, 500, 250 and 0 kJ/mol applied on protein
particles, 10 ns of runs with a timestep of 5 fs for each). In the production phase (10 µs of run
with a timestep of 15 fs), the protein and the aqueous phase (water and ions) were coupled
independently to an external bath at 310 K. No pressure coupling was applied.
4.2.2 Bioinformatics, Docking, and Modeling
Bioinformatics Analysis of Secondary Structures of TFR proteins
Secondary structures were assigned to the representative set of TFR sequences as defined by
Yu and colleagues122 and to COQ9 using ICM-Pro molecular modeling software.33 Each helix
was aligned and centered independently for all the reference TFRs, and the mean helix length
and the standard deviation was computed for each helix. This analysis therefore does not
take into account loop regions. For each residue position of each helix the percentage of TFRs
having a residue that belongs to this helix was calculated.
Ligand Docking
Ligand docking and scoring was performed using the ICM-Pro molecular modeling soft-
ware.33, 123 ICM ligand docking is based on biased probability Monte Carlo (BPMC) optimiza-
tion of the ligand internal coordinates in the set of grid potential maps of the receptor, where
the grid potential maps account for van der Waals, hydrogen-bonding, hydrophobic, and
electrostatic interactions between ligand and receptor. The crystal structure of COQ9 where
the α10 is in an extended conformation (PDB: 6AWL, chain A) was used as the receptor. DMQ5
was used as the ligand instead of DMQ10 because part of the hydrophobic tail of DMQ10 is ex-
pected to reside in the membrane and because using such a long ligand increases the degrees
of freedom and decreases the docking accuracy. The ligand was represented as an all-atom
model and considered fully flexible. The standard docking procedure of ICM was used without
the use of any experimentally derived information. Docking poses were evaluated with the
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ICM ligand binding score:
Sbi nd = Ei nt +∆STor +Evd w +α1Eel +α2Ehb +α3Ehp +α4Es f (4.1)
where Ei nt is the internal strain of the ligand, T =300 K , ∆STor is the conformational
entropy loss of the ligand upon binding, αi are constants independent from the ligand and
receptor. Evd w , Eel , Ehb , Ehp , Es f are van der Waals, electrostatic, hydrogen bonding, and
nonpolar and polar atom solvation energy differences between bound and unbound states, re-
spectively. To compare the docking pose to the co-crystallized isoprenes (PDB: 6DEW), chains
A-F and co-crystallizing isoprenes were superimposed to the docked complex. The RMSD
between the isoprene chain of DMQ5 and that of farnesol (bound to chain A) were calculated
on 15 matching carbon atoms and was found to be 1.5 Å. To visualize the DMQ5-bound COQ9
on the membrane, the globular domain of COQ9 was superimposed in the docked complex
to the globular domain of COQ9 in a membrane-bound state obtained from the CG-MD
simulation. Since the ligand found contacts with W240 in the docking procedure, the crystal
structure conformation of W240 (PDB: 6AWL, chain A) was used for the membrane-bound
state of COQ9 for visualization purposes in Figure 4.11D.
Homology Modeling of COQ7
At present, there are no crystal structures available for human COQ7. Pfam124 identifies COQ7
as a di-iron carboxylate protein that belongs to the ferritin-like superfamily. Members of this
protein family are known to have a four-helix bundle folding architecture with a conserved
iron binding motif.125 Several attempts were previously made to model Coq7 homologues (P.
aeruginosa, R. norvegicus, S. cerevisiae) using homology modeling techniques.125–127 Here,
we used a similar approach to model the structure of COQ7 from H. sapiens starting from
its sequence as obtained from the UniProt database (accession number Q99807).128 SWISS-
MODEL automated comparative protein modeling server129 was used in Automated Mode to
construct a homology model of the human COQ7. The N-terminal 37 residues were removed
from the sequence since they had low conservation and since this region was predicted to be
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disordered; the C-terminal 32 residues were not modeled since this region was missing in all
found templates and was not included in the predicted four-helix bundle. SWISS-MODEL
uses two scores for model evaluation: GMQE and QMEAN. GMQE (Global Model Quality
Estimation) is expressed as a number between 0 and 1, and a higher value means higher
model reliability. QMEAN130 estimates the quality of the model compared to experimental
structures, and a higher value means better agreement between the model structure and
experimental structures of similar size, where scores around zero indicate a good degree of
nativeness and scores lower than or equal to -4.0 indicate a low quality model. The best
template identified by SWISS-MODEL for COQ7 is a ferritin (PDB: 5HJH, 1.88 Å resolution),
which has a 15% sequence identity to COQ7. The generated model has a GMQE score of
0.43 and QMEAN score of -3.09. Despite the initial low sequence identity with templates,
COQ7 shares the well-defined structural fold of the ferritin-like superfamily (as determined
by Pfam124). Therefore, modeling its four-helix bundle structure was facilitated by helical
secondary structure prediction and the strong conservation of the iron binding motif. The
resulting model was consistent with previously published models of Coq7p.125–127
Homology Modeling of Coq9p
COQ9 sequences from H. sapiens (accession number O75208) and S. cerevisiae (accession
number Q05779) were obtained from the UniProt128 database and were aligned using Clustal
Omega.131 This alignment was used to model yeast Coq9p with Modeller version 9.11.120 The
MD refinement parameter was turned off and 5 models were generated, where the model with
the lowest molpdf score was chosen as the final model.
Protein-Protein Docking
To model the COQ9-COQ7 complex, the protein-protein docking server ZDock was used.132
In predicting protein-protein complexes, ZDock takes into account shape complementarity,
electrostatics and desolvation free energy.133 The crystal structure of COQ9, where the α10 is
in an extended conformation (PDB: 6AWL, chain A), and the homology model generated for
COQ7 were used as input structures. Protein-protein docking was guided by (i) the experimen-
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tal data (Fig. 4.10A), where residues that disrupted binding were forced to be included in the
interface and residues that did not affect binding were forced not to be included and (ii) the
preferred membrane orientation of COQ9 and COQ7 as obtained from CG-MD simulations.
Ten poses were obtained where the intermolecular contacts of Fig. 4.10A were fulfilled and the
ZDock score of the least favored pose was lower by at most 30% of the best pose. Seven of the
ten complex conformations were not occluding the membrane binding surface of COQ9 as
identified through CG-MD simulations, and the top two conformations of this cluster were
not occluding the membrane binding surface of COQ7. These two conformations showed only
minor differences and an equivalent complex architecture having an RMSD as low as 5.2 Å.
The best ZDock pose between these two conformations was therefore used as representative
of COQ9-COQ7 interactions and is reported in Figure 4.11.
4.3 Results
4.3.1 COQ9 Specifically Binds Aromatic Isoprenes
Recently, the fortuitous co-crystallization of COQ9 with a mixture of phospholipids was re-
ported.15 This discovery, along with structural homology to ligand binding domains of the
TFRs and a predominantly hydrophobic cavity, defined COQ9 as a lipid-binding protein. Yet,
the identity of bona fide COQ9 ligands remains unknown.
To identify endogenous lipid ligands of COQ9, we purified a tagged version of its yeast or-
tholog (Coq9p-FLAG) from Saccharomyces cerevisiae and identified ligands by mass spectrom-
etry. Among various co-purifying lipids were several CoQ intermediates (Figures 4.2B, 4.2C).
Membrane-associated proteins purified from endogenous sources are often accompanied
by non-specific lipids. Therefore, to distinguish specific lipid interactions from non-specific
binders, we mutated the highly conserved, surface-exposed tryptophan that resides near the
co-crystallizing phospholipid in our previous COQ9 structure (Figure 4.2D) and is essential for
COQ9 function.15 Interestingly, this mutation was not well tolerated in S. cerevisiae (see Figure
4.12), so we performed these experiments in E. coli, which lack a COQ9 homolog.
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Figure 4.2 – LC-MS/MS Analysis of COQ9 Lipid Ligands, Related to Figures 4.3 and 4.12. (A)
Head group modifications of eukaryotic CoQ biosynthesis post-attachment of the polyprenyl tail
(R) where S. cerevisiae (Coq#p) and H. sapiens (COQ#) protein names are shown. PPHB, polyprenyl-
hydroxybenzoate; PPAB, polyprenyl-aminobenzoate; PPDHB, polyprenyl-dihydroxybenzoate; PPVA,
polyprenyl-vanillic acid; DDMQ, demethoxy-demethyl CoQ; DMQ, demethoxy CoQ; DMeQ, demethyl
CoQ; CoQH2, reduced CoQ. Below, chemical head group bypasses used in Figures 4.12 and 4.13, where
pre-modified moieties are in purple. (B) Sypro-stained SDS-PAGE of Coq9p-FLAG immuno-purification
from S. cerevisiae. (C) Top ranking identified lipids enriched (enrichment > 3, p-value < 0.05) in Coq9p-
FLAG pull-down from S. cerevisiae compared to whole cell lysate. CoQ intermediates are highlighted
in red in panels A and C. (D) Co-crystallized phospholipid with COQ9, where W240 is in red and the
phospholipid is in black stick, PDB ID 4RHP. (E) LC-MS/MS quantification of enriched E. coli lipids
from purified protein in Fig. 4.3, where WT is His8-MBP-COQ9N∆79, W240K is His8-MBP-COQ9N∆79,
W240K and MBP is His6-MBP. Lipid peak areas are normalized to the total peak area per sample and
error bars represent standard deviation (n=3). (F) LC-MS/MS quantification of E. coli lipids in Fig. 1
from the E. coli lysates expressing recombinant protein, with bar colors described in panel F: WT is
His8-MBP-COQ9N∆79, W240K is His8-MBP-COQ9N∆79, W240K and MBP is His6-MBP. Lipid peak areas
are normalized to the total peak area per sample and error bars represent standard deviation (n=3).
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Figure 4.3 – COQ9 Binds Aromatic Isoprenes. (A) LC-MS/MS total ion chromatograms of lipids co-
purifying with Tag-COQ9N∆79, Tag-COQ9N∆79, W240K, and Tag expressed in E. coli where “Tag” is His8
followed by maltose binding protein. (B) Chemical structures of identified enriched lipids (fold-change
> 4, p-value < 0.01) in Tag-COQ9N∆79 compared to Tag-COQ9N∆79, W240K and Tag. The enriched
lipid with the highest intensity signal is highlighted in red. (C) Representative isoprene positions
(stick) observed on a hydrophobic surface and in the cavity of COQ9N∆79,C∆31 with W240 in red and
the hydrophobic surface in light blue (PDB: 6DEW). Of six isoprenes that co-crystallized in various
positions on four of the six COQ9 chains (A,B,D,F) in the unit cell, the three shown are representative of
distinct placements and are all mapped to a single COQ9 molecule (chain A). (D) Model for how an
aromatic long-chain isoprene could potentially bind on the surface of COQ9, where the COQ9 cavity is
shaded, the hydrophobic surface is outlined, and potential pi-pi stacking interactions with W240 on
α7-α8 loop are highlighted. See also Figures 4.2, 4.4 and Table 4.2.
Specifically, we purified tagged (His-MBP) versions of human COQ9N∆79 (the version
of COQ9 whose structure was solved previously; see Table 4.1), COQ9N∆79,W240K (this same
construct with the tryptophan mutated to lysine), and His-MBP alone from E. coli, and again
identified co-purifying lipids by mass spectrometry (Figure 4.3A). Consistent with our previous
work, phospholipids were the most abundant species co-purifying with COQ915; however,
the W240K construct also co-purified with many phospholipids (Figure 4.3A). Remarkably, all
identified lipids specifically enriched in WT COQ9N∆79 were aromatic isoprenes, including
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CoQ(reduced), menaquinone (a bacteria-specific CoQ-like molecule), and their various pre-
cursors (Figure 4.3B, 4.2E). This enrichment in lipids resembling CoQ was not due to a global
change in lipid levels in the E. coli expressing the recombinant protein (Figure 4.2F).
Table 4.1 – Protein Constructs, Related to Figures 4.3, 4.10, 4.11 and 4.12.
Experiment Expression
system
Protein construct description
S. cerevisiae APMS S. cerevisiae (“Coq9p-FLAG”) Full length S. cerevisiae Coq9p with
C-terminal linker (LDLE) and FLAG tag
E. coli APMS E. coli (“His8-MBP-tev-COQ9N∆79”) Solubility tag
(His8-MBP) with linker and TEV protease cleavage site
N-terminal to H. sapiens COQ9 amino acids 79-318
(N-terminal 79 residues deleted)
Crystallography E. coli (“COQ9N∆79” and “COQ9N∆79,C∆31 aka COQ9∆α10”) H.
sapiens COQ9 amino acid residues 79-218 or 79-287
(C-terminal 31 residues deleted that correspond to the
10th alpha helix) with two additional amino acids
residual from TEV protease cleavage
Co-purification of
COQ7
Cell-free wheat
germ extract
(“SII-COQ9N∆45” or “His6-COQ7N∆38”) N-terminally
tagged H. sapiens protein with 45 or 38 N-terminal
amino acids deleted, respectively
S. cerevisiae growth S. cerevisiae (“Coq8p-FLAG” and “Coq9p-FLAG”) Full length S.
cerevisiae proteins with C-terminal linker (LDLE) and
FLAG tag
To understand how COQ9 accommodates isoprenes, we co-crystallized COQ9 with
the isoprene lipid geranylgeraniol (Figure 4.3C), as CoQ intermediates themselves have low
solubility and are not commercially available. We performed these co-crystallization experi-
ments with a truncated protein (COQ9N∆79,C∆31) to remove a C-terminal amphipathic helix
that previously co-crystallized near the lipid binding site, possibly occluding ligand entry
into the binding pocket when COQ9 is not associated with a membrane (Figure 4.5B). We
determined the geranylgeraniol:COQ9N∆79,C∆31 structure to 2 Å (Table 4.2, PDB: 6DEW). Six
isoprene positions on multiple COQ9 chains in the unit cell were well-defined in the electron
density (Figures 4.4A, 4.4B), with isoprenes commonly positioned along a hydrophobic surface
of COQ9 and in the hydrophobic cavity (Figures 4.3C, 4.4D).
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Table 4.2 – Data Collection and Refinement Statistics. Statistics for the highest-resolution shell are
shown in parentheses.
COQ9N∆79 P21 COQ9N∆79, C∆31 GG
(PDB: 6AWL) (PDB: 6DEW)
Wavelength 1.033 1.127
Resolution range 48.69 – 2.0 (2.071 – 2.0) 48.0 - 2.0 (2.071 - 2.0)
Space group P 1 21 1 C 2 2 21
Unit cell 38.11 97.39 63.65 90 95.4 90 116.45 222.78 130.78 90 90 90
Total reflections 159831 (15769) 1545884 (159984)
Unique reflections 31219 (3066) 114146 (11326)
Multiplicity 5.1 (5.1) 13.5 (14.1)
Completeness (%) 99.90 (100.00) 99.68 (99.87)
Mean I/sigma(I) 12.38 (1.25) 15.48 (1.51)
Wilson B-factor 36.31 37.83
R-merge 0.09055 (1.355) 0.1274 (1.759)
R-meas 0.101 (1.51) 0.1325 (1.824)
R-pim 0.04409 (0.658) 0.03598 (0.4802)
CC1/2 0.998 (0.48) 0.998 (0.622)
CC* 1 (0.805) 1 (0.876)
Reflections used in refinement 31212 (3066) 114124 (11326)
Reflections used for R-free 2000 (197) 2045 (197)
R-work 0.1974 (0.3016) 0.1692 (0.2626)
R-free 0.2454 (0.3183) 0.2094 (0.3055)
CC(work) 0.957 (0.710) 0.967 (0.817)
CC(free) 0.962 (0.679) 0.947 (0.730)
Number of non-hydrogen atoms 3564 9744
Macromolecules 3313 9183
Ligands 46 106
Solvent 205 455
Protein residues 409 1138
RMS(bonds) 0.003 0.019
RMS(angles) 0.64 1.59
Ramachandran favored (%) 97.52 97.69
Ramachandran allowed (%) 1.98 2.13
Ramachandran outliers (%) 0.50 0.18
Rotamer outliers (%) 1.12 0.51
Clashscore 4.21 4.09
Average B-factor 43.21 52.11
Macromolecules 42.82 51.61
Ligands 63.56 102.08
Solvent 44.83 50.57
Number of TLS groups N/A 36
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Figure 4.4 – Crystal Structure of COQ9 with Geranylgeraniol and Extended Helix 10, Related to
Figures 4.3 and 4.5. (A) Six modeled isoprene positions (black, #1-6) on six COQ9 chains (A-F) in
the asymmetric unit (PDB: 6DEW), where Chains A-F are in blue, light blue, blue-white, white, light
cyan, and light teal respectively. All chains and co-crystallizing isoprenes were then aligned to Chain
A. Isoprene positions shown in Fig. 4.3 are in black and those co-crystallizing in similar positions are
in white. (B) Composite simulated annealing omit maps showing electron density (1σ) for the most
ordered isoprenes (FOH ligands in Chains A and B). Similar electron density that was somewhat less well
defined was observed at the same sites in all of the protomers. (C) Overlay of COQ9N∆79,C∆31 chains A
(blue) and F (teal), where conformations of theα7-α8 loop are in cartoon and COQ9 residues important
for COQ7 binding (D237, W240, Y241) are highlighted. The difference between loop conformations is
17.7 Å, at its widest point (dotted line). (D) Electrostatic potential of COQ9 Chain A generated by the
Adaptive Poisson-Boltzmann Solver (Jurrus et al., 2018). The α7-α8 loop is excluded from the surface.
Negative electrostatic potential is red, positive is blue, and zero is white. The hydrophobic surface was
outlined and mapped to Figure 4.3C.
Additionally, the α7-α8 loop that contains W240 adopted multiple conformations in
the crystal lattice, moving up to 17.7 Å, indicating dynamic movement of the residue that
conferred ligand specificity above (Figure 4.4C). The multiple isoprene positions suggest a
model whereby the long-chain isoprene of a CoQ-like molecule would occupy the hydrophobic
regions of COQ9 while the aromatic head group extends towards a flexible W240 (Figure 4.3D).
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Together, the co-purification of COQ9 with CoQ intermediates from an endogenous context
in yeast, its selective co-purification with several aromatic isoprenes from bacteria, and its
crystallization with an isoprene lipid suggest that binding CoQ isoprene intermediate(s) is
central to COQ9’s molecular function. To our knowledge, this is the first lipid binding protein
with specificity for this lipid class.
Figure 4.5 – The 10thα-Helix of COQ9 is Unique, Amphipathic, and Flexible. (A) Consensus helices
of TetR Family Regulators with average length and standard deviation across 27 representative struc-
tures (Yu et al., 2010). COQ9 helices and lengths are mapped below withα10 in dark blue. The presence
and length of COQ9’sα10 is uncommon among TFRs. (B) Modeled position ofα10 in the original COQ9
structure (PDB: 4RHP) where the α9-α10 loop was not resolved. Symmetry mates are in gray, a single
COQ9 protomer is outlined in surface, and α10 is in either dark blue or black. (C) Helical wheel of α10
(A287-L311) with the hydrophobic face highlighted in green, hydrophobic residues in black, A and G
in gray, and polar residues in white. (D) Position of α10 in the structure reported in this work (PDB:
6AWL) where the α9-α10 loop was resolved and shows that α10 extends away from globular COQ9 to
form crystal contacts with an adjacent COQ9 molecule. Symmetry mates are in gray, a single COQ9
protomer is outlined in surface, and α10 is in either dark blue or black. (E) Snapshots of COQ9 with
three positions of α10 (dark blue) sampled during CG-MD solution simulations, where hydrophobic
residues are green. See also Figure 4.4 and Table 4.2.
4.3.2 The Amphipathic 10th α-Helix of COQ9 Drives Membrane Association
Within mitochondria, CoQ isoprene intermediates are thought to be either embedded in
the inner mitochondrial membrane (IMM), like mature CoQ, or to be channeled through
the membrane-associated complex Q in a ‘metabolon’-like fashion.16 We sought to define
how COQ9 might access CoQ intermediates from the IMM and how COQ9 accessed the
membrane-embedded lipids reported here (Figure 4.3). In addition to its core TetR fold—a
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base architecture that can enable binding of specific metabolites, including hydrophobic
polyketides and fatty acids122, 134, 135—COQ9 also possesses a distinct, amphipathic C-terminal
10th α-helix (α10) not typical among TFR proteins (Figures 4.5A, 4.5C).
Figure 4.6 – COQ9 Associates with Membranes in 5 Steps. (A) Snapshots representative of the multi-
step COQ9 membrane binding mechanism observed in CG-MD simulations (phospholipid head
groups in gray and membrane-interacting residues of COQ9 in green; COQ9 model based on PDB:
6AWL). (B) SDS-PAGE of liposome co-flotation of COQ9N∆79 alanine mutants with PC/PE/CL/NBD-PE
(68.9/9/22/0.1%) liposomes where L is ladder; In, protein input; B, liposome bound protein; and UB,
unbound protein. (C) Quantification of liposome bound COQ9 alanine mutants (MT) in panel B relative
to WT by densitometry (100x(BMT/TotalMT - BWT/TotalWT) where * indicates a significant (p-value <
0.05, n=3) difference from WT binding and error bars represent standard deviation. (D) SDS-PAGE of
liposome co-flotation of COQ9 α10 mutants in PC/PE/CL/NBD-PE (68.9/9/22/0.1%) liposomes where
Quint S is V290S,L297S,V298S,L301S,M302S, ∆α10 is COQ9N∆79,C∆31. (E) Quantification of liposome
bound COQ9 mutants in panel D relative to WT by densitometry (100×(BMT/TotalMT - BWT/TotalWT))
where * indicates a significant (p-value < 0.05, n=3) difference from WT binding and error bars represent
standard deviation. (F) Liposome co-flotation schematic where liposome bound (B) and unbound
(UB) fractions quantified by SDS-PAGE densitometry are shown. (G) Thermal melt curve derivative
plots (∆fluorescence/∆temperature from 40–65 °C) for proteins assayed by liposome co-flotation as
measured by differential scanning fluorimetry. All plots are scaled as shown in WT and the thermal
melting temperature (Tm) is at the apex of the melt curve derivative plot.
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Similar structural features are used by other lipid binding proteins to drive their in-
teractions with membranes,136–138 leading us to hypothesize that α10 has a role outside the
canonical TetR fold, potentially to localize COQ9 to membrane-bound cargo in the IMM. We
determined the structure of the α10-containing COQ9N∆79 to 2 Å resolution and discovered
that α10 extends away from the rest of COQ9, forming a crystal contact at the interface of two
adjacent COQ9 chains in the crystal lattice (Figure 4.5D; Table 4.2, PDB: 6AWL). Furthermore,
coarse-grained molecular dynamics (CG-MD) simulations of COQ9 in solution revealed a
dynamic 200-degree movement of α10 where α10 collapsed on the hydrophobic surface of
COQ9 within 3 µs, moved across this surface for 7 µs, and eventually re-extended (Figure 4.5E).
To examine the mechanism of COQ9 membrane association, including a potential role
for α10, we performed CG-MD simulations of COQ9 with membrane models comprised of
phosphatidylcholine (PC), phosphatidylethanolamine (PE), and cardiolipin (CL) to resemble
the IMM (Daum, 1985). In these simulations, COQ9 invariably associated with the mem-
brane in a multi-step fashion (Figure 4.6A). COQ9 first diffused in the aqueous environment
until two lysines (K288, K291 in Step 1) in the α9-α10 loop interacted electrostatically with
phosphate head groups of negatively charged cardiolipin. Second, hydrophobic residues of
α10 (V290, L297, V298, L301, M302 in Step 2) interacted with the membrane, reaching the
glycerol backbones of membrane phospholipids. Next, the protein core (α1-α9) approached
the membrane, first with α8 (W240, Y241 in Step 3) and then with α7 (P210, H211 in Step
4). Finally, residues along the hydrophobic surface of COQ9 were exposed to the membrane
(P201, L204, I206, M208, L209, I213, L217, L256 in Step 5).
To investigate the step-wise membrane binding mechanism biochemically, we tested
whether COQ9 alanine mutants of residues contributing to Steps 1-4 affected liposome co-
flotation (Figures 4.6A-4.6C, 4.6F). Consistent with simulations, neutralizing the electrostatic
interaction in Step 1 decreased membrane association, while mutations to residues mediating
Steps 3 and 4 did not (Figures 4.6B, 4.6C). Alanine mutants of α10 hydrophobic residues in
Step 2 reduced liposome association the most (Figures 4.6B, 4.6C). Similarly, mutating α10
hydrophobic residues to serine or fully deleting α10 reduced liposome association by more
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than 60% (Figures 4.6D, 4.6E). Importantly, all tested mutants had robust thermal melt curves,
indicating stably folded protein (Figure 4.6G).
4.3.3 COQ9 Association with Cardiolipin-Rich Membranes Warps the Lipid Bi-
layer
COQ9 membrane association was strongly influenced by CL, a quintessential mitochondrial
lipid with key roles in cristae organization and respiratory supercomplex formation.12, 139–141
In CG-MD simulations featuring a simple PC-based membrane model, COQ9, although
approaching the membrane several times, was not able to establish a specific and stable
interaction with the membrane (Figures 4.7A, 4.7B). Consistently, cardiolipin specificity was
observed biochemically in liposome co-flotation assays (Figures 4.7C-4.7H).
Our simulations also revealed striking features of membrane lipid organization upon
COQ9 association. In Step 5, the hydrophobic surface of COQ9 displaced lipid head groups,
creating a deformation in the membrane, an area void of phosphate head groups, and a
higher concentration of CL surrounding α7, α8 and α10 (Figure 4.8A). Lipids interacting
with COQ9 had low diffusion coefficients, where recurrently binding CL molecules persisted
for over 5 µs and established favorable interactions with residues K288 and W240 (Figure
4.8B). The local deformation of the membrane surface caused lipids surrounding COQ9 to
be orthogonally displaced from the membrane surface by 5 Å while their hydrophobic tails
entered the hydrophobic cavity of COQ9 (Figures 4.8C, 4.8D).
Such lifting of lipids off the membrane by a peripheral membrane protein is reminis-
cent of, although distinct from, the mechanism observed in a previous MD study reporting
the partial extraction of a single PC molecule into the hydrophobic pocket of phosphatidyli-
nositol transfer protein-α (PITPα).142 These observations in CG-MD simulations provide
a potential molecular mechanism for how COQ9 extracted lipid cargo in the adventitious
co-crystallization with phospholipids and in the specific co-purification with aromatic iso-
prenes. Collectively, our computational and biochemical findings support a model whereby
the amphipathic α10 drives membrane association in a multi-step fashion and poises the
hydrophobic surface of COQ9 to deform the IMM in order to access membrane-bound lipids.
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Figure 4.7 – COQ9 Membrane Association is Strongly Influenced by Cardiolipin. (A) Time evolu-
tion of the minimum pairwise distance between COQ9 and the membrane (PC (black) or PC/PE/CL
(red)) in CG-MD simulation replica 1. (B) Time evolution of the minimum pairwise distance between
COQ9 and the membrane (PC (black) or PC/PE/CL (red)) in CG-MD simulation replicas 2 (solid)
and 3 (dotted). (C) SDS-PAGE of liposome co-flotation of COQ9N∆79 with PC/NBD-PE (99.9/0.1
molar %), PC/PE/NBD-PE (90.9/9/0.1%), PC/CL/NBD-PE (77.9/22/0.1%), or PC/PE/CL/NBD-PE
(68.9/9/22/0.1%) liposomes, as described in Figure 4.6. (D) Quantification of liposome bound COQ9 in
panel C by densitometry (100×B/Total) where * indicates a significant (p-value < 0.05, n=2) difference
from PC liposomes and error bars represent standard deviation. (E) SDS-PAGE of liposome co-flotation
of COQ9N∆79 in PC/CL/NBD-PE, PC/PA/NBD-PE, PC/PS/NBD-PE, PC/PG/NBD-PE, or PC/PE/NBD-PE
(all 77.9/22/0.1 molar %) liposomes. (F) Quantification of liposome bound COQ9 in panel E by densito-
metry (100×B/Total) where error bars represent standard deviation (n=2). (G) SDS-PAGE of liposome
co-flotation of COQ9N∆79 with PC/CL/NBD-PE liposomes, with increasing CL molar %(10,15,20,25,30)
where NBD-PE is at a constant 0.1 molar %, as described in Figure 4.6. (H) Quantification of liposome
bound COQ9 in panel G by densitometry (100×B/Total) where error bars represent standard deviation
(n=2).
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Figure 4.8 – COQ9 Warps Cardiolipin-Containing Membranes. (A) The occupancy of lipid phos-
phate head groups averaged throughout a 7.5 µs CG-MD simulation during membrane interaction,
with phosphate head groups of CL in red and PC/PE in gray, viewed from inside the membrane. (B)
Mean square displacement of representative CL (red), PC (gray), PE (blue) lipids, for those that establish
a stable interaction with COQ9 (“int,” dark colors) and never interact with COQ9 (“non,” light colors)
for a PC/PE/CL membrane (replica 1). Lateral diffusion coefficients are given in nm2/µs in parentheses
in the legend for replica 1. Lateral diffusion coefficients in nm2/µs for replica 2: CL-int: 0.4, PC-int:
22.4, PE-int: 7.5, CL-non: 90.5, PC-non: 157.6, PE-non: 136.5, and for replica 3: CL-int: 2.3, PC-int:
9.1, PE-int: 7.2, CL-non: 112.3, PC-non: 131.0, PE-non: 123.9. (C)Snapshot from a CG-MD simulation
after Step 5 where CL (red) and PC (gray) acyl tails enter the COQ9 hydrophobic cavity (yellow), viewed
from the N-terminus of COQ9. (D) The z-shift of lipid phosphate head groups that are within 12 Å of
membrane-bound COQ9 relative to the base plane of membrane lipid phosphate head groups, for
replicas 1 (solid), 2 (dashed), and 3 (dotted). For each replica, t=0 µs refers to the beginning of a stable
interaction of the protein with the membrane (Step 4 in Fig. 4.6A); therefore, each replica has a different
total membrane interaction time.
4.3.4 COQ9 Interaction with Aromatic Isoprenes Illuminates Mechanisms of Speci-
ficity
Investigating the interaction of COQ9 with membrane-embedded isoprene molecules could
illuminate mechanisms of specificity. To investigate how CoQ interacts with COQ9, we per-
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formed CG-MD simulations of COQ9 with a PC/PE/CL/CoQ10 membrane.
In this new simulation, as observed previously with PC/PE/CL membranes, COQ9
created an area void of lipid phosphate heads and all four CoQ molecules migrated to this
"tightly sealed" hydrophobic region created by COQ9 (Figure 4.9A). Once COQ9 associated
with the membrane, one CoQ molecule quickly occupied the hydrophobic pocket of COQ9
and established a very stable interaction (residence time > 10 µs, Figure 4.9B). Other CoQ
molecules interacted more transiently with the hydrophobic surface of COQ9. The interaction
was always through the CoQ head group, whereas the isoprene tail extended towards the
membrane (Figure 4.9A). This simulation supports a model whereby, COQ9 acts as an attractor
or a hub for CoQ molecules, creating a favorable environment for them. Our simulation also
highlights possible modes of entry and mechanisms of specificity for isoprene lipids into the
COQ9 pocket. Namely, the simulations revealed aromatic stacking interactions between W240
and multiple CoQ molecule headgroups (Figure 4.9B).
The multiple isoprene positions in the geranylgeraniol-bound COQ9 crystal structure
could serve as an independent check of the accuracy of our simulations. We therefore com-
pared the CoQ poses from our simulation to the geranylgeraniol poses in the crystal structure.
Our reasoning for not using geranylgeraniol in our simulations is that (1) geranylgeraniol is
not an endogenous ligand of COQ9 (it was used in co-crystallization experiments because
of its higher solubility) and (2) geranylgeraniol is likely to behave differently in a simulated
membrane than in co-crystallization experiments, which lack a membrane and the corre-
sponding COQ9:membrane interactions. Generally, our crystallography and simulations were
highly consistent with the COQ9 hydrophobic surface and cavity binding CoQ-like molecules
(Figures 4.9C-E).
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Figure 4.9 – COQ9 Creates a Hub for CoQ Molecules. (A) Side view of all four CoQ molecules (head
groups shown in dark green and tails in light green) interacting with COQ9. (B) Top view of all four
CoQ molecules (head groups shown in solid green and tails in transparent green) interacting with
COQ9, showing one CoQ molecule bound to the hydrophobic pocket (yellow), and aromatic stacking
interactions between two CoQ molecules and W240 (magenta). Lipid phosphate head groups are
shown in white. (C-E) Comparison of CoQ poses from CG-MD simulations with isoprene poses from
crystallography (PDB: 6DEW) or with the docking pose of DMQ5. (C) Overlay of a CoQ pose from
the CG-MD simulation (green) with the farnesol molecule (black) in the hydrophobic cavity of COQ9.
(D) Overlay of a CoQ pose from the CG-MD simulation with the geraniol molecule (gray) on the
hydrophobic surface of COQ9. (E) Overlay of a CoQ pose from the CG-MD simulation with the docking
pose of DMQ5 (black) with W240 in red and lipid phosphate head groups in white.
4.3.5 COQ9 Interaction and Interface with COQ7 Suggest a Lipid Presentation
Role
Prior studies in human patients,112, 113, 117 mice,15, 114, 116, 143 and yeast115, 144, 145 have sug-
gested that COQ9 may be especially important for the C6-hydroxylation step of CoQ biosyn-
thesis performed by the di-iron carboxylate hydroxylase COQ7.125, 146–148 Previously, an in
vitro interaction between COQ9 and COQ7 was identified, revealing through mutagenesis that
a conserved surface patch of COQ9 (D237, W240, Y241 in the flexible α7-α8 loop, Figure 4.4C)
mediates COQ7 binding.15
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Figure 4.10 – Biochemical Data Illuminates Possible COQ9-COQ7 Intermolecular Contacts. (A)
Mutants tested in COQ9:COQ7 reactions (in this work and also in Lohman et al.15) and their incorpo-
ration as constraints for molecular docking. (B) SDS-PAGE of His6-COQ7N∆38 mutants co-translated
with SII-COQ9N∆45 or SII-COQ9N∆45,C∆31 in cell-free wheat germ extract and purified by the SII-tag on
COQ9. (C) Protein translations in cell-free wheat germ extract from which SII-COQ9N∆45 in panel B
was purified. (D) Predicted structure of COQ7 with residues tested in panel B labeled, where mutants to
residues that affect COQ9 binding are in red, those that do not are in green, and the putative active site
residues are highlighted in orange. (E) Multiple sequence alignment of COQ7 with conserved residues
in orange, residues important for the COQ9 interaction outlined in blue, and species lacking COQ9
homologues highlighted in blue.
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Here, we identified residues of COQ7 that, reciprocally, are required for COQ9 binding
(Figures 4.10A-4.10D). We designed 13 COQ7 point mutants based on evolutionary conserva-
tion and predicted solvent accessibility, and we discovered that mutants within a predicted
loop of COQ7 and mutants at the C-terminus fail to bind COQ9 (Figures 4.10B-4.10D). Interest-
ingly, some of these residues, although generally conserved, are absent in certain nematodes
that lack COQ9 homologs (Figure 4.10E).
We used these biochemical data reporting on possible COQ9-COQ7 intermolecular
contacts combined with the orientation of COQ7 and COQ9 on the IMM identified by our
individual simulations (Figure 4.11A) to determine a potential molecular interface of the
complex. The modeled conformation that fulfills these spatial constraints places the COQ9
hydrophobic surface (where isoprenes bind) adjacent to the COQ7 active site (Figures 4.11B,
4.11E). The protein-protein interface comprises α7, α8, and the α7-α8 loop of COQ9 with α1,
α2, and a loop of COQ7, where key contacting interfacial residues include W240 and Y241 of
COQ9, and P108 and W115 of COQ7.
To visualize this complex in a more endogenous context, we incorporated a partial COQ7
substrate (demethoxy CoQ with 5 isoprene units, DMQ5) into our COQ9 model associated
with the IMM (Figures 4.11B, 4.11E, 4.11G).109, 145 In this conformation, molecular docking
predicted that two isoprene units of DMQ5 fit into the COQ9 hydrophobic cavity in a pose
consistent with a co-crystallized isoprene (RMSD=1.5 Å, Figures 4.10C, 4.11C). The rest of
the DMQ5 tail lay on the hydrophobic surface such that the aromatic head group extends
towards W240—the residue that conferred aromatic isoprene binding specificity above (see
Figure 4.3) (Figures 4.11C-4.11E, 4.11G). The predicted architecture of the membrane-bound
COQ9-COQ7 complex suggests that COQ9 could lift the COQ7 substrate from the membrane
and present it to the COQ7 active site, similar to lipid metabolic nanoreactors.149, 150 Moreover,
we again observed in simulations an increased CL occupancy around COQ7 (Figure 4.11F),
as was observed for COQ9 simulations (Figure 4.8A), suggesting that this lipid species can be
important for mediating the interaction of these proteins with the IMM and thus facilitating
COQ9-COQ7 complex formation.
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Figure 4.11 – COQ9 and COQ7 Predicted Molecular Interface Suggests Substrate Presentation. (A)
Membrane binding CG-MD simulations of COQ9 and COQ7 with protein-protein interface residues in
red. (B) Predicted COQ9-COQ7 complex with the IMM overlaid. (C) Molecular docking of DMQ5 (stick)
on COQ9N∆79 (PDB: 6AWL, Chain A) where α10 (dark blue) and W240 (red) are labeled. (D) Molecular
docking of DMQ5 (stick) superimposed on the membrane-bound conformation of COQ9N∆79 where
W240 is shown in red, membrane phospholipid head groups in gray, andα10 in dark blue. (E) Predicted
model of the COQ9-COQ7 complex with DMQ5 docked to COQ9 overlaid. (F) Occupancy of lipid
phosphate head groups in CG-MD simulations of COQ9 (left) and COQ7 (middle) with CL in red and
PC/PE in gray, where CL-rich regions are circled and COQ9 and COQ7 are oriented as in the modeled
COQ9:COQ7 complex (right). (G) Model for how COQ9 could potentially present substrate to COQ7,
viewed from inside the membrane.
4.3.6 COQ9 Lipid- and Membrane-Binding Residues are Critical for CoQ Produc-
tion In Vivo
The work above identifies structural features of COQ9 predicted to facilitate CoQ intermediate
selection from the IMM and delivery to COQ7. To test the importance of these features in
vivo, we engineered two Coq9p-FLAG mutants in S. cerevisiae: W188K (analogous to W240K in
humans, to disrupt aromatic isoprene and COQ7 binding) and ∆α10 (to disrupt membrane
binding) (Figure 4.12A). Both mutants failed to rescue respiratory growth in ∆coq9 S. cerevisiae
(Figures 4.12B, 4.13A), indicating their importance for core COQ9 function.15 Additionally,
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Coq9p chimeras possessing other amphipathic or transmembrane domains in lieu of its α10
could not rescue ∆coq9 respiratory growth defects (Figures 4.14A-D).
Figure 4.12 – Coq9p Protein-, Lipid- and Membrane-Disrupting Mutants Perturb Endogenous
CoQ Biosynthesis. (A) Homology model of S. cerevisiae Coq9p with W188K (lipid- and COQ7-disrupting
mutant that is analogous to W240K in human) in red and∆α10 (Coq9pC∆28, membrane-disrupting mu-
tant) in blue. (B) Genetic complementation of ∆coq9 S. cerevisiae in fermentation (CoQ-independent)
and respiration (CoQ-dependent) conditions where EV is empty vector and mutants have a C-terminal
FLAG tag. (C) Respiration growth rates (OD600/hr, linear slope post-diauxic shift as shown in in-
set) of ∆coq9 S. cerevisiae overexpressing Coq8p-FLAG along with Coq9p-FLAG mutants, and the
Coq7p chemical bypass 2,4-dihydroxybenzoate (gray bars) where * indicates a significant difference
(p-value < 0.05, n=3) and error bars represent standard deviation. (D) Growth curves of WT S. cerevisiae
overexpressing Coq9p-FLAG mutants in respiration conditions, plotted as an average of monoclonal
transformants (n=3). (E) Fold changes of CoQ intermediates from monoclonal WT S. cerevisiae overex-
pressing Coq9p-FLAG mutants compared to WT Coq9p-FLAG. PPAB is 3-hexaprenyl-4-aminobenzoate,
DMQ is demethoxy CoQ, and * indicates a significant difference (absolute value ∆Log2 > 1, p-value <
0.05, n=3) from WT Coq9p-FLAG. (F) Fold changes of complex Q protein levels from monoclonal WT
S. cerevisiae overexpressing Coq9p-FLAG mutants compared to WT Coq9p-FLAG, where * indicates
a significant change (absolute value ∆Log2 > 1, p-value < 0.05, n=3) from WT Coq9p-FLAG. See also
Figures 4.13 and fig:q9-S7.
Previous work has shown that certain defects in CoQ biosynthesis can be bypassed by
providing modified CoQ precursors that obviate the need for a specific enzyme116, 143, 151 (Fig-
ure 4.2A), or by overexpressing Coq8p,152, 153 which confers stability to complex Q by an unclear
mechanism. Overexpression of Coq8p-FLAG partially rescued ∆coq9 yeast expressing W188K,
but had no effect on∆α10, consistent with these mutants disrupting CoQ biosynthesis through
distinct means (i.e., isoprene binding and membrane binding, respectively) (Figures 4.12C,
79
Chapter 4. Membrane, Lipid, and Protein Interactions of Coenzyme Q Biosynthesis
Protein COQ9
4.13B). Additionally, levels of the Coq7p substrate (DMQ) were particularly elevated in the
Coq8p-FLAG + Coq9pW188K strain (Figure 4.13D), and 2,4-dihydroxybenzoate—a compound
capable of specifically bypassing a Coq7p enzymatic defect—augmented the Coq8p-FLAG res-
cue of the W188K growth defect. Together, these results clearly indicate compromised Coq7p
activity in this strain, as would be predicted from our experiments above. Notably, both strains
contained CoQ intermediates that resembled those in ∆coq9 + Coq8p-FLAG (including those
associated with Coq6p defects, Figure 4.13D),144, 153, 154 which indicates Coq9p is important
for other biosynthesis steps, possibly through a role in complex Q formation or stabilization.
Interestingly, both mutants inhibited respiratory growth in WT yeast, demonstrating that
they are both non-functional and also confer dominant-negative inhibition (Figures 4.12D,
4.13C). Mass spectrometry-based lipidomics and proteomics analyses revealed that these
strains had decreased levels of CoQ, enhanced levels of an early CoQ biosynthetic intermediate
(PPAB), and decreased levels of complex Q proteins, consistent with the predicted disruption
in CoQ biosynthesis (Figures 4.12D-F). Together, these in vivo data further support the func-
tional importance of COQ9 isoprene-, membrane-, and COQ7-binding, and suggest a model
whereby COQ9 acts as a ‘lipid presenter’ to overcome hydrophobic barriers associated with
CoQ biosynthesis.
4.4 Discussion
The spatiotemporal organization of lipids in metabolism, signaling, and membrane structure
poses significant biophysical barriers within the largely aqueous cellular environment. Many
strategies—from lipid transport proteins155 to organelle contact site complexes156–158—serve
to minimize these barriers, and each begins with recognition of membrane-embedded cargo.
CoQ biosynthesis, the bulk of which occurs within complex Q or the CoQ metabolon (a
supramolecular complex of enzymes and structural elements159), shares these hydrophobic
barriers. Several additional features make CoQ biosynthesis a notable case study in lipid
biology: the discovery of a key lipid-binding protein, the tethering of complex Q to the inner
mitochondrial membrane, the proposed dynamic nature of complex Q, and the exceptional
hydrophobicity of CoQ intermediates.16, 109, 152 We sought to further define the mechanism of
COQ9 lipid binding and its role in enabling the CoQ biosynthetic process.
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Figure 4.13 – Coq9p Mutant Growth Inhibition Profile, Related to Figure 4.12. (A) Growth curves of
∆coq9 S. cerevisiae overexpressing Coq9p mutants in respiration (CoQ-dependent) and fermentation
(CoQ-independent) conditions. (B) Respiration growth rates (OD600/hr post-diauxic shift) of ∆coq9 S.
cerevisiae overexpressing Coq9p-FLAG mutants and combinations of Coq8p-FLAG, empty vector, and
chemical bypasses for Coq6p, Coq5p, and Coq3p+Coq6p (see Figure 4.3). Overexpressed WT Coq9p-
FLAG (black bar) is a reference for complete rescue (dotted line) and EV refers to empty vector for Coq9p
expression (p416GPD). Error bars represent standard deviations of growth rates (n=3). (C) Growth
curves of WT S. cerevisiae overexpressing Coq9p mutants, as described in panel A. (D) S. cerevisiae CoQ
intermediates in Coq9p mutants. Levels of CoQ intermediates in ∆coq9 yeast overexpressing either
Coq9pWT, empty vector (EV), Coq9p∆α10, or Coq9pW188K with and without Coq8p-FLAG co-expressed
(n=3). Heat maps correspond to individual intermediate levels relative to ∆coq9 + Coq9pWT + EV
(white) without Coq8p, where red shows a decrease, green shows an increase, and the layout for each
heatmap is shown in the legend. Intermediates associated with Coq6p defects (4-HP, 4-AP, and IDMQ)
are annotated with an asterisk.
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Figure 4.14 – Phenotypes of α10 Swap Chimeric Proteins, Related to Figure 4.12. (A) Table of
amphipathic and transmembrane helix swaps: Kes1p,160 VLCAD,161,162 Opi1p,163 Coq8p,164.52 (B)
Drop assay of ∆coq9 yeast expressing helix swap chimeras or controls (WT Coq9pFLAG, empty vector,
∆α10 Coq9pFLAG) on fermentation or respiration media. (C) Western blot (anti-FLAG) of whole cell
WT yeast containing FLAG-tagged helix swap constructs. (D) Representative growth curves for helix
swap chimeras (red dots) expressed in ∆coq9 or WT yeast, in fermentation or respiration media. WT
Coq9pFLAG curves are shown in black dots, α10 Coq9pFLAG in teal dots.
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4.4. Discussion
Recent advances in structural biology, bioinformatics, and in vitro biochemistry have
equipped researchers with powerful tools to study how cells manage lipid metabolism and
transport.155, 165, 166 Yet, defining the biochemical mechanisms that control lipid cargo se-
lection faces the substantial challenge of studying protein function at the membrane-water
barrier. Here, we combined molecular dynamics simulations with traditional biochemical and
structural approaches to describe the stepwise mechanism for cargo selection by COQ9. We
discovered that COQ9 uses a distinct amphipathic helix connected to a foundational ligand
binding domain to associate with membranes. In our molecular simulations, COQ9 deforms
the membrane bilayer by extruding polar head groups at the protein-IMM interface. During
the simulation, this warping effect of the membrane surface allows lipid tails to be drawn
into the COQ9 hydrophobic cavity at sites consistent with isoprene moieties found in our
co-crystallization experiments. The creation of such a peculiar environment in the mem-
brane—a continuous and tightly sealed hydrophobic region encompassing both the IMM and
COQ9—could be key to solving the hydrophobicity problem of extracting CoQ intermediates
from the membrane. This mode of action shares parallels with the “liftase” model proposed
for how lipid transfer proteins (e.g. saposins,167, 168 GM2-AP,169 and PlsC106) overcome the
topological challenge of reaching substrates located inside the membrane. Upon membrane
binding, these proteins are envisaged to improve lipid accessibility and processing through
modifying membrane organization (e.g. lifting lipids out of the membrane, distorting and
destabilizing the membrane). We showed here, for the case of COQ9, that molecular simula-
tions and biochemical approaches can be used together to molecularly dissect the mechanism
of membrane reshaping and lipid trafficking adopted by lipid binding proteins.
This proposed role for COQ9 to retrieve CoQ intermediates from the bilayer is sup-
ported by its binding specificity for aromatic isoprenes. This specificity is guided by a highly
conserved and mobile tryptophan (W240 in human or W188 in yeast), and the proximity of this
residue to DMQ5 in molecular docking experiments suggests that pi-pi stacking interactions
could contribute to substrate specificity, to dynamic sensing, and/or to lipid presentation
and transfer (Figure 4.3D). Importantly, CoQ intermediates are thought to be protected from
water—whether they are embedded in the lipid bilayer, channeled through complex Q, or
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passed along the periphery of the IMM by a lipid chaperone. Correspondingly, COQ9 could
act as a lipid presenter at the membrane surface and/or between enzymes in complex Q.
Lipid-presenting proteins are notoriously challenging to characterize because of their
dynamic nature, their dependence on other proteins, and their function at the membrane-
water barrier. The case of Coq9p is further complicated by its concurrent role in complex Q
stability, as dysfunctional CoQ proteins can cause the degradation of complex Q. Nonetheless,
perturbations to Coq9p membrane (α10) and lipid binding (W188) residues severely disrupt in
vivo CoQ biosynthesis by compromising the integrity of complex Q stability and by hindering
Coq7p enzymatic activity. The specific connection between Coq9p function and Coq7p activ-
ity is reflected in patients with primary CoQ deficiency caused by mutations to COQ9.112, 113
To date, six reports of COQ9 patient mutations result in decreased levels of COQ7 and the
apparent accumulation of the COQ7 substrate, DMQ.112, 113, 117 Interestingly, one of the two
reported patient mutations in COQ7 (L111P) is a point mutant at the predicted COQ9:COQ7
molecular interface.143 Our predicted architecture of the membrane-bound COQ9-COQ7
complex suggests that COQ9 could lift the COQ7 substrate from the membrane and present it
to the COQ7 active site—a model reminiscent of lipid metabolic nanoreactors,149, 150 but one
which will require further experimentation and structural analyses to validate.
In addition to mechanistic insights into how a peripheral membrane protein can extract
membrane-embedded cargo, our work introduces a potential mechanism for the spatial orga-
nization of membrane lipids and, possibly, for complex Q seeding. In both our simulations and
liposome co-flotation studies, CL had a role in the binding and dynamics of COQ9-membrane
interactions. Indeed, we recently demonstrated that CL likewise enhances the membrane
association and ATPase activity of COQ8, a second poorly characterized protein in the CoQ
pathway.164 If complex Q is localized to specific sites on the mitochondrial cristae, these
findings suggest that its position and assembly could be influenced by local CL concentration.
Cardiolipin is known to have a pivotal role for the formation and stability of several inner
mitochondrial membrane protein complexes.12, 139, 140 Cardiolipin occupancy and persistency
around COQ9 and COQ7 observed in our membrane binding simulations suggests that CL is
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important for establishing and maintaining the specific interaction of these proteins with the
IMM, and thus for facilitating COQ7-COQ9 complex formation. These observations suggest
that cardiolipin-rich areas might template the membrane with a preferential surface pattern
able to favor COQ9-COQ7 complex formation, as well as the recruitment of other members of
complex Q. Further study of the localization, components, and connectivity of complex Q will
inform these models.
Finally, there is speculation that complex Q is not a static metabolon, but that it might
instead form upon substrate availability, and that CoQ or a pathway intermediate is part of the
complex.109, 170 Work from us and others suggest Coq8p could assist with sensing and deliver-
ing substrates based on its lipid interactions, ATPase activity, and apparent ability to stabilize
complex Q.19, 20, 153, 164 The structural homology of COQ9 with ligand-sensing transcription
factors also makes COQ9 a plausible “sensor” candidate.15 Here, we introduce the flexible
α7-α8 and α9-α10 loops that guide ligand interactions, COQ7-binding, and membrane inter-
actions as possible key features in metabolon formation and activity.
Overall, our analyses present COQ9 as a new model for how nature employs peripheral
lipid binding proteins to surmount hydrophobic challenges. These insights into how a protein
can access, bind, and present a hydrophobic ligand may also inform new strategies to treat
lipid deficiency disorders that are recalcitrant to supplementation, including many CoQ-
related diseases. Moreover, our integrative approach combining structural, biochemical, and
computational studies was effective at providing sub-nanometer resolution of COQ9 function
at the protein-membrane interface and may thus serve as a model for interrogating other
lipid binding proteins or lipid metabolism or signaling pathways whose investigations present
similar challenges.
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4.5 Supplementary Information
This Section details the work done by our experimental collaborators to support our compu-
tational findings. The experimental work included in this Chapter was led by Dr. Danielle C.
Lohman and Prof. David J. Pagliarini in University of Wisconsin-Madison.
Saccharomyces cerevisiae strains (WT and ∆coq9) were the haploid MATalpha BY4742
(his3∆1 leu2∆0 lys2∆0 ura3∆0) from the gene deletion consortium (Thermo #YSC1054). Es-
cherichia coli strains for protein overexpression were BL21[DE3]-RIPL from Agilent and for
cloning applications, DH5α from NEB were used. Unless specified otherwise, E. coli were
grown at 37 °C in LB media with antibiotics and S. cerevisiae were grown at 30 °C in drop-out
minimal media.
4.5.1 DNA Constructs and Cloning
Point mutants were generated by standard site-directed mutagenesis while insertions and
deletions were generated by standard PIPE92 cloning methods.
4.5.2 Protein Expression and Purification
COQ9N∆79 and COQ9N∆79, C∆31 Expression and Purification
His8-MBP-tev-COQ9N∆79 and mutants were expressed in E. coli (BL21[DE3]-RIPL strain) by
autoinduction as previously described.15 Cells were isolated and resuspended in buffer A
supplemented with 1 mg/mL Lysozyme (Sigma): 50 mM HEPES pH 7.5, 400 mM NaCl, 0.3
mM TCEP, 0.25 mM PMSF, and peptide protease inhibitors: 500 ng/mL leupeptin hemisulfate,
pepstatin A, chymostatin, aprotinin, and antipain dihydrochloride at pH 7.2. Cells were lysed
by sonication (4 °C), clarified by centrifugation (15,000 x g, 30 min, 4 °C), and bound to cobalt
IMAC resin (TALON, Clontech, 1 hr, 4 °C). Resin was washed with Buffer A and his-tagged
protein was eluted with Buffer A supplemented with 100 mM imidazole. Eluted protein was
concentrated (50-kDa MW-cutoff spin filter, Merck Millipore Ltd.) and exchanged into Storage
Buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.3 mM TCEP). For experiments with untagged
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protein, His8-MBP-tev-COQ9N∆79 was incubated with TEV protease (prepared in-house, 1:50
TEV/fusion protein, mass:mass using ε280 = 102,130 M-1cm-1 and MW = 71.3 kDa, 2 hrs, 25
°C), then bound to cobalt IMAC resin (1 hr, 4 °C). Cleaved COQ9N∆79 (ε280 = 36,130 M-1cm-1,
MW = 27.4 kDa) was collected, concentrated (10-kDa MW-cutoff spin filter), and exchanged
into Storage Buffer. Protein was aliquoted, frozen in N2(l), and stored at -80 °C.
SII-COQ9N∆45 and His6-COQ7N∆38 Expression and Purification
SII-COQ9N∆45 and His6-COQ7N∆38 were expressed and purified in wheat germ extract (WE-
PRO2240, CellFree Sciences, Matsuyama, Japan) as previously described.15 Transcription
reactions (0.2 mg/mL DNA, 20 mM magnesium acetate, 2 mM spermidine trihydrochloride, 10
mM DTT, 80 mM HEPES-KOH pH 7.8, 4 mM each NTP pH 7.0, 1.6 U/µL SP6 RNA polymerase
(Promega, Madison, WI), and 1 U/µL RNasin (Promega)) were incubated for 4 h at 37 °C.
Single or mixed 1:1 COQ9:COQ7 transcription products were added to wheat germ extract in a
dialysis cup reaction: 60 O.D. wheat germ extract, 24 mM HEPES-KOH, pH 7.8, 100 mM potas-
sium acetate, 6.25 mM magnesium acetate, 0.4 mM spermidine trihydrochloride, 4 mM DTT,
1.2 mM ATP, 0.25 mM GTP, 16 mM creatine phosphate, 0.0005% sodium azide, 0.04 mg/mL
creatine kinase, 0.3 mM each amino acid at pH 7.0, and 5 µL of RNA. Translation reactions
were incubated (18 hr, 22 °C) in 32-fold excess dialysis buffer (without wheat germ extract,
creatine kinase, or RNA). Duplicate translations were pooled and centrifuged (5 min, 20,000 ×
g, 10 °C). Soluble protein was incubated with StrepTactin resin, washed in 25 mM HEPES pH
7.8, 150 mM NaCl, 1 mM DTT using a 96-well filter plate (HTS Multiscreen, Millipore), and
eluted with 2.5 mM desthiobiotin.
4.5.3 Biochemical Assays
Differential Scanning Fluorimetry
DSF was performed as previously described.15 Reactions (20 µL) of protein (2 µM), SYPRO
Orange dye (Invitrogen) (5X), NaCl (150 mM), HEPES (100 mM, pH 7.5) were prepared in Micro
Amp Optical 96 (0.2 mL) Well Reaction Plates and sealed with Optical Adhesive Covers (Applied
Biosystems). Fluorescence was measured (excitation filter x1 470 ± 15 nm and emission filter
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m4 623 ± 14 nm) during heating (15 to 95 °C, 0.017 °C/s) in Applied Biosystems QuantStudio
6 Flex Real Time PCR System. Tm values were calculated in Protein Thermal Shift software
(Applied Biosystems).
Western Blot
Western blots of yeast whole cell lysate (4×107 cells) were probed with primaryα-FLAG (Sigma-
Aldrich F1804), secondary α-mouse IgG (RDye® 800CW), then visualized on a LI-COR imager.
Liposome Co-Flotation Assays
Liposomes were made with the following lipids from Avanti Polar Lipids reference: PC(#840051C);
NBD-PE(#810145C); PE(#850725C); CL(#710335C). Unless otherwise specified, liposome com-
positions were PC/PE/CL/NBD-PE 68.9/9/22/0.1 molar percent. Lipid films were prepared by
drying well-mixed lipids in organic solvent first under Ar(g) then by vacuum chamber (25-30
inHg, 17 hrs, 20 °C). The lipid film was reconstituted in HBS buffer (20 mM HEPES pH 7.5, 150
mM NaCl) to 10 mM total lipids by incubation (30 min, 30–35 °C) followed by 3 freeze/thaw
cycles in N2(l). Liposomes were extruded through 100 nM membranes (Avanti Polar Lipids, 11
passes, 30–35 °C) and used within 4 hours of preparation.
Liposome co-flotation was adapted from Connerth et al.97 Liposomes (100 µL) were
incubated with protein (50 µL) (10 min, 20 °C) and final reactions contained: 2.5 µM protein,
6.66 mM liposomes, 20 mM HEPES pH 7.5, 150 mM NaCl. Sucrose (2.72 M, 110 µL) was added
to the protein liposome mixture and transferred (250 µL) to an ultracentrifuge tube (Beckman
#343776). A sucrose gradient in HBS was layered: 1.15 M sucrose with reaction (250 µL), 0.86
M sucrose (300 µL), 0.29 M sucrose (250 µL), and 150 µL HBS. After centrifugation (240,000×g,
1 h, 4 °C, Sorvall MX 120 Plus Micro-ultracentrifuge), fractions were removed from top (450
µL) to bottom (450 µL). Liposome content was quantified by NBD-PE fluorescence (excitation:
460 nm, emission: 535 nm) to validate flotation. Proteins in each fraction were CHCl3:MeOH
precipitated, following a method adapted from Wessel and Flugge98 with methanol (1800
µL) and chloroform (450 µL). After vortexing, water (1350 µL) was added and samples were
vortexed and centrifuged (5 min, 4,000×g, 20 °C). The upper aqueous layer was discarded and
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methanol (1000 µL) was added to the protein disc. After mixing by inversion, samples were
centrifuged (5 min, 20,000×g, 20 °C) and all liquid removed. The precipitated protein pellet
was vacuum dried (25-30 inHg, 30 min, 20 °C), resuspended in denaturing loading buffer with
10 mM DTT, and analyzed by SDS-PAGE. Protein bands were quantified by densitometry on a
LiCOR Odyessey CLx (700 nm) using Image Studio v5.2 software. Error bars represent standard
deviation of co-flotations performed in parallel (n=2 or 3) and Student’s t-test was used to
determine statistical significance assuming two tailed distributions and equal variance.
4.5.4 S. cerevisiae Growth Assays
∆coq9 or WT S. cerevisiae (BY4742) were transformed as previously described with p416GPD
(Ura selection) plasmids encoding Coq9p variants and grown on Ura drop-out synthetic media
plates containing glucose (2%, w/v).96 Individual colonies were used to inoculate starter
cultures, which were incubated (30 °C, ∼18 h, 230 rpm). Serial dilutions of yeast (104, 103, 102,
or 10 yeast cells) were dropped onto Ura– agar media plates containing either fermentation (2%
glucose, w/v) or respiration (3% glycerol, w/v) media and incubated (30 °C, 2-4 days). To assay
yeast growth in liquid media, yeast from a starter culture were swapped into selective synthetic
media with in fermentation (2% glucose, w/v) or respiration (3% glycerol 0.1% glucose, w/v)
media at an initial density of 5×106 cells/mL.91 The cultures were incubated in a sterile 96
well plate with an optical, breathable cover seal (1140 rpm) and optical density readings were
obtained every 10 min. For co-overexpression experiments, yeast were co-transformed with
p413GPD (His selection) plasmids encoding Coq8p-FLAG and subsequent plating and growth
assays performed in Ura–His– media. For small molecule bypass experiments, small molecules
were added to 1 mM final concentration to the growth assay media: 2,4-dihydroxybenzoic acid
(Coq7p bypass, Sigma D109401); 3,4-dihydroxybenzoic acid (Coq6p bypass, Sigma P5630);
vanillic acid (Coq6p+Coq3p bypass, sigma H36001); 4-hydroxy-2-methylbenzoic acid (Coq5p
bypass, Sigma 653160).
4.5.5 Crystallography
COQ9 was purified as described in “COQ9N∆79 and COQ9N∆79,C∆31 expression and purification”
and then subjected to size exclusion chromatography on HiLoad 16/600 Superdex 75 pg (GE
89
Chapter 4. Membrane, Lipid, and Protein Interactions of Coenzyme Q Biosynthesis
Protein COQ9
Healthcare) in Storage buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.3 mM TCEP). Fractions
containing COQ9, assessed by SDS-PAGE, were pooled to >10 mg/mL, concentrated with a
MW-cutoff spin filter, frozen in N2(l), and stored at -80 °C.
COQ9N∆79 was screened for crystallization using IndexHT (Hampton Research) and
JCSG+ (Molecular Dimensions) screens and optimized using a TTP Labtech Mosquito crys-
tallization robot using MRC SD-2 sitting drop plates. Crystals were imaged using a UVEX-P
UV/Visible microscope. 200 nL protein at 4.89 mg/mL in 10 mM HEPES buffer at pH 7.5 and
100 mM NaCl was mixed with 200 nL crystallization reagent. Optimized crystals were obtained
from a reservoir of 21% w/v PEG3350, 0.25 M Nacl, 0.1 M bistris, pH 6.5. The crystal was
cryoprotected by soaking the crystal in reservoir solution supplemented to 35% w/v PEG3350.
Diffraction data was collected at the Advanced Photon Source on GM/CA@APS 23-ID-B beam-
line, using an Eiger 16M detector. Data was collected at 12keV (1.0332Å) 350 mm 0.2 degrees
per frame, 0.2 seconds per frame, 70x50 micron slits, 40x attenuation. Data was reduced using
XDS, scaled with XSCALE.171 The structure was solved by molecular replacement with Phaser
in the Phenix suite172 using PDB 4RHP as a search model.173 The structure was refined using
alternating rounds phenix.refine174 and model building in Coot.175
COQ9N∆79,C∆31 was screened for crystallization using the same workflow as COQ9N∆79.
Reasonable crystals were obtained from ammonium sulfate and tris buffer. This crystallization
condition was favored for isoprene co-crystallization trials, since polymeric precipitants like
polyethylene glycol might be mistaken for isoprene alcohols. Initial optimization experiments
using farnesol and geranylgeraniol in plastic crystallization plates yielded no obvious electron
density for bound isoprenols. Optimal crystals were obtained by microseeding into droplets
hanging from glass coverslips, hanging over glass concavity plates, sealed with perfluoroether
oil. The reservoir solution was 50 µL of 1.2 M ammonium sulfate, 0.1 M Tris buffer, pH 8.5,
mixed with 4 µL of neat geranylgeraniol, the majority of which formed a second phase. Two
microliters of protein at 5.8 mg/mL, diluted from a 21.7 mg/mL protein stock in 160 mM NaCl,
20 mM HEPES buffer, pH 7.5 and 0.3 mM TCEP was mixed with 1 µL of seed stock derived
from a previous batch crystallization experiment conducted at 1.5 M ammonium sulfate, 0.1
M Tris pH 8.5. Crystals grew over a week. They were cryoprotected by supplementing the
droplet with 2 µL of reservoir solution, and then replacing it with 3 M ammonium sulfate, 0.1
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M Tris pH 8.5, supplemented with neat geranylgeraniol. The droplet was allowed to equilibrate
overnight, and crystals were harvested by drawing them through a layer of perfluoroether
oil in a Mitegen microcrystal mount, wicking away excess mother liquor, and plunging then
into liquid nitrogen. Data was collected at the Advanced Photon Source on LS-CAT 21-ID-D
beamline, using a Eiger 9M detector. Data was collected at 100K, using an 11 keV (1.12723Å)
beam, 170 mm, 0.2 degrees per frame, 50 micron beam. Data reduction, structure solution
and refinement used the same workflow as COQ9N∆79, except that a version of 6AWL with
the 10th helix truncated was used as the starting model for molecular replacement. Long
tubes of electron density were observed at consistent sites on all of the monomers. Using
constituents present in the crystallization mixture, the extent and shape of these features could
only be successfully modeled using isoprenols. Features at these sites were less clear or absent
in previous electron density maps from preceding crystallization attempts with isoprenols
conducted in plastic 96 well plates. Isoprenols were docked into the electron density using
phenix.ligandfit using geranylgeraniol, farnesol and geraniol as probes. Three farnesol (three
isoprene units) and three geraniol (2 isoprene units) were successfully modeled into the most
orderly sites.
4.5.6 Liquid Chromatography Mass Spectrometry Lipidomics
LC-MS samples contained either lipid extractions of S. cerevisiae pellets (either 1×108 cells
or 50 mL of OD600=3), E. coli pellets (1×1010 cells), His8-MBP-tagged protein (40 nmols),
or Coq9p-FLAG protein (normalized to an equal amount by gel quantitation) prepared as
described elsewhere. LC-MS analysis was performed on an Acquity CSH C18 column held
at 50 °C (100 mm × 2.1 mm × 1.7 µm particle size; Waters) using a Vanquish Binary Pump
(400 µL/min flow rate; Thermo Scientific). Mobile phase A consisted of 10 mM ammonium
acetate in ACN/H2O (70:30, v/v) containing 250 µL/L acetic acid. Mobile phase B consisted of
10 mM ammonium acetate in IPA/ACN (90:10, v/v) with the same additives. Mobile phase B
was initially held at 2% for 2 min and then increased to 30% over 3 min. Mobile phase B was
further increased to 50% over 1 min and 85% over 14 min and then raised to 99% over 1 min
and held for 7 min. The column was reequilibrated for 2 min before the next injection. Ten
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microliters of sample were injected by a Vanquish Split Sampler HT autosampler (Thermo
Scientific). The LC system was coupled to a Q Exactive mass spectrometer by a HESI II heated
ESI source kept at 325 °C (Thermo Scientific). The inlet capillary was kept at 300 °C, sheath gas
was set to 25 units, auxiliary gas to 10 units, and the spray voltage was set to 4,000/5,000 V. For
targeted analysis the MS was operated in positive parallel reaction monitoring (PRM) mode
and negative targeted single ion monitoring (t-SIM) acquiring scheduled, targeted scans to
CoQ intermediates: PPAB, DMQ, CoQ. For discovery analysis, the MS was operated in polarity
switching dd-MS2 mode. MS acquisition parameters were 17,500 resolving power, 3×106
automatic gain control (AGC) target for MS1 and 5×105 AGC target for MS2 scans, 100-ms MS1
and 35-ms MS2 ion accumulation time, 240- to 1,600-Th MS1 scan range, 1.4-Th isolation
width for fragmentation, stepped HCD collision energy (20, 25/30 units), 1.0% under fill ratio,
and 10 s dynamic exclusion.
For extended CoQ intermediate detection (Figure 4.13D) the LC-MS was performed as
described above, with the following differences: Acquity CSH C18 column (150 mm × 2.1 mm ×
1.7 µm particle size); Vanquish Binary Pump (250 µL/min flow rate); ACN/H2O (90:10, v/v) in
Mobile phases A and B; Mobile phase B increased from 65-99% over 9 min, held at 99% (2 min),
then returned to 65% over 0.5 min, column re-equilibration (2.5 min); Q Exactive HF mass
spectrometer; HESI II heated ESI source (300 °C); S-lens RF level to 50.0 and spray voltage
set to 4,000 V for positive and 3,500 V for negative modes. MS was operated in positive and
negative PRM mode, respectively, acquiring targeted scants to detect CoQ intermediates: 4-HP,
PPHB, PPAB, 4-AP, HHAB, DDMQ, DMQ, IDMQ, CoQ6, CoQ10. MS acquisition parameters
were 60,000 resolving power for MS2 scans, 5 x 105 AGC, 200-ms MS2 ion accumulation time,
2.2-Th isolation width for fragmentation, and stepped HCD collision energy of 15, 25, and 35
units.
Data Analysis
The resulting CoQ intermediate data were processed using TraceFinder 4.0 (Thermo Fisher
Scientific). The resulting discovery lipidomics raw files were converted to mgf files via MSCon-
vertGUI (ProteoWizard, Dr. Parag Mallick, Stanford University) and processed using Com-
pound Discoverer 2.0 (Thermo Fisher Scientific) and an in-house developed software suite,
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LipiDex.176 All raw files were loaded into Compound Discoverer with blanks marked as such
to generate two result files using the following Workflow Processing Nodes: Input Files, Select
Spectra, Align Retention Times, Detect Unknown Compounds, Group Unknown Compounds,
Fill Gaps and Mark Background Compounds for the so called “Aligned” result and solely Input
Files, Select Spectra, and Detect Unknown Compounds for an “Unaligned” Result. Under
Select Spectra, scan type was set to Full and unrecognized mass analyzer replacement to FTMS,
the retention time limits were set between 0.4 and 21 min, MS order as well as unrecognized
MS order replacements were set to MS1. Under Align Retention Times the mass tolerance was
set to 10 ppm and the maximum shift according to the dataset to either 0.8 min. Under Detect
Unknown Compounds, the mass tolerance was also set to 10 ppm, with an S/N threshold
of 3, and a minimum peak intensity of 5E4. Further, [M+H]+1 and [M-H]-1 were selected
as ions and a maximum peak width of 0.75 min as well as a minimum number of scans per
peak equaling 5 were set. Lastly, for Group Unknown Compounds as well as Fill Gaps, mass
tolerance was set to 10 ppm and retention time tolerance to 0.2 minutes. For best compound
selection rules #1 and #2 were set to “unspecified,” while MS1 was selected for preferred MS
order and [M+H]+1 as the preferred ion. For everything else, the default settings were used.
Resulting peak tables were exported as excel files in three levels of Compounds, Compound
per File and Features (just Features for the “Unaligned”) and later saved as csvs. Normalization
and enrichments calculations were performed and p-values were calculated via Student’s T
Test assuming two-tailed distributions and equal variance.
4.5.7 Sample Preparation for S. cerevisiae Lipids Enriched in Coq9p-FLAG Pull-
Downs
Coq9p-FLAG Expression and Immunoprecipitation
S. cerevisiae (BY4742) expressing p416GPD Coq9p-FLAG were grown in Ura- synthetic com-
plete media with 1% glucose (1L inoculated with 1×108 cells in triplicate, 30 °C, 220 rpm,),
harvested by centrifugation (4,000×g, 5 min, 25 °C) 4 hours post diauxic shift, frozen in N2(l),
and stored at -80 °C. Yeast pellets (1×108 cells in triplicate) containing overexpressed protein
were harvested in parallel.
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Yeast spheroplasts were prepared as previously described.177 Yeast pellets were resus-
pended in 35 mL of pretreatment buffer (0.1 M TrisSO4, pH 9.4, 10 mM DTT), incubated (30 °C,
220 rpm, 15 min), and pelleted by centrifugation (1,500×g, 5 min). Pellets were resuspended in
SP buffer (1.2 M Sorbitol, 20 mM KPi, pH 7.4), zymolyase (7.5 mg zymolyse per g pellet, MP
Biomedicals 0832092) was added, and incubated (30 °C, 220 rpm, 40 min). Yeast spheroplasts
were pelleted by centrifugation (4,500×g, 5 min, 4 °C), washed with 40 mL SP buffer, and
pelleted by centrifugation (4,500×g, 5 min, 4 °C). Yeast spheroplasts were resuspended in 25
mL lysis buffer with protease inhibitors (10 mM TrisCl pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 140
mM NaCl, 1 mM PMSF and peptide protease inhibitors: 500 ng/mL leupeptin hemisulfate,
pepstatin A, chymostatin, aprotinin, and antipain dihydrochloride at pH 7.2) and lysed by son-
ication (3 pulses of 15 sec). Digitonin in lysis buffer (0.4% final digitonin by weight) was added
and lysate was incubated (4 °C, 30 min, nutating) then clarified by centrifugation (15,000×g for
30 min at 4 °C). Clarified lysate was added to 300 µL FLAG-conjugated magnetic bead slurry
(Sigma M8823) equilibrated with lysis buffer and incubated (4 °C, 2.5 hrs, end-over-end). FLAG
beads were pelleted by centrifugation (700×g, 3 min, 4 °C), resuspended in lysis buffer (1 mL),
washed 5X in lysis buffer with 0.4% digitonin, and washed 2X in lysis buffer without digitonin
with magnetization. Protein was eluted into 1 mL of elution buffer (10 mM TrisCl pH 8.0, 1
mM EDTA, 0.5 mM EGTA, 140 mM NaCl, and 0.2 mg/mL FLAG peptide, Sigma F3290) with
gentle agitation (1 hr, 25 °C).
Lipid Extraction
Immuno-purified Coq9p-FLAG (triplicates normalized to the lowest concentration by gel
quantification) was thawed and transferred to 5 mL Eppendorf tubes. Buffer (10 mM TrisHCl
pH 7.8, 140 mM NaCl) was added to 580 µL and vortexed (30 s). Extraction was initiated by
CH3Cl:MeOH (1:1, v/v, 3 mL) and vortexing (2×30 s). Samples were acidified to pH 0.5-2 (100µL
1 M HCl) and mixed by vortexing (2×30 s). Phase separation was completed by centrifugation
(3,220×g, 2 min, 4 °C), and the organic layer (1.5 mL) was transferred to a new 1.5 tubes and
dried under Ar(g). The dried lipids were reconstituted in ACN/IPA/H2O (65:35:5, v/v/v, 50 µL)
by vortexing (2×30 s), transferred to a sample vial and stored under Ar(g) at -80 C. Frozen yeast
pellets (1×108 cells by OD600) were extracted similarly with the following exceptions: glass
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beads (0.5 mm diameter, 100 µL) added upon thawing, 900 µL of CH3Cl:MeOH, 200 µL 1 M
HCl and 400 µL of organic transferred.
4.5.8 Sample Preparation forE. coli Lipids Co-Purifying with His8-MBP-COQ9N∆79
Sample Preparation
His8-MBP-[TEV]-COQ9N∆79, His8-MBP-[TEV]-COQ9N∆79,W240K, His6-MBP proteins were ex-
pressed and purified as described in “COQ9N∆79 and COQ9N∆79, C∆31 expression and purifica-
tion” from 1L of E. coli in triplicate. Upon E. coli harvest, cell pellets (1×1010 cells by OD600)
were collected in triplicate. Upon protein collection, the elution was performed in a column,
collected in 1 mL aliquots by gravity flow, and frozen in N2(l), and stored at -80 °C for lipid
extraction at the first IMAC elution.
Lipid Extraction
Cell pellets were thawed on ice, resuspended in 400 µL PBS by vortexing (30 s). Purified
protein (40 nmol by A280) was brought to 456 µL in 50 mM Tris pH 7.4, 200 mM NaCl, 100 mM
imidazole. The aqueous samples were transferred to clean glass tubes and lipid extraction
was initiated by addition of CH3Cl:MeOH (1:1, v/v, 5 mL) and vortexing (30 s) to form a single
phase. Samples were acidified to pH 0.5-2 (250 µL 1 M HCl) and mixed by vortexing (1×30 s,
1×15 s). After inducing phase separation by addition of 500 uL of brine, vortexing (15 s), and
centrifugation (1,800×g, 4 min, 4 °C), the aqueous layer was aspirated, and organic layer dried
under Ar(g). The dried lipids were reconstituted in ACN/IPA/H2O (65:35:5, v/v/v, 100 µL) by
vortexing (2×30 s), transferred to a sample vial, and stored under Ar(g) at -80 C.
4.5.9 Sample Preparation for CoQ Intermediates in S. cerevisiae
Sample Preparation
(A) For PPAB, CoQ, DMQ detection (Figure 4.12E): S. cerevisiae (WT BY4742) expressing
plasmids encoding Coq9p-FLAG variants in p416GPD were cultured as described previously.91
Yeast were grown in synthetic media (Ura–) respiration media (0.1% glucose, 3% glycerol w/v)
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to early respiration growth. Specifically, 100 mL was inoculated with 2.5×106 cells, from 12
h overnight cultures grown in Ura– 2% glucose, and incubated at 30 °C for 25 h at 230 rpm.
Cells were grown and harvested in triplicate (1×108 cells by OD600) by centrifugation (3,000 g,
3 min, 4 °C).178 The supernatant was aspirated and pellets frozen in N2(l) and stored at -80
°C. (B) For extended CoQ intermediate detection (Figure 4.13D): S. cerevisiae (WT BY4742)
expressing plasmids encoding Coq9p-FLAG variants in p416GPD or Coq8p-FLAG in p413GPD
were cultured as described previously.153, 179 Yeast were grown in synthetic media (Ura–His–)
fermentation media (2% galactose, 0.1% dextrose, 100 µM pABA). Specifically, 50 mL was
inoculated with 6 mL pABA-starved yeast in stationary phase and incubated at 30 °C at 230
rpm until OD ∼3. Cells were grown and harvested in triplicate (50 mL of OD600=3 cells) by
centrifugation (3,000 g, 3 min, 4 °C).
Lipid Extraction
(A) For PPAB, CoQ, DMQ detection (Figure 4.12E): Frozen yeast pellets (1×108 cells) were
thawed on ice and mixed with glass beads (0.5 mm diameter, 100 µL). CHCl3/MeOH (1:1, v/v,
4 °C, 900 µL) was added and samples were vortexed (2×30 s). HCl (1 M, 200 µL, 4 °C) was
added and samples vortexed (2×30 s). The samples were centrifuged (5,000 g, 2 min, 4 °C) to
complete phase separation. 400 µL of the organic phase was transferred to a clean tube and
dried under Ar(g). The organic residue was reconstituted in ACN/IPA/H2O (65:30:5, v/v/v)
(100 µL) for LC–MS analysis. (B) For extended CoQ intermediate detection (Figure 4.13D):
Yeast pellets were resuspended in water (100 µL) and submitted to a Soxhlet extraction with
added internal standard (CoQ10, 1µM in final reconstitution) as described previously.153, 179
Aqueous sample was submitted to two iterative extractions: vortexed (30s) with methanol (1
mL) and petroleum ether (2 mL). The organic phases were transferred to a clean tube and
dried under Ar(g). The organic residue was reconstituted in ACN/IPA/H2O (65:30:5, v/v/v)
(200 µL) for LC–MS analysis.
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4.5.10 LC-MS/MS Proteomics Analysis of S. cerevisiae
Sample Preparation
Frozen yeast pellets (1×108 cells) were re-suspended in 100 µL guanidine-HCl (6M) and boiled
for five minutes at 100 °C. Methanol was added to a concentration of 90% to precipitate protein
and the sample was centrifuged for 10 min at 14,000×g. The resulting pellet was re-suspended
in 100 µL lysis buffer (8 M Urea, 100 mM Tris, 20 mM TCEP, 80 mM Chloroacetamide) and
diluted with 1 mL 50 mM Tris. Protein digestion was performed overnight with trypsin (4
µg) and centrifuged the following morning for 5 min at 14,000×g prior to de-salting resulting
supernatant with Strata C18 solid phase extraction cartridges. Peptides were dried in a vacuum
centrifuge before re-suspending in 0.2% formic acid and quantified using Pierce Quantitative
Colorimetric Peptide Assay (Thermo Fisher Scientific).
LC-MS/MS Label-Free Proteomics
Samples were analyzed using an LC-MS instrument comprising an Orbitrap Fusion Lumos
Tribrid mass spectrometer (Thermo Fisher Scientific) and an Ultimate 3000 RSLCnano chro-
matography system. Mobile phase A consisted of 0.2% formic acid in water and mobile phase
B consisted of 0.2% formic acid in acetonitrile. A 75-min gradient ranging from 0% to 50%
B was employed spanning a total runtime of 90 min. 2 µg analytes were injected onto a 1.7
micron C18 column packed in-house to a length of 35 cm and heated to 55 °C. Survey scans
of peptide precursors were collected from 350-1350 Th with an AGC target of 1,000,000 and
a resolution of 60,000 in the Orbitrap followed by HCD MS/MS scans taken at top speed in
the ion trap. The resulting LC-MS proteomics data were processed using Maxquant software
version 1.5.2.8 and searched against a S. cerevisiae database downloaded from Uniprot on
8/10/16.180–182 The digestion enzyme was set to trypsin with up to two missing cleavages,
carbamidomethylation of cysteine as a fixed modification, and oxidation of methionine and
protein N-terminal acetylation as variable modifications. The match between runs feature
was utilized to decrease missing data values within the data set. Precursor mass tolerance was
20 ppm and product ions were searched at 0.5 Da tolerances. Peptides were filtered to a 1%
FDR and combined to protein groups based on the rules of parsimony.
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4.5.11 Quantification and Statistical Analysis
See each individual method for the associated statistical analysis. The majority of p-values in
this report were calculated using an unpaired, two-tailed, Student’s t-test. MS data analysis
was performed as described in each MS analysis section. In all cases, n represents independent
replicates of an experiment and error bars represent standard deviation.
4.5.12 Experimental Data Availability and Accession Codes
The crystallography coordinates have been deposited in the Protein Data Bank under ID codes
6AWL and 6DEW. Raw image data has been deposited in Mendeley:
http://dx.doi.org/10.17632/63ztbyhx5h.1
Raw mass spectrometry files have been deposited in Chorus under accession numbers 1532
(proteomics) and 1533 (lipidomics).
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The biological membrane provides a physical and regulatory barrier between the cell and its
environment. It is a dynamic and complex system containing a variety of biological molecules,
notably lipids, and proteins. Integral and peripheral membrane proteins account for more
than one-third of the human proteome, and are estimated to represent the target for over 50%
of modern drugs; however, there is a great disparity between our understanding of soluble
and membrane proteins.
New and powerful techniques including cryo-electron microscopy and tomography,
state-of-the-art lipidomics, mass spectrometry, membrane imaging by high-speed atomic
force microscopy, are nowadays revolutionizing the way protein-membrane interplay is stud-
ied, but still cannot provide a detailed description of the molecular events that govern it. This
has spearheaded the emergence of integrative modeling techniques that blend information
from various experimental sources with theoretical and computational descriptions of the
underlying biophysics into structural models.
Lipid metabolism and transport rely on proteins that operate at the membrane-water
barrier and have dynamic interactions with membranes, lipids, and other proteins. In this
thesis, we elaborate on the use of combined computational and experimental approaches to
reveal structure-function relationships of membrane proteins and their close interplay with
their respective membrane environments. How this integrative approach helps gaining robust
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insights into the function of membrane-associated protein systems is illustrated through the
interrogation of two poorly characterized membrane-associated proteins, namely coenzyme
Q (CoQ) biosynthesis proteins COQ8 and COQ9.
In mitochondria, CoQ precursors are likely buried between the leaflets of the inner
mitochondrial membrane due to their extreme hydrophobicity. In Chapter 3 of this thesis,
the computational analysis regarding COQ8 helped us discover that a conserved domain
on COQ8 drives the electrostatic membrane association, where specific interactions with
cardiolipins (the signature mitochondrial lipids) are observed. A diverse array of experimental
input provided by experimental collaborators validated our computational findings, and
demonstrated that COQ8 exhibits a conserved ATPase activity that is activated by COQ8
binding to cardiolipin-containing membranes. Our findings suggest that COQ8 might sense
CoQ precursors within the membrane and then couple ATP hydrolysis to the partial extraction
of these precursors into the aqueous matrix environment where they could be modified by
CoQ biosynthesis enzymes.
The synthesis and transport of lipids in an aqueous cellular environment poses a long-
standing biological question. In Chapter 4 of this thesis, through molecular simulations, we
discovered that COQ9 uses a unique, amphipathic C-terminal helix connected to a founda-
tional ligand-binding domain to peripherally associate with membranes, and we described the
molecular mechanism of membrane interaction and cargo selection, which were confirmed
by biochemical experiments. Our simulations also revealed a striking mechanism of how
peripheral membrane proteins can lift lipids off the membrane, which helped answer the
question of how proteins overcome the topological challenge of reaching substrates located
inside the membrane. In this sense, our findings suggest that COQ9 acts as a bridge between
two worlds: positioned at the membrane-water barrier to bring hydrophobic CoQ precursors
close to the water to enable their interaction with CoQ pathway enzymes.
Overall, our results emphasize the importance of membrane composition, and the
effects of protein interaction on membrane dynamics. Our work also highlights how the
combination of experimental and computational techniques provides a unique and valu-
able perspective that neither of them could have provided alone. A full integration of these
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techniques is the key to open the doors to a detailed understanding of protein-membrane
interplay, which still remains elusive for many systems nowadays despite its pharmacological
and biological relevance. The work presented in this thesis may therefore serve as a model
for investigating other biosynthesis pathways, or other peripheral membrane proteins whose
analyses involve similar challenges.
The most immediate follow-up study on this work is the structural determination
of the COQ9:COQ7 complex, and visualization of the liposome-bound COQ proteins and
protein complexes through cryo-EM studies. We already initiated an effort in this area through
our experimental collaborators, and believe that these findings would pave the way for new
hypotheses that would be investigated through molecular modeling and simulations. Another
interesting idea that we would like to pursue is the effect of membrane curvature on the
membrane binding and activity of the COQ proteins, as these proteins are located on the
highly curved inner mitochondrial membrane. Membrane curvature can be induced by using
different cardiolipin concentrations on the two leaflets of a finite (noncontinuous) membrane
patch in coarse-grained MD simulations. The local curvature in the simulations can be
quantified, and liposome co-flotation assays can be performed with matching curvatures,
using liposomes of different sizes dictating their curvature.
These studies will also stimulate new work on approaching the remaining knowledge
gaps on the biosynthesis of CoQ and the CoQ synthome. What is the three-dimensional
structure of the CoQ synthome? Does it interact with any of the mitochondrial respiratory
chain complexes? How are the hydrophobic CoQ and its intermediates transported within the
membrane and also to other organelles? As the known functions of CoQ in human health and
disease expand, filling these gaps through a full integration of experimental and computational
techniques will help understand mitochondrial diseases, and will guide treatment strategies.
101

A Using Energy Grids to Constrain the
Search Space of Small Molecules
During Docking
This Chapter presents a study related to the methods used in this thesis. The Chapter is
formatted as the following manuscript to be submitted for publication:
“Using Energy Grids to Constrain the Search Space of Small Molecules During Docking."
Tamò G*, Aydin D*, Träger S, Dal Peraro M. (*Contributed Equally)
Molecular docking is a foundational tool used in structure-based drug design to predict
the preferred binding mode of a ligand in the binding site of a protein. Docking protocols
generally use a scoring function to estimate the binding affinity of the ligand, which linearly
combines quantitative features describing the binding pose. The weight constants assigned to
balance the relative contribution of these features require careful and tedious computations,
hindering the addition of new feature terms inside an already established scoring function. In
this Chapter, we present a new docking procedure that makes the addition of new features
possible and effortless by switching from an unconstrained to a constrained optimization
protocol. To achieve this, the well-established AutoDock Vina scoring function is used as
objective while energy grid-based parameters are introduced as inequality constraints to
guide the assembly towards favorable areas of the optimization search space. The constrained
optimization method is applied to flexible small molecule docking and achieves a success rate
of 77% for the Astex diverse set containing 85 high-resolution protein-ligand structures.
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A.1 Introduction
The field of computer-aided drug discovery has emerged over four decades ago with the
ultimate goal of providing the most accurate predictions that would enable the cost- and
time-efficient delivery of a new drug. Molecular docking is an indispensable computational
tool that is now routinely used in structure-based drug design.183 Given the three-dimensional
structures of the unbound protein target and a database of compounds, molecular docking
programs aim to predict the most probable bound conformation of a ligand in the receptor
binding site. Practically, the molecular docking process can be decomposed into two steps:
ligand pose generation by the sampling algorithm, and ranking of the poses using a scoring
function.
To date, more than 60 molecular docking methods have been implemented, the strength
and limitations of which have been extensively reviewed in the literature.184–188 Amongst the
most popular molecular docking methods one can find AutoDock Vina,37 which is currently
one of the most cited open source docking methods in the scientific literature189, 190 with over
7,000 citations as of March 2019. Importantly, AutoDock Vina has displayed great accuracy
when tested in its ability to predict the bound conformation of ligands and their binding
free energies. To achieve such performance, it relies on a carefully calibrated global scoring
function composed of linearly added energy terms.37 Coefficients in the form of weight
constants are assigned to balance the contribution of these uncorrelated terms, which are
obtained from regression analyses by iteratively fitting the scoring function to experimentally
determined binding affinities.
One major limitation of such an approach is that, added to the costly calculation of
these weights, the regression coefficients can be heavily dependent on the dataset used to
compute them.191 More importantly, the addition of new terms to an already optimized
scoring function is nearly impossible without rebalancing their contribution. This limitation
comes from the fact that the docking problem is treated as an unconstrained single objective
optimization.
In an attempt to optimize several scoring terms without balancing them, Gu et al.191
converted the docking problem to a multi-objective optimization where multiple scoring
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functions were minimized simultaneously by a genetic algorithm. This approach was tested
against the GOLD test set and showed remarkable docking accuracies compared to other
popular molecular docking methods including GOLD,35 Glide,38 Surflex192 and Dock.193
Another way to circumvent this problem would be to use a constrained optimization
scheme, which aims at minimizing a single objective function while ensuring the satisfac-
tion of pre-defined constraints.45 Constrained optimization schemes have been applied in
various fields including medicine,194 optics,195 engineering.196 Recently, we implemented
a new constrained optimizer named mViE (memetic viability evolution)45 within our open
source optimization framework named power (parallel optimization workbench to enhance
resolution, available at http://lbm.epfl.ch/resources).42, 43 This framework was used in the in
silico prediction of macromolecular assemblies and found to successfully dock symmetric
and heterodimeric assemblies using experimental data to guide the assembly process.46 The
advantage of this optimization scheme is that it facilitates the addition of new constraints to
guide and accelerate the optimization process, without the need of rebalancing the contribu-
tion of the different components.
In the same vein, we sought to design a constrained optimization method suitable for
docking small molecules. To our knowledge, no constrained optimization application has
yet been reported to predict the docking of small molecules. The reason behind this could
be related either to the difficulty to find features to be used as constraints or to the general
complexity of the optimization problem.
In this study, we extended our previously implemented constrained optimization proto-
col power-mViE to support the docking of small molecules. We inherited the accurate scoring
function of AutoDock Vina37 as an objective function, and introduced inequality constraints
in the form of receptor-ligand physicochemical properties, extracted from energy grids, which
were used to guide the ligand docking. In order to test and validate the method, we used
high-resolution receptor-ligand complexes of the PDBbind core set48 to extract and calibrate
the constraints, and the Astex diverse set47 as the validation set. For rigid and flexible docking
settings, our constrained molecular docking approach showed accuracies comparable to that
of state-of-the-art software including the AutoDock Vina program. We envision that the use of
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constraints extracted from energy grids would be critical for docking ligands more accurately
when also the native dynamics of the target protein is considered during docking, for instance,
as accounted for in molecular dynamics simulations.
A.2 Methods
Our constrained molecular docking protocol requires as input the atomistic structures of both
the receptor and the ligand (Figure A.1). From these structures, atom types are assigned based
on the X-Score nomenclature.37, 39 Then, local and global constraints that assist the docking
are computed from atom-type-based pre-computed energy grid maps, using the procedure
outlined in this section. These local and global constraints are simultaneously used during
optimization to guide the docking of the ligand into favorable regions of the receptor binding
site. In order to quantify the binding free energy of the poses during docking, the scoring
function inherited from AutoDock Vina is minimized. At the end of the optimization, the best
receptor-ligand pose, i.e. the pose with the lowest energy which satisfies all the constraints, is
returned.
A.2.1 The Constrained Optimization Strategy
The constrained optimization procedure that minimizes the energy function while satisfying
the constraints was encoded within the power-mViE framework (available at http://lbm.epfl.ch/
resources)42, 43, 46 coupled with the constrained optimizer mViE.45
Briefly, mViE advances a population of solutions based on (1+1)-CMAES strategy to
locally explore the search space and recombines these local units using a differential evolu-
tion operator to perform a global search.45 In this context, mViE attempts to find candidate
solutions that satisfy pre-defined inequality constraints using the concept of viability evolu-
tion,44, 45 which is an abstraction of artificial evolution and aims at selecting the promising
candidate solution by adapting boundaries, termed “viability boundaries”, set around the
inequality constraints. Initially relaxed around the constraints, these viability boundaries are
gradually tightened during optimization. Only the solutions not violating these boundaries
are termed “viable” and are selected for next iterations. This has the effect of gradually driving
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Figure A.1 – Constrained Ligand Docking Workflow. The power-mViE molecular docking method
takes as input the structures of the receptor and the ligand, and a docking box used to define a particular
binding site. Atom types are assigned to both receptor and ligand structures based on the X-Score
nomenclature using MGLTools (http://mgltools.scripps.edu/). Then, grid maps recapitulating the
energy of interaction between each ligand atom type and receptor atoms are computed and constraints
used to guide the ligand docking into favorable regions of the binding site are extracted. A constrained
optimization is then run with the aim of minimizing an objective function estimating binding energy
similar to that of AutoDock Vina, while ensuring the satisfaction of the constraints computed in the
previous step. At the end of the optimization run, the receptor-ligand complex associated with the
lowest estimated binding energy that satisfies all the constraints is returned.
the solutions towards “feasible” areas of the search space where the constraints are satisfied
and the objective is minimal.44 The minute workings of mViE can be found in the work of
Maesani et al.45 and thus will not be discussed further in this work.
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A.2.2 General Formulation of the Docking Problem
In the context of molecular docking, power-mViE was used to sample the position, orientation
and flexibility of the ligand encoded in a vector of design variables X = [x, y, z,α,β,γ,ens],
where x, y and z correspond to the three translations, α, β and γ to the three Eulerian angles
defining the ligand orientation and ens the ligand conformational ensemble generated by
sampling torsional angles of the ligand rotatable bonds, in order to solve the docking problem
generally formulated as:
min f (X ), s.t.
 li ≤ Xi ≤ ui , i = 1,2, ...,ng j (X ) ≤ 0, j = 1,2, ...,m (A.1)
where f (X ) is the objective function to be minimized, li and ui the lower and upper boundary
ranges defining the search space of the variable Xi , and g j (X ) the inequality constraints
defined on each solution X .
A.2.3 The Objective Function
The objective function featured in AutoDock Vina37 was integrated in the new power-mViE
molecular docking method due its proven robustness, and detailed description. Given the
atomistic pair-wise interaction term di j = ri j −Rt i −Rt j , where ri j is the measured Euclidian
distance between the i th and j th atoms and Rt the van der Waals radius of these atoms of type
t , the objective function f (X ) is defined as:
AutoDockV i na f (X )=

w1 ·Gauss1 +
w2 ·Gauss2 +
w3 · Repul si on +
w4 · H ydr ophobi c +
w5 · H ydr og enBond s
(A.2)
where
Gauss1(d)= e−
(
d
0.5
)2
(A.3)
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Gauss2(d)= e
−
(
(d−3)
2
)2
(A.4)
Repul si on(d)=
 d
2, if d < 0
0, if d ≥ 0
(A.5)
H ydr ophobi c(d)=

1, if d < 0.5
1.5 −d , if 0.5 < d < 1.5
0, if d > 1.5
(A.6)
H ydr og enBond s(d)=

1, if d <−0.7
− d−0.7 , if −0.7 < d < 0
0, if d > 0
(A.7)
In the AutoDock Vina scoring function (eq. 2), the steric terms from eq. 3, eq. 4 and eq.
5 essentially reproduce the attractive and repulsive parts found in a standard Lennard-Jones
potential and are applied to every atom irrespective of their type. Instead, the hydrophobic
term depicted in eq. 6 is applicable only when both atoms involved in the interaction are
hydrophobic. Similarly, in eq. 7, the hydrogen bonding term is only applied whenever one
of the atoms participating in the interaction is a hydrogen bond acceptor and the other a
hydrogen bond donor. The coefficients w1, w2, w3, w4, w5 were calibrated respectively at
-0.0356, -0.00516, 0.840, -0.0351 and -0.587 in the original study by Trott and Olson37 to balance
the contribution of the steric terms.
The choice for the AutoDock Vina energy function as the objective function imple-
mented in power-mViE was based on the fact it was open-source, well-documented and
showed remarkable results when integrated into other molecular docking programs.191, 197, 198
Nevertheless, given the flexibility of the power-mViE protocol, in principle any objective
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function can integrated or developed.
A.2.4 Constraint Terms
In the power-mViE protocol, the information encoded in the physicochemical interactions
between the receptor and the ligand is used as constraints to guide the docking procedure.
Precisely, inequality constraints indicating the ideal ligand position and conformation inside
the binding site are extracted as spatial distances from pre-computed grid maps of interaction
energies for different atom types (Figure A.1).
Grid maps have been used previously to speed up the energy calculation by pre-
computing the interaction energies between the ligand and the receptor.199–201 They have also
been used to detect the location of the binding pocket.202, 203 In this work, the pre-computed
grid maps were not used to accelerate the receptor-ligand energy calculation nor to find
potential binding sites. Instead, for the first time, they were used to derive a set of local and
global constraints to guide the docking process.
Assuming the knowledge of the receptor binding site location, a cubic lattice is first
generated at that location with evenly spaced voxels (Figure A.2, panel 1). Voxels found at a
Euclidian distance too close to any receptor atom are removed, therefore leaving only non-
overlapping voxels (Figure A.2, panel 1), from which two types of constraints are extracted:
local and global (Figure A.2, panel 2).
From the atomistic structure of the ligand, atom types are defined based on the X-Score
nomenclature39 and include five atom types: hydrophobic (H), hydrogen bond acceptor (A),
hydrogen bond donor (D), polar (P) and metal (M). Probes, each with the property of the
ligand atom types, are iterated over each non-overlapping voxel, and the energy of interaction
between the atom-type-probe and the receptor atoms is evaluated using eq. 2 (Figure A.2,
panel a).
The non-overlapping voxels associated with the lowest interaction energies are ex-
tracted and then subjected to clustering. The resulting cluster centroids are then used in the
form of local inequality constraints of the type Local Anchor Di st j ≤ Ldi st( j = 1,2, . . . ,m)
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where the Local Anchor Di st is the smallest Euclidian distance measured between one of the
ligand atom and a centroid with a similar atom type, for all the atom types m of the ligand,
and Ldi st is a cutoff distance expressed in angstroms (Å) (Figure A.2, panel b). These local
constraints assist the docking procedure by locally anchoring the ligand atoms to predicted
grid points of the same atom type (Figure A.2, panel 3). Local constraints are considered satis-
fied whenever at least one ligand atom of each atom type is found below the cutoff distance
Ldi st of any anchoring centroid with the same atom type (Figure A.2, panel 3).
Global constraints are computed by combining the lowest energy voxels based on their
3D coordinates to form a cloud of grid points located inside the binding site (Figure A.2, panel
c). The global constraint is used as a global anchor during docking through the introduction
of spatial distances that constrain the ligand inside the binding site where the energies are
minimal (Figure A.2, panel 3). Practically, this is done with the global inequality constraint
Gl obal Anchor Di st ≤ Gdi st , where the Gl obal Anchor Di st is the average Euclidian dis-
tance computed from all ligand atoms and their respective nearest voxels located in the cloud
of grid points, and Gdi st the cutoff distance in angstroms (Å) below which the constraint is
considered satisfied.
This leads us to the formal definition of the molecular docking problem as:
min AutoDockV i na f (X ), s.t.

li ≤ Xi ≤ ui , i = 1,2, ...,n
Local Anchor Di st j ≤ Ldi st , j = 1,2, ...,m
Gl obal Anchor Di st ≤Gdi st
(A.8)
A.2.5 Training the Energy Grid Map Parameters To Obtain Optimal Constraints
The cutoff distance values associated with Ldi st and Gdi st were determinant for the quality
of the local and global constraints as defined in eq. 8 because cutoff distances that are too
high would not be specific enough to constrain the ligand in a desirable area of the binding
site, and conversely cutoff values that are too low might be too specific and be satisfied only
by a subset of receptor-ligand complexes. In turn, the values of Ldi st were dependent on the
parameter values related to the construction and extraction of grid voxels.
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Figure A.2 – Constraint Generation from Energy Grid Maps. (1.) A cubic lattice is generated at the
location of the receptor binding site. Voxels found too close to the receptor atoms are removed, leaving
non-overlapping voxels in the lattice. (2.) For each atom type, the interaction energy between the
lattice and the receptor atoms is computed by eq. A.2. Voxels are then ranked based on their interaction
energy. The lowest energy voxels are extracted and used in two different ways (a-b). (b.) After clustering,
the cluster centers are used as local constraints during docking by acting as docking anchors. (c.)
Alternatively, the lowest-energy voxels for each atom type are combined based on their coordinates to
create a spatial envelope used as the global constraint. (4.) The ligand is docked to the binding site
by minimizing the objective function estimating the binding energy (eq. A.2) while simultaneously
satisfying the global and local constraints. For the global constraint satisfaction, the ligand is spatially
constrained into the cloud of voxels. Instead, for the local constraint, each ligand atom is spatially
anchored to the voxel of the same atom type (same color in figure).112
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Thus, a comprehensive training benchmark was undertaken to find a set of grid pa-
rameter values that minimized Ldi st and Gdi st whilst ensuring they were satisfied in most
receptor-ligand complexes. A simple combinatorial approach was performed to find the
optimal grid parameter values, which were: the distance cutoff that defined an overlap be-
tween grid voxels and receptor atom, the number of low-energy voxels used to compute the
constraints, and the distance separating each voxel of the grid map. Precisely, we combined
values ranging from 2.6 to 3.3 Å for the distance cutoff defining an overlap between grid voxels
and receptor atom, values ranging from 500 to 2000 voxels for the number of low-energy voxels
recorded; and values ranging from 0.375 Å to 1.5 Å defining the voxel spacing37, 199, 200 of the
grid map.
For this benchmark, the PDBbind core set48 containing 195 high-resolution receptor-
ligand complexes was used as the training set. For each combination of these three pa-
rameter values, a grid map was generated on bound receptor-ligand complexes, the value
of Local Anchor Di st and Gl obal Anchor Di st were recorded and a rigid docking was per-
formed to evaluate the quality of the constraints. The cloud of voxels defining the global
constraint required a voxel spacing of 0.375 Å, a cutoff distance defining an overlap between
voxel and receptor atoms of 2.8 Å and fixed number 500 low-energy voxels to be combined
based on their 3D coordinates, for each atom type. In this respect, Gdi st was calibrated at 1.5
Å. Conversely, the extraction of the centroid voxels defining the local constraints required a
voxel spacing of 1.0 Å, a cutoff distance defining an overlap between voxel and receptor atoms
of 3.0 Å and fixed number 600 low-energy voxels to be clustered, for each atom type. In this
case, the cutoff distance Ldi st , applied to all atom type voxels, was calibrated at 2.0 Å.
A.2.6 Step-by-Step Docking Protocol
As a first assessment and in effort to validate the improvement provided by the constraints,
docking was performed on the training set (PDBbind core set48) considering both the ligand
and the receptor as rigid structures. In this case, the location of the binding site was known.
Only the binding pocket residues (protein residues within 10 Å from the ligand center of mass)
were used as the receptor instead of the whole protein to speed up the calculation. In order to
simulate a realistic docking case, the geometric center of the binding site (represented by the
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center of mass of the bound ligand) was randomized. The ligand was then removed and its
orientation and position were randomized. For both the ligand and the receptor, atom types
were assigned using the MGLTools (available at http://mgltools.scripps.edu/). The boundaries
delimiting the ligand search space were represented as a cubic box of 23 Å side length, with
a center corresponding to the randomized binding site geometric center. For comparative
purposes, the number of function evaluations attributed to each receptor-ligand docking
was consistent between docking methods and approximated the number function evaluation
attributed to a standard rigid docking performed by AutoDock Vina, which was set to 120,000
function evaluations.
A second, more unbiased and exhaustive, round of assessment was undertaken on
the Astex diverse set,47 which contained 85 docking cases of high-resolution receptor-ligand
complexes. As the grid parameters and constraints were not trained on this set, it served
as the basis for an unbiased test. Moreover, unlike the previous assessment where both the
ligand and the receptor were treated as rigid bodies, here the flexibility of the ligand was
included in the search space in the form of a conformational ensemble. To account for the
larger search space, the side length of the cubic box defining the search space and the number
of function evaluations were increased to 25 Å and 200,000 respectively. Eventually for all
optimization methods, the time required to compute a docking on a single-threaded execution
(For AutoDock Vina: AutoDock Vina parameter –cpu 1) was recorded on a Xeon E3-1200 3.6
GHz processor.
A.2.7 Generation of the Ligand Conformational Ensemble
Here, the flexibility of the ligand was generated in isolation from the target binding site and
added to the ligand search space during optimization. To address this task, we implemented a
systematic rotatable bond sampler to generate ligand conformers.
The aim of the suggested implementation was to systematically generate all possible
favorable energy conformations of the ligand and eventually add this ensemble of poses,
treated as a conformational database, to the optimization search space. Specifically, for a
given ligand, the number of active rotatable bonds was extracted using the MGLTools. Then,
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discrete angle increments of 120° were performed for each rotatable bond. In order to filter
out physically implausible ligand conformations, the internal ligand energy was computed on
each atom pair separated by at least 3 covalent bonds (1-4 Lennard-Jones contributions) using
a simple 12-6 Lennard-Jones potential, at each step of the permutation. In this case, ligand
conformers with energies > 0.0 kcal/mol were not included in the conformational ensemble.
The conformers were added as an extra dimension in the optimization space and used for the
assessment of the Astex diverse set.
A.2.8 Metrics to Evaluate Accuracy
At end of the docking protocol, the accuracy of the docking was evaluated. For each receptor-
ligand complex, the docked ligand pose associated with the lowest interaction energy (rank1)
was extracted. In the case of power-mViE, an additional selection criterion was that the best
pose should also satisfy all the pre-defined constraints of equation (8). The position and
conformation of the rank1 ligand pose were compared to that of the original crystal structure
using the standard structural similarity metric RMSD =
√
1
N
∑N
i=1δ
2
i , where averaging is done
over the N pairs of equivalent heavy atoms and δi is the distance between the two atoms in the
i -th pair. A docking was considered successful if the structure of the docked ligand was < 2.0 Å
from the original crystal structure. Eventually, a success rate was issued by simply dividing
the number of successful docking cases over all docking cases. This standard evaluation
protocol has been used in several studies37, 187, 199, 204 in order to benchmark and validate
newly developed protein-small molecule docking methods.
A.3 Results and Discussion
Given a receptor molecule that is held fixed in space, and a ligand that is moved around the
receptor, our docking protocol power-mViE attempts to minimize a scoring function describing
the quality of candidate poses by sampling the rotation, orientation and conformation of the
ligand, while simultaneously satisfying pre-defined local and global constraints describing the
ideal position of the ligand inside the binding site (see Methods). Briefly, these local and global
constraints aim to anchor and restrain the ligand to desirable regions of the search space, and
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are extracted from atom-type-specific energy grid maps. The local constraints consist of voxel
centroids extracted by clustering the lowest energy voxels according to their atom types, and
the global constraint is obtained by combining the coordinates of the lowest energy voxels into
one global cloud of grid voxels. Local constraints are considered satisfied whenever at least
one ligand atom of each atom type is found below a cutoff distance Ldi st from any anchor of
the same atom type. The satisfaction of global constraints is computed by making sure the
average distance between all ligand atoms and their nearest cloud voxel is smaller than the
global cutoff value Gdi st .
A.3.1 Constrained Rigid and Flexible Docking
The optimal set of parameters was obtained through an exhaustive rigid docking benchmark
on the PDBbind core set consisting in 195 receptor-ligand complexes where the docking accu-
racy (86.7%) was on par with the accuracy obtained with AutoDock Vina (84.6%). Noteworthy,
the AutoDock Vina docking program was trained on receptor-ligand complexes from the
PDBbind refined set.37
The constrained molecular docking approach was further extended to flexibly dock
ligands inside their respective binding sites. In this case, the receptor was still kept rigid while
ligand flexibility was sampled. We tested this approach on the Astex diverse set,47 which
contains 85 high-resolution receptor-ligand complex structures. In the previously described
rigid docking benchmark, a single randomly chosen binding site geometric center was used
to train the grid parameter values and the constraint cutoff values Ldi st and Gdi st . In order
to ensure that the benchmark is not biased towards these specific geometric centers, and
to assess how the location of the geometric center affected the outcome of the power-mViE
molecular docking, 5 different sets of the 85 complexes were created, each with different
binding site geometric centers. For each of the 5 sets, geometric centers were randomized
from the ligand center of mass with continuous values within ± 2.0 Å in the x, y and z plane.
For each of the 5 sets, 5 trials were performed to increase the statistics, giving a total of 25 x 85
docking trials. The Ldi st , Gdi st and grid parameters were the same as those extracted from
the rigid docking benchmark.
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Ligand flexibility was encoded as a pre-generated ensemble of ligand conformers ob-
tained through incrementing the torsional angles in a combinatorial approach (see Methods).
This conformer ensemble was added as an extra search space dimension and contained the
crystal conformation of the ligand. The accuracy computed from this flexible docking method
was compared to the one obtained using AutoDock Vina in exactly the same conditions (i.e.
geometric center location, starting from the bound ligand structure, equal number of function
evaluations) and are shown in Table A.1.
Table A.1 – Flexible docking of the Astex diverse set and reported accuracies for power-mViE and
AutoDock Vina.
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In this evaluation, power-mViE and AutoDock Vina had similar accuracies (Table A.1).
Importantly, the location of the geometric center used to compute the constraints did not
influence the accuracy of the flexible docking (Table A.1) with an average accuracy estimated at
71.0% ± 3.2% for all the 25 docking trials. These results were found comparable with those ob-
tained using AutoDock Vina with respective geometric centers (mean accuracy: 71.8% ± 1.5%).
Notably, the maximal accuracies obtained both for AutoDock Vina (73.8%) and power-mViE
(77.4%) flexible docking protocols (Table A.1) were comparable to the AutoDock Vina accura-
cies (76.5%) described in the study by Zoete et al.204 obtained with similar conditions. Both
AutoDock Vina and power-mViE show lower accuracies in flexible docking when compared to
rigid docking. Docking accuracies from rigid-body docking methods are known to be higher
compared to flexible docking ones,186 since rigid docking problems have a smaller search
space with only six degrees of freedom consisting of three translations and three rotations.
The Astex diverse set, used to validate the method, includes 5 receptor-ligand complexes
(i.e., 1GPK, 1HNN, 1N1M, 1N2V and 1OYT) that are also present in the PDBbind core set, used
to train the grid parameters. Removing these 5 docking cases when computing the overall
accuracy did not lead to a different overall mean accuracy (70.2% ± 3.2%).
The results presented herein have to be reflected with care since the strategy to sample
ligand flexibility was different between AutoDock Vina and power-mViE. Precisely, AutoDock
Vina samples the angles of each ligand torsion during optimization, while power-mViE assigns
a structure from a pre-computed conformer ensemble by systematically incrementing each
torsional angle by 120°.37 The strategy to sample from a pre-computed set of ligand conform-
ers through a systematic search is a conceptually simpler method compared to sampling each
of the ligand torsions.184, 185 An alternative strategy includes incrementally growing the ligand
into the binding site.205 This method in particular was applied by the Dock34 and FlexX206
programs and involves iteratively docking ligand fragments into the binding site then cova-
lently linking them. Developing a similar sampling strategy for the next molecular docking
implementation of power-mViE would certainly increase the robustness of the approach by
alleviating the conformer search space.
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A.3.2 Evaluation of Successes and Failures
For each of the 84 flexible docking cases featured in the Astex diverse set, the number of
successful trials (i.e. where the best ligand pose is found at RMSD < 2.0 Å of the bound ligand)
was computed over the 25 trials. In 44 receptor-ligand docking cases, both AutoDock Vina
and power-mViE consistently found the native ligand binding mode with success rates ≥ 76%
(20/25 trials).
Conversely, in 10 docking cases which comprises complexes 1GM8, 1HVY, 1JD0, 1JJE,
1Q41, 1R58, 1SQ5, 1TZ8, 1W1P and 1UVF, neither AutoDock Vina nor power-mViE could
consistently find the ligand binding mode as found in the native receptor-ligand complex
(success rates ≤ 20%, 5/25 trials). Upon visual inspection of the receptor-ligand complex
structures and searching through the literature, it appeared that some of these cases were in
fact “usual suspects” previously labeled as difficult docking cases.199, 204 The reason behind
such difficulty lies in the presence of explicit water molecules mediating critical receptor-
ligand hydrogen bonding interactions in the native complex structure, which are removed
prior to docking. This was attributed as the root cause for the docking failures of 1GM8, 1HVY,
1JD0, 1SQ5 and 1W1P. Another reason for failure is due to the ligand interaction with metal
ions as in complexes 1JD0 or 1JJE. The reason for the failure of other docking cases could
not be detected through the visual inspection of the complex crystal structure and thus was
attributed to limitations in the scoring function accuracy.
More interesting docking cases consisted of those where AutoDock Vina and power-
mViE showed conflicting success rates. For complexes 1MMV and 1UML in particular (Figure
A.3A), AutoDock Vina succeeded with a rate of 100% in 25 trials, while power-mViE showed
a success rate of ≤ 20% (5/25 trials). Visual inspection of the native complex structures did
not reveal the presence of water molecules or metal ions mediating the interactions between
the ligand and receptors. In order to check whether the local and global constraints may have
wrongly anchored the ligand into undesirable areas of the binding site, we computed the local
and global constraint satisfaction as well as the energy score, according to eq. 2, for the best
(lowest estimated binding energy) receptor-ligand poses returned by AutoDock and power-
mViE. Such analysis showed that both the correctly docked lowest-energy poses computed
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by AutoDock Vina and the wrongly docked best poses of power-mViE were found to satisfy
the local and global constraints. However, the lowest energies recorded for the best poses of
1MMV (-10.9 kcal/mol) and 1UML (-16.3 kcal/mol) returned by AutoDock Vina were lower
than the ones computed on the crystal structures of 1MMV (-9.6 kcal/mol) and 1UML (-14.9
kcal/mol) respectively, which in turn were lower than the best pose computed by power-mViE
(1MMV: -8.67 kcal/mol, 1UML: -11.7 kcal/mol). This showed in these two cases that while the
constraints were satisfied in the best poses returned by both power-mViE and AutoDock Vina,
failure to compute better poses by power-mViE was probably due to the fact that it was unable
to overcome a local energy minimum. A possible solution to better find the correct binding
pose could be either to increase the number of function evaluations for these two cases or
refine the constraints further so as to more precisely anchor the ligand into the binding site.
Conversely, power-mViE correctly docked the ligand of complexes 1MEH, 1N2V, 1R55
with success rates of ≥ 84% (21/25 trials) while AutoDock Vina consistently failed to find the
native binding mode (0% success rate) for these complexes. Interestingly, visual inspection of
these complexes revealed that both 1MEH and 1N2V contained water molecules, and 1R55
a Zn ion bridging the interaction between the ligand and the receptor. These have been
previously noted as being particularly difficult docking cases.199, 204 Comparisons between the
estimated binding energy associated with the power-mViE best poses (1MEH: -10.2 kcal/mol,
1N2V: -8.4 kcal/mol, 1R55: -9.3 kcal/mol), the energies from the best AutoDock Vina poses
(1MEH: -10.4 kcal/mol, 1N2V: -8.6 kcal/mol, 1R55: -10.2 kcal/mol) and crystal structures
(1MEH: -9.7 kcal/mol, 1N2V: -8.0 kcal/mol, 1R55: -8.0 kcal/mol) indicated that both power-
mViE and AutoDock Vina found lower energies than that of the complex structure. Moreover,
the local and global constraints were satisfied in the best poses returned by both power-mViE
and AutoDock Vina, and in the crystal structures. Thus, we suggest that the reason for the
success of power-mViE in this case might be due to a combined effect of constraints anchoring
the ligand to a suitable region of the binding mode and to the coarse angular step of 120° which
might have prevented the ligand to adopt a conformation leading to a non-native binding
mode.
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Figure A.3 – Docking Success and Failures of power-mViE and AutoDock Vina. (A) Comparison of
the crystal structure and the best ligand poses returned by the power-mViE and AutoDock Vina for
1UML (left panel) and associated local and global constraints satisfaction (right panel). (B) Comparison
of the crystal structure and the best ligand poses returned by the power-mViE and AutoDock Vina
for 1YWR (left panel) and associated local and global constraints satisfaction (right panel). For the
representation of constraint satisfaction for both 1UML and 1YWR (right panels), the white cloud
surface represents the global constraint, the full blue circles represent the satisfied local polar centroids
(Ldi st < 2 Å), which are located close to polar ligand atoms also colored in blue, and the empty white
circles represent unsatisfied local polar centroids.
The docking cases of 1YWR (power-mViE: 72%, AutoDock Vina: 0%) and 1G9V (power-
mViE: 52%, AutoDock Vina: 0%) were found to also be worth mentioning since they illustrated
how the use of constraints helped find the correct binding mode of the ligand. Visual inspec-
tion of the 1YWR crystal structure did not reveal the presence of water molecules or metal
ions inside the binding site. Evaluating the level of constraint satisfaction on the best poses
returned by AutoDock Vina over the 25 trials showed that a local constraint specifying the
minimum distance between a polar centroid voxel and a polar atom of the ligand was always
> 2.0 Å, which is above the Ldi st cutoff value, and thus violates that local constraint (Figure
A.3B). Unlike the best AutoDock Vina poses, both the crystal structure 1YWR and the best
power-mViE poses were found to satisfy all the local and global constraints. Additionally,
the estimated binding energy associated with the best pose returned by power-mViE (-13.7
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kcal/mol) was lower than the ones of the crystal structure (-12.4 kcal/mol), which was in turn
lower than the best AutoDock Vina pose (-12.0 kcal/mol). This remarkable example served as
a showcase illustrating how the use of constraints by power-mViE was useful in anchoring the
ligand in favorable regions of the binding site where the minimal binding energy was found,
leading to a pose resembling that of the native binding mode.
Anecdotic cases like those of 1MEH, 1N2V, 1R55, and particularly 1YWR put forward
the usefulness of using pre-computed constraints to assist the docking of ligands inside
their binding site. Noteworthy, 1MEH and 1N2V featured water-mediated ligand-receptor
interactions and 1R55 contained Zn ions in the binding site. Such cases are considered difficult
to solve. Nevertheless, similar water- and metal ion-mediated docking cases such as 1GM8,
1HVY, 1JD0, 1JJE, 1Q41, 1R58, 1SQ5, 1TZ8, 1W1P and 1UVF still remain elusive to most small
molecule docking algorithms including power-mViE and AutoDock Vina. If present in the
receptor crystal structure, a suggested strategy to improve the docking performance is to keep
and optimize the orientation and position of the water hydrogen atoms, using specific energy
minimizations.207, 208 If not present in the receptor crystal structure, water molecules can
be added to the binding site using grid-based or molecular dynamics simulations and can
be selected based on their energetic stability for docking.209 The presence of metal ions can
hinder the performance of molecular docking programs because it may affect the hydration
and protonation states of charged residues,210 which are factors still difficult to predict using
available methods as they often require more expensive calculations at the quantum level.211
A.4 Conclusions
In the work presented here, we applied the principles of constrained optimization to assist the
docking of small molecules inside the binding site of their respective targets. Precisely, local
and global constraints were extracted from pre-computed energy grid maps at the location of
the binding site. These constraints were essentially used during docking to anchor ligands
inside desirable binding site areas by constraining their global position inside low-energy
areas, and by locally matching ligand atoms to areas favoring their associated atom types.
Using power-mViE on a constrained rigid docking setting, we combined these local
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and global constraints together with the AutoDock Vina scoring function and witnessed an
almost fourfold improvement in docking accuracy compared to a rigid docking setting where
an unconstrained optimization was performed. Moreover, in a flexible docking setting, we
obtained accuracies comparable to state-of-the-art small molecule docking methods.
Despite the encouraging results obtained in this work, we suggest necessary improve-
ments for the future implementation of the method. To increase the robustness of our ligand
conformer sampling approach, we suggest a sampling method similar to Dock34 and FlexX206
programs, which consists in first dividing the ligand into fragments and then individually
docking the fragments by respecting their covalent bonding.
Similar to other small molecule docking methods,199, 204 we faced difficulties in docking
cases where water or metal ions were mediating the interaction between the ligand and
the receptor. A suggested approach to improve docking accuracies when water mediates
ligand-receptor interactions could be to first to refine the hydrogen atom positions of the
water molecules found in the complex crystal structure, then to use these waters as a part
of the receptor structure during docking.207, 208 When not present in the complex crystal
structure, water molecules can be added using molecular dynamics-based techniques, which
assess their relative positional retention inside the binding site.209 As for docking cases where
protein-ligand interactions are mediated through a metal ion, more refined techniques are
suggested which include calculation at the quantum level.211
Finally, we envision this approach to be advantageous in more difficult, but more real-
istic docking cases such as those where both the ligand and receptor flexibility are sampled
during optimization. Instead of using a single receptor conformation, the inclusion of recep-
tor flexibility in small molecule docking holds promise for increasing docking accuracy and
capturing a better physical representation of the ligand-receptor interactions.190, 212 In the
best-case scenario, receptor flexibility can be accounted for by including different experimen-
tally solved structures of the protein target in the docking process, determined for instance via
X-ray crystallography or NMR. However in more realistic docking cases where only a single
conformation of the receptor is available, receptor flexibility can be sampled using in silico
methods. A popular way to treat receptor flexibility using in silico methods consists in using
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amino-acid side-chain rotamer libraries,205 which locally samples the binding site flexibility
based on experimentally observed amino-acid side-chain conformations. This approach
however has limited use in docking cases where the binding site is expected to undergo sub-
stantial backbone conformational change in order to accommodate the ligand,184 e.g. in
loopforming active sites213 or cryptic pockets.214 For such flexible cases, more expensive
techniques, including molecular dynamics simulations, can be used on the receptor in its
apo form to generate different snapshots of binding site conformations. This ensemble of
binding site conformations can be used directly during docking, as in ICM (4D docking)33, 215
and is expected to provide not only significant enrichment in virtual screening but also more
chemically diverse hits.
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Oral Presentations in International Conferences
2019 AydinD. “Overcoming theHydrophobic Barrier of theMembrane: A Lipid-Binding Protein Promotes
Coenzyme Q Biosynthesis.”
The American Chemical Society (ACS) National Meeting, Orlando, FL, USA, March 31 - April 4.
Division of Biological Chemistry Travel Award Winning Abstract.
2019 AydinD. “Overcoming theHydrophobic Barrier of theMembrane: A Lipid-Binding Protein Promotes
Coenzyme Q Biosynthesis.”
CECAMMeeting on Multiscale Modeling, EPFL, Switzerland, February 4 - 6.
2018 Aydin D. “Isoprene andMembrane Binding Capabilities of COQ9 in Coenzyme Q Biosynthesis.”
The Young Scientist Symposium, Bordeaux, France, May 4 - 5.
2017 AydinD. “An Integrative Approach to StudyMembrane Proteins, andNewOptimization Strategies for
Computational Drug Design.”
Invited talk at Stanford University, CA, USA, July 3.
2017 Aydin D. “An Integrated Computational and Experimental Study to Investigate the Role of COQ8 in
Promoting Coenzyme Q Biosynthesis.”
Gordon Research Seminar: Proteins, Holderness, NH, USA, June 17-18.
Participated as part of the SNSF Doctoral Mobility Fellowship.
2017 Aydin D. “An Integrated Computational and Experimental Study to Investigate the Role of COQ8 in
Promoting Coenzyme Q Biosynthesis.”
Lightning talk in Gordon Research Conference: Proteins, Holderness, NH, USA, June 18-23.
Participated as part of the SNSF Doctoral Mobility Fellowship.
Poster Presentations in International Conferences
2018 Aydin D, Lohman DC, Pagliarini DJ, Dal Peraro M. “An Integrated Computational and Experimental
Study to Investigate the Role of COQ9 in Promoting CoQ Biosynthesis.”
The Biophysical Society (BPS) Annual Meeting, San Francisco, CA, USA, February 17-21.
Best Poster Presentation and Student Research Achievement Award in Membrane Structure & Assembly.
International Travel Award Winning Abstract.
2017 Aydin D, Reidenbach AG, Pagliarini DJ, Dal Peraro M. “An Integrated Computational and
Experimental Study to Investigate the Role of COQ8 in Promoting CoQ Biosynthesis.”
Computational Advances in Drug Discovery, EPFL, Switzerland, September 5-8.
2017 Aydin D, Reidenbach AG, Pagliarini DJ, Dal Peraro M. “An Integrated Computational and
Experimental Study to Investigate the Role of COQ8 in Promoting CoQ Biosynthesis.”
Gordon Research Conference: Proteins, Holderness, NH, USA, June 18-23.
Participated as part of the SNSF Doctoral Mobility Fellowship.
2016 Aydin D, Dal Peraro M. “Unraveling the Interaction Surface of COQ8A Kinase with Inner
Mitochondrial Membrane.”
The Biophysical Society (BPS) Thematic Meeting on Liposomes, Exosomes, and Virosomes, Ascona,
Switzerland, September 11-16.
2016 Aydin D, Reidenbach AG, Pagliarini DJ, Dal Peraro M. “Unraveling the Interaction Surface of COQ8A
Kinase with Inner Mitochondrial Membrane.”
Swiss Institute of Bioinformatics (SIB) Days, Biel/Bienne, Switzerland, June 7-8.
2015 Aydin D, Marcaida MJ, Dal Peraro M. “Atomistic Molecular Dynamics Study of 4-Thiazolidinone
Compounds Bound to Aurora-A Kinase.”
Computational Advances in Drug Discovery, EPFL, Switzerland, September 22-25.
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Supervision of Students
06/2018 - 07/2018 Bachelor’s internship project, Yildiz Aydin, EPFL.
“Atomistic molecular dynamics simulations to probe protein-protein interactions.”
Supervised the parametrization of a large dataset for the initial phase of a Swiss National
Supercomputing Centre (CSCS) funded project.
03/2016 - 01/2017 Master’s internship project, Alexander Lorkowski, EPFL.
“Comparative molecular dynamics simulations of atypical kinase COQ8 structures.”
Supervised the comparative analysis of ATP- and ADP-bound, and unbound states of COQ8 to
understand how ligand binding aﬀects the conformational dynamics.
09/2015 - 02/2016 Master’s internship project, Helena Vincentelli, EPFL.
“Structural analysis and ligand binding capabilities of COQ8 and kinase-like UbiB proteins.”
Supervised the investigation of small-molecule binding capabilities anddimerizationmechanism
of COQ8 and homologues.
Teaching Activities
Spring 2016 & Graduate Biomolecular Structure andMechanics, EPFL
Spring 2015 Developed exercises andprojects; corrected assignments; assisted students for the practical sessions
on computational structural biology; and supervised students for their semester project and
presentation.
Spring 2016 Undergraduate Global Issues: Health, EPFL
Proposed and assigned major global health issues to ﬁve groups of students; and supervised the
preparation of their semester project and ﬁnal poster presentation.
Fall 2015 Graduate Scientiﬁc Literature Analysis in Bioengineering, EPFL
Proposed and assigned controversial, retracted articles to a group of students; and supervised the
critical analysis of the scientiﬁc literature and the preparation of an oral presentation.
Spring 2015 Undergraduate Physical Biology of the Cell II, EPFL
Developed weekly exercises and assisted students for the practical sessions.
Spring 2014 Undergraduate General Chemistry Lab, Koç University
Developed weekly quizzes; graded quizzes and lab reports; and taught lab sessions.
Fall 2013 Graduate StatisticalThermodynamics, Koç University
Developed and graded weekly exercises; and taught practical sessions.
Spring 2013 Undergraduate Introduction to Science, Koç University
Assumed full responsibility on interactive lectures and lab sessions on important scientiﬁc
discoveries, which involved designing class lectures and assignments, teaching, and grading.
Fall 2012 Undergraduate Organic Chemistry Lab, Koç University
Developed weekly quizzes; graded quizzes and lab reports; and taught lab sessions.
Skills
Languages
English (Fluent)
French (Advanced)
Turkish (Native)
Computer Skills
Molecular Dynamics Simulations: Gromacs, NAMD, AMBER, Gaussian
Molecular Docking: ICM, Schrödinger Suite (Glide)
Molecular Modeling and Visualization: PyMOL, VMD, Schrödinger Suite (Maestro)
Computing: Python, Matlab, Tcl, Shell, LaTeX
Computer Graphics: Illustrator, Photoshop
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